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Executive Summary 
Background 
The National Institute for Health and Clinical Excellence’s (NICE) 
Intrapartum Care Guidelines included a review of the relevant cost-
effectiveness literature in relation to planned place of birth and concluded 
that ‘the poor quality of the UK data on health outcomes by place of birth makes it 
extremely difficult to make meaningful comparisons across different birth settings 
at the current time. These limitations in the data mean that good evidence-based 
conclusions about the relative cost-effectiveness of different birth settings in the UK 
cannot be made…’(2007) 
Aims 
The study aim was to estimate the cost-effectiveness of births planned in 
different settings: home, FMU, AMU and OU, for women and babies at ‘low 
risk’ of complications prior to the onset of labour. As a first step in this 
process, we have assessed the cost-effectiveness of births planned in the 
different settings using individual level data collected from the Birthplace 
prospective cohort study for both the mother and the baby. A second 
report, to follow, will use a decision-analytic modelling approach to 
synthesise these data from Birthplace with published clinical, 
epidemiological and economic evidence within a cost-effectiveness 
modelling framework. 
Methods 
Economic evaluation perspective and time horizon 
The study population included all women in the Birthplace prospective 
cohort study at ‘low risk’ of complications prior to the onset of labour where 
the primary outcome and potential confounders were not missing. The 
economic evaluation was conducted from a health system perspective and 
consequently only direct costs to the NHS are included. The time horizon 
primarily mirrored the duration of follow-up of the Birthplace prospective 
cohort study, which identified women at the start of their care in labour and 
was completed when the intrapartum and related postnatal care for both 
mother and baby ended, be it at home or discharge from an FMU, AMU or 
OU. Typically, this might be anytime between a few hours or a few days 
after the birth of the baby. If higher level care following the birth was 
required for either the mother or the baby, or both, this was included. 
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Data collection 
Individual data collection forms, including relevant resource use variables, 
were designed as part of the Birthplace prospective cohort study and were 
completed by the attending midwife at the time of each woman’s labour 
episode. In addition, maternal and neonatal morbidity forms were 
completed during or after maternal or neonatal discharge from a higher 
level of care in hospital. 
‘Top-down’ costing methods were used to contribute to the estimation of a 
total cost per woman. Finance managers were contacted in each trust where 
a regional co-ordinating midwife was working for Birthplace to obtain details 
of unit overheads and costs involved in running the unit. Incomplete data 
were supplemented with costs modelled from data available from the Health 
Care Commission survey of maternity units (2007). Relevant ‘bottom up’ 
unit costs were informed by data collected from the participating Birthplace 
regional lead midwives. Staff costs for midwives and clinicians who had 
direct contact with women during their episode of labour care were 
separately attributed, as were Clinical Negligence Scheme for Trust (CNST) 
contributions. Costs were supplemented using data from secondary sources 
where necessary, and these included medication costs from the British 
National Formulary and costs for medical supplies from the NHS Supply 
Chain Catalogue. The PSSRU compendium of Unit Costs of Health and Social 
Care and the NHS reference costs provided some unit cost data for the 
study. 
Representation of cost-effectiveness 
Three sets of cost-effectiveness analyses were conducted; for the baby, the 
mother and for the outcome of ‘normal birth’. 
For the baby, cost-effectiveness was expressed in terms of incremental cost 
per adverse perinatal outcome avoided. Adverse perinatal outcome was 
defined as ‘intrapartum stillbirth, early neonatal mortality and specific 
neonatal morbidity’, which is a composite measure and was the primary 
outcome in the prospective cohort study. Additional subgroup analyses by 
parity were also undertaken for this cost-effectiveness outcome. 
For the mother, cost-effectiveness was expressed in terms of incremental 
cost per adverse maternal morbidity avoided. ‘Maternal morbidity avoided’ 
included the avoidance of at least one of the following: general anaesthetic; 
instrumental birth; caesarean section; third or fourth degree perineal 
trauma; blood transfusion; admission to an intensive therapy unit, high 
dependency unit or specialist unit; and maternal death (within 42 days of 
giving birth). This ‘maternal morbidity avoided’ outcome was a composite of 
secondary outcomes included in the prospective cohort study. 
For ‘normal birth’, cost-effectiveness was expressed in terms of incremental 
cost per additional ‘normal birth’. ‘Normal birth’ was defined by the 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  15    
      
 
Maternity Care Working Party as birth without any of the following 
interventions: induction of labour; epidural or spinal analgesia; general 
anaesthetic; episiotomy; forceps, ventouse or caesarean section. 
All the above analyses were repeated for women without complicating 
conditions at the start of care in labour. 
Differences in resource use estimates and costs were tested using t tests 
and differences in effects were tested using the statistical tests from the 
prospective cohort study. Non-parametric bootstrapping was used to 
generate 1,000 bias-corrected replications of each of the incremental cost-
effectiveness ratios (ICERs) and scatterplots of these were represented in 
four quadrant cost-effectiveness planes. 
A series of sensitivity analyses was undertaken to explore the implications 
of uncertainty surrounding the base-case ICERs. This included varying the 
key cost-drivers in intrapartum care and the variables where there was the 
most uncertainty surrounding cost estimation. They included varying the 
overheads, occupancy rates and staffing costs linked to the duration of 
labour care in order to determine the effects of such changes on the total 
mean cost of planned place of birth, as well as ICER estimates. 
Results 
Socio-demographic characteristics 
A total of 62,036 women at ‘low risk’ of complications prior to the onset of 
labour were included in these analyses. Of these, 18,847 planned to give 
birth in an OU, 16,187 planned to give birth at home, 10,971 planned to 
give birth in a freestanding midwifery unit and 16,031 planned to give birth 
in an alongside midwifery unit. 
The socio-demographic characteristics of women planning a birth at home 
were more similar to those planning birth in an FMU. The characteristics of 
women planning birth in an AMU were generally more similar to those of the 
planned OU group. The most marked contrast between the planned home 
birth group and the three other planned groups was in the distribution of 
parity: 27% of women planning a birth at home were nulliparous compared 
to 46%, 50% and 54%, respectively, in the planned FMU, AMU and OU 
groups. 
Costs 
Total costs captured all the resource use and the unit costs associated with 
intrapartum care and the immediate postnatal period after birth, including 
any higher level care for the mother or baby. The total unadjusted mean 
costs per woman at ‘low risk’ of complications prior to the onset of labour 
planning a birth in each setting were as follows: OU £1,631.2, AMU 
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£1,461.2, FMU £1,434.9 and home £1,066.5. The total unadjusted mean 
costs per ‘low risk’ woman without complicating conditions at the start of 
care in labour were: OU £1,510.6, AMU £1,426.4, FMU £1,405.0 and home 
£1,026.9. 
 
Adjusted cost differences were calculated for planned place of birth with 
birth in an OU as the reference group. The estimates were cost saving for 
all births planned in non-OU settings and this was statistically significant. 
The adjusted cost savings averaged £310.0 (home), £130.1 (FMU) and 
£134.4 (AMU). Adjusting for parity in a regression analysis on total cost 
resulted in sizable and significant cost differences, which overshadowed all 
other adjustments for confounding. The mean costs of care were 
substantially reduced for women who were parous compared to nulliparous. 
This cost-saving was accentuated for each previous pregnancy. The costs of 
care increased for a baby born above forty weeks gestation, representing a 
cost increment per additional week of gestation. A maternal age of thirty 
years and above was associated with an increase in the costs of care, and 
this was more apparent in women aged over forty years. 
Mean differences in costs per woman for planned OU and non-OU births 
were weighted, adjusted and bootstrapped in an additional analysis. All 
means costs of births in planned non-OU settings were cost-saving when 
compared with the mean cost of births planned in OUs, and the cost savings 
were as follows: £366.8 (home), £182.1 (FMU), £129.3 (AMU). 
Additional subgroup analyses by parity were conducted. These identified 
that the total bootstrapped weighted mean costs per ‘low risk’ nulliparous 
woman was £2075.2 (OU), £1,983.1 (AMU), £1,912.5 (FMU) and £1,793.7 
(home). In contrast, the total bootstrapped weighted mean costs per ‘low 
risk’ multiparous woman was: £1,142.4 (OU), £991.3 (AMU), £968.9 (FMU) 
and £780.4 (home). 
Cost-effectiveness 
The incidence of adverse perinatal outcomes was low in all settings. The 
ICERs showed that, on average, births planned in non-OU settings would be 
cost saving when compared with births planned in an OU, and would lead to 
improved perinatal outcomes on average for births planned in the midwifery 
units, although considerable uncertainty surrounded the latter. Although the 
cohort study found no significant differences in the primary outcome by 
planned place of birth for ‘low risk’ women, analyses stratified by parity 
identified a significantly increased odds of an adverse perinatal outcome for 
‘low risk’ nulliparous women in the planned home birth group. A cost-
effectiveness analysis performed on nulliparous women who planned a birth 
at home resulted in a less-costly intrapartum maternity option but with 
increased adverse perinatal outcomes. This finding was repeated for 
nulliparous ‘low risk’ women without complicating conditions at the start of 
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care in labour where the economic evaluation showed planned home birth 
to be less costly but with statistically significant worse perinatal outcomes. 
For multiparous women, there were no statistically significant differences 
between births planned in the different settings in rates of adverse perinatal 
outcome. For all bootstrapped replicates of the primary cost-effectiveness 
outcome for multiparous women, the scatterplots of mean ICERs fell across 
the south east and south west quadrants of the cost-effectiveness plane, 
reflecting lower costs in planned non-OU settings accompanied by 
uncertainty surrounding changes to perinatal outcomes when compared to 
planned births in an OU. 
The cost-effectiveness analyses conducted for maternal outcomes showed 
that planned births in non-OU unit settings led to reductions in costs and 
improvements in maternal outcomes when compared to planned birth in an 
OU. All bootstrapped ICERs fell within the south east quadrant of the cost-
effectiveness plane, confirming that births in planned non-OU settings 
would generate less costly care and positive maternal health effects. 
All planned births in non-OU settings led to significant reductions in costs 
and significant increases in ‘normal birth’ when compared to planned birth 
in an OU. 
Sensitivity analyses 
Uncertainty surrounded the modelled overhead costs and the midwifery 
costs, which included CNST contributions. These were also seen to be 
generic cost drivers relevant to all settings of birth. We compared the 
effects of variations in these costs on all three incremental cost 
effectiveness measures. Results from the sensitivity analyses showed that 
the study findings were generally robust and the ICERs responded to 
changes in the cost variables in a manner consistent with expectations. 
Conclusions 
There are cost differences between planned births in different settings for 
women at ‘low risk’ of complications prior to the onset of labour and these 
influence cost-effectiveness. With regards to the baby, a change from 
planned place of birth in an OU to a non-OU setting will generate lower 
costs, but this is accompanied by uncertainty surrounding effects on 
adverse perinatal outcomes. With regards to the mother, a change from 
planned place of birth in an OU to a non-OU setting will generate 
incremental cost savings and improved health outcomes. Planned birth at 
home reflects reduced medical intervention and a higher incidence of 
‘normal birth’. When compared to women planning to give birth in an OU, 
however, women planning a birth at home or in an FMU were more likely to 
be multiparous, white and have a fluent understanding of English, be 
married or living with a partner and to be living in a more socioeconomically 
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advantaged area. Each of the above characteristics is associated with cost-
savings. A regression analysis conducted on average total cost, adjusting 
for these confounders, found that planned births in non-OU settings were 
still cost saving compared with planned birth in an OU. However, the 
prospective cohort study found a significant interaction effect by parity. 
Costs and effects differ by parity. The costs of providing intrapartum 
maternity care for nulliparous women were higher than for multiparous 
women and the cost differences between the different settings for birth for 
this group of women substantially narrowed. When women without 
complicating conditions were excluded the cost differences narrowed even 
further. The cost-effectiveness analyses described in this report will be 
investigated further in a second report, to follow, and will use a decision-
analytic modelling approach to synthesise these perinatal and maternal 
cost-effectiveness results in one analysis. 
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1 Introduction 
Maternity care for women who are at ‘low risk’ of complications prior to the 
onset of labour is currently provided for in four settings in the NHS. These 
include care in an obstetric unit or a midwifery unit, on the same site or 
geographically separate from the hospital obstetric unit, or at home. The 
National Institute for Health and Clinical Excellence’s (NICE) Intrapartum 
Care Guidelines review of economic evidence related to care in each of 
these settings led to inconclusive results.(1) This gap in evidence is 
important as reliable evidence is needed by service commissioners and 
clinical managers, policy makers and parent representatives for planning 
maternity services; health professionals for guiding practice; and women 
and their families for making informed decisions about their planned place 
of birth. 
1.1 Aims and objectives 
This study aims to estimate the cost-effectiveness of the different planned 
settings for birth: home, FMU, AMU and OU, for women and babies at ‘low 
risk’ of complications prior to the onset of labour. In the original proposal 
this component of Birthplace was specified as a review of economic 
evidence captured in a decision-analytic model. However the National 
Institute for Health and Clinical Excellence’s (NICE) Intrapartum Care 
Guidelines attempted to populate a decision-analytic model for place of birth 
with a very similar design and concluded that ‘the poor quality of the UK 
data on health outcomes by place of birth makes it extremely difficult to 
make meaningful comparisons across different birth settings at the current 
time. These limitations in the data mean that good evidence-based 
conclusions about the relative cost-effectiveness of different birth settings in 
the UK cannot be made…The main conclusion to be drawn is that there is a 
need for better data.’ (1) As a first step in this process, we have assessed 
the cost-effectiveness of the different settings of planned place of birth 
using individual level data collected from the Birthplace prospective cohort 
study for both the mother and the baby. A second report, to follow, will use 
a decision-analytic modelling approach to synthesise these data from 
Birthplace with published clinical, epidemiological and economic evidence 
within a cost-effectiveness modelling framework. Evidence from this 
individual level analysis (part 1) will be directly incorporated into the 
decision-analytic model because the perinatal and maternal outcomes 
estimated in this report will be combined together in a composite outcome 
measure, and cost-effectiveness expressed in the model in terms of an 
incremental cost per healthy woman and baby at hospital discharge. Many 
of the model’s parameters will be populated with data from the Birthplace 
prospective cohort study and more specifically from this cost-effectiveness 
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analysis. Decision analytic modelling is a robust method which enables the 
integration of all relevant sources of evidence within one model. The use of 
a decision tree as the basis for this model will enable a detailed description 
of the pathways of care that women engage with during labour. Associated 
costs, effects and weighting probability parameter values may be 
synthesized from many relevant sources. If robustly designed, a decision-
analytic model is a valuable source of information because it can be 
responsive to changes in the parameter values, generating plausible cost-
effectiveness scenarios within a broader framework of uncertainty. 
1.1.1 Aims 
To determine the cost-effectiveness of planned place of birth in the 
following settings: home, FMU, AMU and OU, for women and babies at ‘low 
risk’ of complications prior to the onset of labour, based on individual level 
data collected in the prospective cohort study within Birthplace. 
1.1.2 Objectives 
1. To estimate the cost-effectiveness of births planned at home, in 
FMUs and in AMUs, in comparison with births planned in OUs, in terms of 
incremental cost per adverse perinatal outcome avoided for babies of 
women judged to be at ‘low risk’ of complications prior to the onset of 
labour. 
The composite measure of adverse perinatal outcome used for the economic 
evaluation was defined as ‘intrapartum stillbirth, early neonatal mortality 
and specific neonatal morbidities’, the primary effectiveness measure in the 
Birthplace prospective cohort study. This composite measure is described in 
more detail in the prospective cohort study report. 
2. To estimate the cost-effectiveness of births planned at home, in 
FMUs and in AMUs, in comparison with births planned in OUs, in terms of 
incremental cost per maternal morbidity avoided for women judged to be at 
‘low risk’ of complications prior to the onset of labour. 
The composite measure of maternal morbidity used for the economic 
evaluation represented a subset of secondary outcomes in the prospective 
cohort study and included at least one of the following: general anaesthetic; 
instrumental birth or intrapartum caesarean section; third or fourth degree 
perineal trauma; blood transfusion; admission to an intensive therapy unit, 
high dependency unit or specialist unit; and maternal death (within 42 days 
of giving birth). 
3. To estimate the cost-effectiveness of births planned at home, in 
FMUs and in AMUs, in comparison with births planned in OUs, in terms of 
incremental cost per additional ‘normal birth’ for women judged to be at 
‘low risk’ of complications prior to the onset of labour. 
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‘Normal birth’ was defined by the Maternity Care Working Party as birth 
without any of the following interventions: induction of labour; epidural or 
spinal analgesia; general anaesthetic; episiotomy; forceps, ventouse or 
caesarean section.(2) 
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2 Methods 
2.1 Principles of cost-effectiveness analysis with 
individual level data 
Cost-effectiveness analysis (CEA) is a form of economic evaluation that 
compares the relative costs and outcomes (effects) of two or more courses 
of action, using a common outcome measure. In cost-effectiveness 
analyses, the costs are expressed in monetary units, while benefits are 
expressed in natural or physical units, such as years of life gained, hospital 
episodes or clinical events avoided. 
CEA involves calculating the difference in costs and difference in outcomes 
between the health care interventions or courses of action being compared, 
and then expressing these as a ratio. The denominator of the ratio usually 
represents a measure of health gain and the numerator usually represents 
an incremental cost associated with the health gained. Cost-effectiveness is 
expressed as an incremental cost-effectiveness ratio (ICER), which is simply 
the difference in costs divided by the difference in effects: 
ICER = (change in costs) / (change in effects) 
ICER = (cost of scenario A – cost of scenario B) / (effectiveness of 
scenario A - effectiveness of scenario B) 
The ICER represents the additional cost of achieving an additional unit of 
outcome through a healthcare intervention or course of action, when 
compared to the next best alternative, mutually exclusive intervention or 
strategy. 
A CEA requires detailed data about both resources used and unit costs 
associated with alternative interventions or courses of action. A unit cost is 
the cost per standard unit applied to each resource item. Resource use and 
unit cost values may be deterministic if they are the same for every 
individual, for example, the unit cost of a syntometrine injection. 
Alternatively, they may be stochastic if they are likely to vary between 
individuals, for example the duration of midwifery care per home birth. 
Total cost for an individual is a combination of the quantity of each resource 
item they use and the unit cost of each item. 
Broadly speaking, there are two different methods for measuring cost data. 
‘Top-down’ costing involves the estimation of the total cost of care in an 
organisation, for example a birth centre, to estimate the unit cost (in this 
case per woman); the total cost is simply divided by the number of women 
receiving the service provided. ‘Bottom-up costing’ (micro-costing) involves 
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measuring each resource component used by the individual before placing 
an economic value on each resource component used. 
 
2.2 Economic evaluation perspective and time horizon 
In this study, the incremental costs and incremental effectiveness of 
planned birth at home, in an AMU or in a FMU for women at ‘low risk’ of 
complications prior to the onset of labour were compared with a reference 
birth setting, namely an OU. The OU group contains the largest number of 
eligible births so using it as a reference group maximised statistical 
efficiency. We do not imply that OUs should be the standard or optimal 
place of birth. All four planned places of birth were additionally compared in 
one analysis and the differences between them expressed as ICERs. 
The economic evaluation was conducted from a health system perspective 
and consequently only direct costs to the NHS were included. The time 
horizon primarily mirrored the duration of follow-up of the Birthplace 
prospective cohort study, which identified women at the start of their care 
in labour and was completed when the intrapartum and related postnatal 
care for both mother and baby ended, be it at home or discharge from a 
midwifery unit or hospital. Typically, this might be anytime between a few 
hours or a few days after the birth of the baby. If higher level care following 
the birth was required for either the mother or the baby, or both, this was 
included in the economic evaluation. 
2.3 Study population 
A detailed overview of the Birthplace prospective cohort study design and 
study population may be seen in the prospective cohort study report. It 
includes a description of the participating trusts, selection of OUs, study 
eligibility criteria, sample size calculations, derivation of risk status and 
potential confounders, derivation of denominator data, and the analyses 
and sensitivity analyses undertaken. 
The study population for the economic evaluation included all women where 
the primary outcome and potential confounders were not missing. This was 
for women who were defined as being of ‘low risk’ of complications prior to 
the onset of labour. 
2.4 Resource use data collection 
2.4.1 Measurement of resource use data 
Individual data collection forms were designed as part of the Birthplace 
prospective cohort study and were completed by the attending midwife at 
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the time of each woman’s labour episode. In addition, maternal and 
neonatal morbidity forms were completed during or after maternal or 
neonatal discharge from a higher level of care in hospital. Appendix 1 
identifies the resource use data collected from these Birthplace data 
collection forms. 
2.4.2 Additional resource use data collection to supplement the 
Birthplace data collection forms 
The brevity of the Birthplace data collection forms meant that additional 
data were required to identify and quantify the resource use variables more 
thoroughly. The additional resource use variables are shown in columns 4 & 
5 in Appendix 1. Five informal focus groups were held with Birthplace local 
coordinating midwives who attended Birthplace meetings at several time 
points, early in the project timeline. The optimal ways of obtaining resource 
use data, to capture variation in the data, and to collect related ‘top down’ 
and ‘bottom up’ cost data were discussed in these meetings. Following the 
focus group meetings, structured resource use data collection forms were 
designed (Appendices 2, 3, 4 and 5). They represent a detailed approach to 
capturing all possible NHS resources used in the care of the mother and 
baby during the period between admission and discharge in midwifery units 
and hospitals. Appendix 2 shows this supplemental data collection form for 
birth in a FMU and an AMU; and Appendix 3 for birth in an OU. 
In developing these supplemental data collection forms, Birthplace was able 
to draw on the work done in one of its linked adjunct studies. This 
compared the costs of care in the Barkantine Birth Centre (a FMU) with care 
in the Royal London Hospital, an OU in the Barts and London Trust. Data 
collection forms were designed for the adjunct study, which acted as a pilot 
for Birthplace as well as being a distinct small study in its own right. 
Anonymised data collected retrospectively from 167 maternity notes in the 
Barkantine Birth Centre and 164 maternity notes in the Royal London 
Hospital were analysed. The data were collected by midwives who worked in 
both settings and therefore had access to the data; they were extracted 
directly from women’s notes. The adjunct study thus enabled the 
identification of detailed resource use which would otherwise not have been 
obtained. This included staffing patterns under different scenarios of care, 
e.g. continuous and intermittent midwifery care during the successive 
stages of labour. Information was also obtained about the numbers of 
women using alternative forms of pain relief. In the OU, the profiles of the 
complications experienced by mothers and babies, the types and quantities 
of treatments, surgeries, diagnostic imaging tests, scans and medications 
administered and ambulance transfers undertaken for both mothers and 
babies (if provided separately) were documented. 
The supplemental data collection forms were designed to capture the 
‘pathway of care’ experienced by a woman progressing through the stages 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  25    
      
 
of labour according to a planned place of birth. This reflected the design of 
the Birthplace data collection forms more broadly. Having been piloted in 
the Barkantine study, they were then reviewed individually in a structured 
interview with each of the four Birthplace appointed regional lead midwives, 
to take account of differences in maternity care practices nationally. 
Appendix 4 was generated to be a working document for the interviews, 
intended to capture the generalisability and variability in the process 
management of labour and birth. For each scenario the regional lead 
midwife was asked to describe in detail the ‘standard procedures’ that would 
be undertaken for labour and birth events and, where possible, the typical 
ratios of ‘staff to woman’ care. Scenarios were then varied to the least and 
then most complex with a description of the change in practice, and related 
resource items. The interviews included approximately one and a half hours 
of structured, recorded time plus an additional one and a half to two hours 
of discussion and clarification. 
The interviews with the Birthplace appointed regional lead midwives were 
undertaken at Liverpool Women's Hospital NHS Foundation Trust, Taunton 
and Somerset NHS Trust, the Oxford Radcliffe Hospitals NHS Trust and 
Kings College Hospital NHS Foundation Trust, and the data were collected 
from these trusts. The trusts represented contrasting geographical regions 
of England (north, south west, central and London), as well as providing 
different configurations of maternity services, and were chosen so that the 
variations in regionality and service configuration could be captured in the 
unit cost estimations for this report. Further details of the interviews can be 
seen in Appendix 4. The interviews were recorded and then transcribed. The 
data were then compiled into comparative resource use spreadsheets and 
cross-referenced. 
2.5 Unit cost data collection 
The research for the costing component of this economic evaluation used 
both ‘top down’ and ‘bottom up’ methods to identify costs relevant to 
Birthplace. All unit costs in this study were expressed in pounds sterling and 
valued at 2009-10 prices. 
2.5.1 ‘Bottom up’ unit cost data 
Prior to interview the regional lead midwives were sent a lengthy cost sheet 
(Appendix 5), which listed every item identified in an action, event or 
procedure from the structured questionnaires (Appendix 4) and the data 
collection forms from the adjunct study (Appendices 2 and 3). Midwives 
documented the staffing, medications and equipment that might be required 
for birth related procedures such as augmentation, different modes of 
delivery or perineal repair. They were asked to update the sheet to specify 
their own resource components according to their trust or unit protocols and 
policies. This captured all resource components that might be used in any 
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labour, birth or after birth event. The regional lead midwives were asked to 
supply the contact details for the person who could be contacted to price 
each resource component or to supply it themselves. 
The following procedures were microcosted using ‘bottom up’ methods (see 
Appendix 6 for details): 
• Homebirth delivery pack 
• NHS re-imbursement for midwifery travel costs to attend a birth at home 
• NHS re-imbursement for midwifery travel costs to attend a transfer from a 
planned birth at home 
• Entonox for a home-birth 
• Augmentation of labour with syntocinon 
• Epidural and spinal analgesia 
• General anaesthetic 
• Spontaneous vertex birth 
• Ventouse birth 
• Forceps delivery 
• Caesarean section 
• Active management of the third stage of labour 
• Suturing episiotomy 
• Suturing third and fourth degree perineal tear 
• Manual removal of the placenta 
• Blood transfusion 
• Care following a stillbirth or neonatal death 
2.5.2 ‘Top down’ cost data 
This research aimed to collect all other cost data that could contribute to a 
total cost per woman for the individual level cost effectiveness analysis. 
Finance managers were contacted in each trust where there was a regional 
co-ordinating midwife working for Birthplace to obtain details of unit 
overheads and all other costs involved in running the unit. These included 
management and administrative costs, operational costs (including heating 
and lighting, training, building maintenance), indirect overheads including 
the personnel and finance functions, and capital costs based on the new 
build and land requirements of NHS facilities. They also included the 
proportional use of other hospital services such as screening, haematology 
and pathology and followed the costing guidelines detailed in the NHS 
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costing manual. (3) Contact with finance managers was often difficult to 
attain and patchy. Finance staff changes, work commitments and a lack of 
comparable data collection methodology in the finance departments 
resulted in inadequate responses and incomplete data returns. As a 
consequence, the data that were received were included in a purpose 
designed model to calculate trust overheads apportioned to intrapartum 
care. The model used data from the Healthcare Commission’s review of 
maternity services (published January 2008, which was mandatory and 
captured unit data from every trust in England) to generate running costs, 
bed days and occupancy rates adjusted for unit operational days per year, 
numbers of women delivering and intrapartum transfers. The overheads 
data that were received from trust finance departments were subsequently 
included in the model, and the disaggregated costs were modelled into a 
generic ‘overheads cost per place of birth per hour’ variable. This cost was 
then varied in a sensitivity analysis. 
Staff costs for midwives and clinicians who have direct contact with women 
during their episode of labour care were excluded from the overheads 
calculations, because they were separately attributed to each individual 
woman’s duration of labour care. Firstly, midwifery staff time which is 
considered to be the main cost driver generalisable across all settings for 
birth, was allocated directly to the duration (hours) of the labour episode 
per woman. This duration variable was calculated directly from the 
Birthplace data collection forms. The midwifery staff cost was calculated 
using data from the Unit Costs of Health and Social Care 2010 compendium, 
developed by the Personal Social Services Research Unit (PSSRU). (4) This 
unit cost therefore included the midpoint salary for both a Band 6 and 7 
midwife, including salary oncosts, indirect and direct overheads and 
contribution to qualifications adjusted for working hours per week, study 
and leave days. The cost of administration of the birth at home service 
within the community was captured by the ‘overheads’ cost within the 
midwifery staffing variable, as apportioned direct and indirect overheads are 
included in cost calculations for midwifery staff in the PSSRU compendium. 
Midwifery staff time was considered to approximate continuous care in the 
non-OU settings and was calculated to approximate 65% intermittent care 
in the OU setting. If a woman was transferred into an OU, then her 
midwifery staffing and overheads costs changed accordingly. These costs 
were varied in a sensitivity analysis. 
The Clinical Negligence Scheme for Trust (CNST) contributions per staff 
member (per hour) were added to the cost of direct maternity contact time 
documented for midwifery staff. The actual value of the CNST contribution 
was developed through primary data collection, in conjunction with the NHS 
Litigation Authority and was calculated using the contributions to CNST by 
the trust finance managers we had contacted. Although paid for by the trust 
as part of overheads, CNST contributions are calculated per whole time 
equivalent (WTE) staff member using a trust apportioned risk formula, 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  28    
      
 
which is measured in terms of clinical specialty, staff grade, proportional 
WTEs, the numbers of registered births in the trust and a pooled relative 
risk rating. (5) It was allocated directly to the staffing component to capture 
the real cost of staffing across all settings for birth. 
Medical staffing costs were calculated in a similar way, using the costs 
allocated to direct person contact from data in the PSSRU compendium with 
the addition of the CNST contribution. Medical staffing (consultant 
obstetrician, paediatrician, neonatologist, anaesthetist, obstetric registrar 
and foundation year doctor [including senior house officers]) costs were 
allocated per patient contact hour and were calculated in this study within 
labour related events or procedures. Medical staff time was included in 
events such as the augmentation of labour, administration of an epidural, a 
general anaesthetic or perineal repair. All unit costs calculated for maternity 
staffing can be viewed in Appendix 6. 
Medication costs were supplemented with data from the British National 
Formulary, version 61. (6) Pharmacy departments had initially been 
contacted in the hope of capturing variation in medication costs. The 
response to numerous follow up contacts was minimal with incomplete data 
returns. Similarly, the NHS Supply Chain Catalogue version April 2009 was 
used to capture the costs of resource items such as medical supplies as it 
was not possible to comprehensively collect these from maternity units. (7) 
The PSSRU compendium of Unit Costs of Health and Social Care and the DH 
reference costs both include detailed ‘bottom up’ costing of emergency and 
non-emergency transfers, including obstetric and neonatal ambulance 
transfers. Time-weighted cost variables were created from these two 
sources. (4, 8) Primary data collection was required for the calculation of 
other modes of transfer, such as transfer in a helicopter. Only medical staff 
time was attributed to helicopter transfer as the cost of the service is not 
funded by the NHS. 
The most recently published Department of Health reference costs (2008/9) 
capture per diem costs for admissions to a neonatal intensive care unit, 
high dependency care unit or special care baby unit. A per diem cost is also 
available for adult intensive and high dependency admissions, and for 
admissions to a specialist ward. The cost of higher level care provided 
within the labour ward immediately after labour is also included. All 
Department of Health NHS reference costs used in this study were taken 
from the reference costs appendix NSRC4: Trust and PCT combined 
reference cost schedules. (8) 
2.5.3 Quality of the data 
Data management procedures for the Birthplace prospective cohort study 
are described in the cohort study report.(9) 
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The additional resource use and unit cost data collected directly from 
regional lead midwives were single entered at the NPEU. The data were 
compiled into comparative resource use spread sheets and cross-referenced 
between the four trusts. It was then checked for face-validity with an 
obstetrician at the NPEU and presented to the Birthplace Co-investigator 
Group in December 2010 and the Birthplace Advisory Group in March 2011. 
2.6 Representation of cost-effectiveness 
Differences in resource use and costs were tested using t tests and 
differences in effects were tested using the odds ratios from the prospective 
cohort study data. Cost effectiveness was expressed as incremental cost per 
(i) adverse perinatal outcome averted, (ii) maternal morbidity avoided and 
(iii) additional ‘normal birth’. All of these analyses were repeated for women 
without complicating conditions at the start of care in labour. Nonparametric 
bootstrapping was used to calculate uncertainty around all cost-
effectiveness estimates. 9, 10 Non-parametric bootstrapping is a statistical 
method that estimates measures of distribution for the variables of interest; 
it is based on repeated sampling (with replacement) from the dataset. This 
is used to establish confidence intervals for any test statistic and allows for 
tests of statistical significance.(10, 11) Non-parametric bootstrapping was 
used to generate 1,000 bias-corrected replications of each of the ICERs, 
which were represented on four quadrant cost-effectiveness planes. An 
ICER represents the additional cost of achieving an additional unit of 
outcome through a course of action, when compared to the next best 
alternative, mutually exclusive intervention or strategy. The cost-
effectiveness results reflected in the ICER scatterplots reflect data that were 
weighted for each unit’s duration of study participation and takes into 
account the clustered nature of the data within the prospective cohort 
study. Probability weights were incorporated in the analysis to adjust for the 
probability of selection of each woman. The weight applied to each 
observation was inversely proportional to the probability of selection of the 
unit and the duration of data collection in that unit. The weights were re-
calculated for each bootstrapped sample. All ICERs express bootstrapped 
weighted data using 1,000 replications with resampling. Decision 
uncertainty was addressed by estimating net benefit statistics and 
constructing cost-effectiveness acceptability curves across cost-
effectiveness threshold values of between £0 and £100,000 for the 
outcomes of interest. This range of cost-effectiveness threshold values 
includes the thresholds implicitly used by NICE for broader cost-
effectiveness purposes. Although this study was not able to estimate a cost 
per quality-adjusted life year (QALY) gained attributable to alternative 
planned places of birth, the cost-effectiveness thresholds used more broadly 
by NICE seemed appropriate for the primary outcome measure. 
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A series of sub-group analyses repeated all analyses by parity sub-group for 
the primary cost-effectiveness outcome, namely incremental cost per 
adverse perinatal outcome avoided. In addition, a series of sensitivity 
analyses was undertaken to explore the implications of uncertainty 
surrounding the key cost-drivers in intrapartum care and the variables 
where there was the most uncertainty surrounding the resource use 
parameters. These included varying the overheads, occupancy rates and 
staffing costs attributed to the duration of labour care. The ICERs were re-
calculated following these sensitivity analyses. 
Multivariable analyses of the outcomes data are reported in the prospective 
cohort study report. Multiple regression was used to estimate the 
differences in total cost between the settings for birth and to adjust for 
potential confounders such as maternal age, parity, ethnicity, understanding 
of English, marital status, BMI, index of multiple deprivation score, parity 
and gestation, which may each be associated with planned place of birth 
and with adverse outcomes. For the generalized linear model (GLM) on 
costs, a gamma distribution and identity link function was selected in 
preference to alternative distributional forms and link functions on the basis 
of its low Akaike's Information Criterion (AIC) statistic. The GLM 
approximates linear regression by allowing the linear model to be related to 
the response variable via a link function and by allowing the magnitude of 
the variance of each measurement to be a function of its predicted value. 
GLM has the ability to predict confidence bounds. In addition to predicting a 
best estimate and a probability for each row, GLM identifies an interval 
wherein the prediction (regression) will lie. 
The data were originally entered into Microsoft Access software. All analyses 
were performed using Stata version 11, SPSS (the Statistical Package for 
the Social Science) version 17 (SPSS, Chicago, IL) and Microsoft Excel 
(Microsoft, Seattle, WA) 2010 software. 
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3 Results 
3.1 Study population 
A total of 62,036 women at ‘low risk’ of complications prior to the onset of 
labour, where the primary outcome data and potential confounders were 
not missing, were included in this analysis. This corresponds to the 
population used for the adjusted analyses in the prospective cohort 
study.(9) Of these, 18,847 planned to give birth in an OU, 16,187 planned 
to give birth at home, 10,971 planned to give birth in a freestanding 
midwifery unit and 16,031 planned to give birth in an alongside midwifery 
unit. The socio-demographic and clinical effectiveness differences between 
the birth settings are presented in detail in the prospective cohort study 
report. (9) 
In brief, compared to women planning to give birth in an obstetric unit, 
women planning a birth at home tended to be older (28% aged 35 or over 
at home compared with 16% aged 35 or over in OUs), were more likely to 
be white and have a fluent understanding of English, be married or living 
with a partner, to be living in a more socioeconomically advantaged area, 
and were markedly more likely to have had one or more previous 
pregnancies. 
The characteristics of women planning a birth in an FMU or AMU tended to 
lie between those of the OU and home birth groups, with the characteristics 
of women in the AMU group generally more similar to that of the OU group, 
and the characteristics of women planning a birth in a FMU more similar to 
those planning a birth at home. Relative to women planning a birth in an OU 
or AMU, women planning a birth in an FMU were more likely to be white, 
have a fluent understanding of English and to live in a more 
socioeconomically advantaged area. 
There were marked differences between planned places of birth in the 
proportion of women at ‘low risk’ with complicating conditions identified by 
the attending midwife at the start of care in labour. Almost 20% of women 
whose planned place of birth was an obstetric unit had at least one 
complicating condition noted at the start of care in labour compared with 
fewer than 7% for all other planned places of birth. The most common 
complicating conditions noted by the attending midwife at the start of care 
in labour were prolonged rupture of membranes and meconium stained 
liquor. The prevalence of proteinuria was similar for OUs and AMUs, but for 
all other complicating conditions, rates were higher in the women planning 
birth in an OU and similar in the three other settings (home, FMU, AMU). 
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The higher prevalence of women with complicating conditions at start of 
care in labour in the planned obstetric unit group was unexpected in this 
‘low risk’ group. Possible reasons are discussed in the prospective cohort 
study report. The higher prevalence of complicating conditions at the start 
of care in labour was noted and discussed by the co-investigators and the 
independent Advisory Group prior to the analysis of the primary outcome; it 
was agreed to modify the analysis plan to include additional analyses of 
outcomes by planned place of birth, restricted to women without 
complicating conditions at the start of labour care. 
This was replicated in the cost-effectiveness analyses and separate cost-
effectiveness results were generated for women without complicating 
conditions for each measure of outcome. 
3.2 Resource use 
Appendix 7 shows the resource use values from the start to end of the 
episode of labour care, including post-natal, neonatal and maternal higher 
level admissions for each planned place of birth. The values are given as 
means (standard deviations). 
The mean duration (hours) of labour care for all women who were not 
transferred from their initial planned place of birth differ within a range of 
approximately 2.4 hours. It was longest in the OU (9.01), then similar in 
the AMU (7.92) and FMU (7.49), and shortest for home (6.61). For the 
planned non-OU births where a transfer did occur, the duration of labour 
care prior to transfer was longest in the FMU (6.68), similar in the AMU 
(6.5), and shortest at home (5.71). For women who were transferred, the 
duration of transfer (hours) was longer from the FMU compared with home 
(0.59 versus 0.48) and substantially longer than transfer from the AMU 
(0.17); this translates to 29 minutes (home), 35 minutes (FMU) and 10 
minutes (AMU), respectively. As expected, the predominant mode of 
transport for transfer from FMU or home was via ambulance or a private 
car. In contrast, transfer from an AMU was most commonly via a wheelchair 
or trolley and then a bed. The average duration of labour care (hours) from 
arrival in the OU after transfer was similar for all women; home (6.8), FMU 
(6.6) and AMU (6.8). 
The highest rates of spontaneous vertex birth occurred for planned birth at 
home (0.93), then in FMUs (0.91), AMUs (0.86) and lastly in the OUs 
(0.74). A much higher assisted delivery rate (with ventouse, forceps or a 
caesarean) occurred for women who had planned their birth in an OU. The 
intrapartum caesarean section rate was highest in the OU (11%) compared 
with home (3%), FMU (4%) and AMU (4%). The assisted delivery rate was 
lowest in the planned home birth group. Differences in mode of birth and 
receipt of intervention are described in more detail in the prospective cohort 
study report. These differences affect costs. 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  33    
      
 
A higher proportion of women who planned their birth in the OU had their 
labour augmented with syntocinon. In the OU, this decreased when women 
with complicating conditions at the start of care in labour were removed 
from the analysis, though there was little change in the other settings for 
birth when this adjustment was done. Proportionately more women who 
planned their birth in an OU received an epidural (0.31 compared with 0.08 
(home), 0.11 (FMU) and 0.15 (AMU)). Similarly, a higher proportion of 
women who planned their birth in the OU had active management of the 
third stage of labour and an episiotomy. The proportion of women with 
perineal trauma ranged between 0.032 (OU) and 0.019 (home). 
A higher proportion of women who planned birth in the OU received high 
dependency care (increased observation) within the labour ward 
immediately after birth compared with women with a planned non-OU birth. 
Most of these cases involved increased care for women following an 
operative delivery (0.18 compared with 0.05 (home), 0.07 (FMU) and 0.09 
(AMU)). There were very small absolute numbers of women admitted to 
higher level care (intensive or high dependency care) after the birth, 
although more women were admitted from planned OU and AMU settings. 
Substantially more babies were admitted to neonatal care from the planned 
OU group, compared with other settings. Very few babies received ECMO or 
total body cooling. Very few babies died (either as a stillbirth or early 
neonatal death). Additional reference to the weighted event rates of the 
primary or secondary outcomes or interventions can be viewed in greater 
detail in the prospective cohort study report. 
3.3 Costs 
Table 1 shows the unit costs for key resource items, episodes or 
procedures. Unit overheads and midwifery staffing were apportioned to 
each woman according to her actual place of labour and birth, and the 
duration in hours that they spent there. If a woman was transferred then 
her overheads and staffing costs were adjusted accordingly. Analyses 
wereby ‘intention to treat’, so the final costs incurred were attributed to the 
setting where the woman planned to give birth at the start of care in labour 
and included costs when she transferred care. Medical staff time was 
incorporated into specific intrapartum care procedures. The detailed bottom 
up costing results can be viewed in Appendix 6. 
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Table 1. Unit costs per resource item (£ sterling, 2009/10 prices) 
Resource item (unit) Unit cost or range Source of unit cost 
 
GENERIC COSTS APPLIED TO DURATION VARIABLES 
 
Unit financial overheads (hour)   
OU 
63.7 (50.9 – 76.4) Primary cost data 
collection 
Home 0.0 Primary cost data 
collection 
FMU 55.4 (44.3 – 66.5) Primary cost data 
collection 
AMU 54.4 (43.5 – 65.3) Primary cost data 
collection 
Midwifery staffing (hour)   
OU 81.3 
Intermittent care 65% 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
Home 81.3 
Continuous care plus one 
extra midwife for an hour at 
birth 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
FMU 81.3 
Continuous care 100% 
 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
AMU 81.3 
Continuous care 
 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
Medical Consultant (hour)  
389.4 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
Registrar (hour)  
179.5 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
Foundation House Officer (F2) (hour) 
Senior House Officer/ Specialty or Core 
Training year 1 
 
 
141.8 
PSSRU Unit Costs of 
Health and Social care 
2010 
Primary cost data 
collection for CNST 
COSTS INCURRED FOR A PLANNED BIRTH AT HOME 
 
Homebirth packs 
 
34.3 Primary cost data 
collection 
Staff travel to homebirth – distance 23 
miles return trip 
 
 
23.2 
Primary cost data 
collection 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  35    
      
 
COSTS INCURRED FOR PLANNED ‘NON-OU BIRTHS’ IF TRANSFERRED TO AN OU 
 
Mode of transfer (per hour)  
Ambulance 402.0 PSSRU Unit Costs of 
Health and Social care 
2010 
DH reference costs 
Private car 0.0 Cost not attributed to 
NHS 
Wheelchair or trolley 0.01 PSSRU Unit Costs of 
Health and Social care 
2010 
Bed 0.01 PSSRU Unit Costs of 
Health and Social care 
2010 
Rapid response ambulance car 214 PSSRU Unit Costs of 
Health and Social care 
2010 
DH reference costs 
Helicopter 144.5  Primary data collection 
(NHS staff costs only) 
Taxi 0.0 Cost not attributed to 
NHS 
No physical transfer 0.0 Cost not attributed to 
NHS 
COSTS INCURRED FOR CARE DURING LABOUR AND BIRTH 
Mode of birth 
Spontaneous vertex birth   
OU 26.3 Primary cost data 
collection 
Home 28.5 Primary cost data 
collection 
FMU 29.3 Primary cost data 
collection 
AMU 29.3 Primary cost data 
collection 
Vaginal breech birth 99.1 Primary cost data 
collection 
Ventouse 429.2 Primary cost data 
collection 
Forceps 569.9 Primary cost data 
collection 
Caesarean section 
 
1052.6 Primary cost data 
collection 
Procedures related to intrapartum care  
Augmentation 159.1 Primary cost data 
collection 
Epidural/Spinal 311.1 Primary cost data 
collection 
General Anaesthetic 846.5 Primary cost data 
collection 
Active Management of the third stage of 
labour 
4.1 Primary cost data 
collection 
Episiotomy 24.6 Primary cost data 
collection 
Perineal trauma 595.3 Primary cost data 
collection 
ECMO 1651.0 Primary cost data 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  36    
      
 
 
‎Table 2 combines resource items and their associated unit costs to generate 
costs per woman according to planned place of birth. These are shown as 
means and standard errors. The bootstrap mean differences between the 
comparison groups for each cost category and 95% bootstrap confidence 
intervals are also shown in the table. 
Unit overheads and staffing costs are shown to be the key cost drivers in 
the study. The average cost attributed to unit overheads was highest in the 
planned OU setting (£569.4 compared with £426.1 (FMU), £450.6 (AMU) 
and £93.1 (home), p<0.001). Unit overheads are not directly attributed to 
women who plan birth at home, but these accrue when the woman is 
transferred for care in an OU. Thus unit overheads and midwifery staff costs 
capture both directly apportioned overheads and staffing, but also capture 
the adjusted overheads and staff costs following a transfer from any non-
OU setting into an OU. 
Midwifery staffing, although attributed the same unit cost per hour in all 
birth settings, was highest in the planned AMU group, reflecting a longer 
duration of labour care in comparison with the other non-OU settings 
(£611.0 (AMU) compared with £580.5 (home), £577.9 (FMU) and £472.4 
(OU) p<0.001). Planned births at home were attributed a second midwife 
for an hour during the birth of the baby and this is captured in the staffing 
cost. The calculation of this additional staffing measure was made with 
reference to interviews about staff to woman ratios from data collection 
collection 
Total body cooling 2110.0 Primary cost data 
collection 
Care following a stillbirth 644 Primary cost data 
collection 
Care following a neonatal death 644 Primary cost data 
collection 
POST NATAL AND HIGHER LEVEL CARE FOR THE MOTHER 
Postnatal care (days) 95 
DH reference costs 
High dependency care following birth 
provided within the labour ward (per 4 
hours) 
 
80 DH reference costs 
Admission to intensive care unit (days) 560 
DH reference costs 
Admission to high dependency unit (days) 1525 
DH reference costs 
Admission to specialist care (days) 400 
DH reference costs 
HIGHER LEVEL OF CARE FOR THE BABY 
 
Admission to neonatal intensive care unit 
(days) 
1081 
DH reference costs 
Admission to neonatal high dependency 
unit (days) 
759 
DH reference costs 
Admission to neonatal specialist care 
(days) 
429 
DH reference costs 
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meetings with the Birthplace regional lead midwives. The midwifery staff 
cost in the OU is the lowest, most likely reflecting the 65% intermittent 
support during labour allocated there. 
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Table 2. Mean cost per woman according to planned place of birth for all ‘low risk’ women 
Cost category OU Home FMU AMU P value Bootstrap mean difference (95% CI) 
 Mean (SE) Mean (SE) Mean (SE) Mean (SE)  OU-Home OU-FMU OU-AMU 
Overheads 
569.4 (2.9) 92.6 (1.9) 426.1 (3.1) 450.6 (2.8) p<0.001 -475.6 (-
482.0, -
468.8) 
-143.3 (-
152.2, -
134.9) 
-118.7 (-
126.9, -
110.6) 
Midwifery 
staffing 
472.4 (2.4) 580.5 (2.8) 577.9 (3.8) 611.1 (3.4) p<0.001 108.1 
(100.2, 
116.4) 
105.2 (95.9, 
114.4) 
138.7 
(130.4, 
147.2) 
Homebirth 
resources 
0.0 (0.0) 111.8 (0.2) 0.0 (0.0) 0.0 (0.0) p<0.001 111.7 
(111.2, 
112.1) 
0.0 (0.0, 
0.0) 
0.0 (0.0, 0.0) 
Transfer 
0.0 (0.0) 33.9 (0.7) 49.3 (1.0) 0.003 (0.0) p<0.001 33.7 (32.4, 
35.1) 
49.1 (46.9, 
51.2) 
0.0036 
(0.0034, 
0.0037) 
Procedures after 
transfer 
0.0 (0.0) 53.1 (0.9) 36.4 (0.7) 43.0 (0.6) p<0.001 53.0 (51.2, 
54.8) 
36.4 (34.9, 
37.8) 
42.9 (41.8, 
44.2) 
Birth 
207.0 (2.5) 76.5 (1.5) 93.9 (2.1) 114.1 (1.9) p<0.001 -130.1 (-
135.8, -
124.7) 
-113.4 (-
119.9, -
107.2) 
-92.9 (-99.2, 
-86.6) 
Procedures 
during labour 
care  
174.1 (1.9) 49.9 (1.3) 64.9 (1.7) 83.9 (1.5) p<0.001 -122.8 (-
127.1, -
118.2) 
-109.3 (-
114.2, -
104.4) 
-89.9 (-94.9, 
-85.1) 
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Postnatal care 
122.0  (0.6) 17.7  (0.4) 127.2 (0.9) 101.9 (0.6) p<0.001 104.3(-
105.9,-
102.5) 
5.1 (2.7, 
7.6) 
-20.1 (-22.1, 
-18.3) 
Higher care – 
mother  
21.7 (0.9) 7.9 (0.8) 9.3 (0.9) 11.8 (0.6) p<0.001 -13.2 (-
15.5, -10.8) 
-11.9 (-
14.3, -9.8) 
-9.6 (-11.8, -
7.6) 
Admission to 
higher care – 
baby 
64.2 (5.2) 42.1 (4.3) 49.6 (7.5) 44.7 (6.2) 0.037 -21.9 (-
36.6, -9.4) 
-15.0 (-
32.8, -3.7) 
-19.6 (-35.6, 
-1.9) 
Total cost 
1631.2  (10.1) 1066.5  (8.9) 1434.9  (13.5) 1461.2  (11.1) p<0.001 -564.6 (-
591.7, -
533.9) 
-195.4 
(129.1, -
157.4) 
-169.5 (-
199.7, -
137.4) 
 
Table 3. Mean cost per woman according to planned place of birth for women at ‘low risk’ without complicating 
conditions at the start of care in labour 
Cost category OU Home FMU AMU P value Bootstrap mean difference 
(95% CI) 
 Mean (SE) Mean (SE) Mean (SE) Mean (SE)  OU-Home OU-FMU OU-AMU 
Overheads 544.5 (3.1) 81.3 (1.8) 419.7 (3.2) 441.5 (2.8) p<0.001 -463.2 (-
473.6, -
453.8) 
-125.2 (-
138.8, -
111.5) 
-103.2 (-
115.7, -
90.2) 
Midwifery staffing 451.7 (2.6) 573.6 (2.9) 572.6 (3.9) 602.9 (3.5) p<0.001 121.9.0 
(109.8, 
133.3) 
-120.9 
(107.7, 
137.6) 
151.1 
(136.9, 
165.2) 
Homebirth 
resources 
0.0 (0.0) 112.0 (0.2) 0.0 (0.0) 0.0 (0.0) p<0.001 111.7 
(111.2, 
112.1) 
0.0 (0.0, 
0.0) 
0.0 (0.0, 
0.0) 
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Transfer 0.0 (0.0) 31.6 (0.7) 46.3 (1.0) 0.003 (0.0) p<0.001 31.6 (29.1, 
33.8) 
46.2 (42.2, 
49.2) 
0.0036 
(0.0034, 
0.0037) 
Procedures after 
transfer 
0.0 (0.0) 49.4  (0.9) 34.0  (0.7) 40.3 (0.6) p<0.001 49.4 (47.6, 
51.2) 
33.9 (32.5, 
35.4) 
40.2 (38.9, 
41.5) 
Birth 175.4 (2.5) 71.1 (1.5) 89.2 (2.1) 108.2 (1.9) p<0.001 -104.4 (-
113.3, -
95.8) 
-86.2 (-
95.9, -76.2) 
-67.4 (-76.1, 
-56.1) 
Procedures 
during labour 
care  
151.5 (2.0) 46.1 (1.2) 61.5 (1.7) 79.6 (1.5) p<0.001 -105.3 (-
112.7, -
96.1) 
-90.1 (-
98.2, -82.4) 
-71.8 (-78.9, 
-63.3) 
Postnatal care 114.2  (0.7) 15.5  (0.4) 125.7 (0.9) 100.0 (0.6) p<0.001 -98.8 (-
101.3, -
96.1) 
11.5 (7.63, 
14.9) 
-14.23 (-
17.7, -11.7) 
Admission to 
higher care – 
mother  
18.5 (0.9) 7.3 (0.8) 8.9 (0.9) 11.0 (0.6) p<0.001 -11.3 (-15.3, 
-7.6) 
-9.6 (-15.4, 
-5.1) 
-7.6 (-10.8, 
-4.5) 
Admission to 
higher care – 
baby 
54.4 (5.8) 37.6 (4.3) 47.3 (7.8) 42.6 (6.4) 0.037 -16.9 (-39.5, 
5.5) 
-7.02 (-
38.9, -35.1) 
-11.7 (-27.1, 
20.3) 
Total cost 1510.6 (10.1) 1026.9 (8.8) 1405.0  (13.7) 1426.4  (11.3) p<0.001 -483.8 (-
537.5, -
435.6) 
-105.1 (-
165.4, -
45.6) 
-84.0 (-
114.4, -
55.2) 
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The mean cost of transfer per woman was highest for the FMU group 
compared with the other planned places of birth, though a small absolute 
cost, which reflected the slightly greater use of ambulance services and the 
comparatively longer distances travelled from FMUs. 
The mean cost of procedures during labour care included the costs of 
augmentation of labour, epidural or spinal analgesia, general anaesthesia, 
episiotomy, active management of the third stage of labour, repair of 
perineal trauma and the cost of blood transfusion. It was substantially 
higher in the women who planned to give birth in the OU (£174.1) 
compared with the planned non-OU settings; £64.9 (FMU), £83.9 (AMU) 
and £49.9 (home), p<0.001. 
Although the absolute costs for higher level post-natal and neonatal care 
were small, and few mothers or babies were admitted, the costs were still 
significantly higher in the planned OU birth setting, (p<0.05). 
‘Normal birth’ is that defined by the Maternity Care Working Party as birth 
with none of the following interventions: induction of labour, epidural or 
spinal analgesia; general anaesthetic; episiotomy; forceps, ventouse or 
caesarean section. Women with an induction of labour were excluded from 
the ‘low risk’ cohort included in this study. The following average costs were 
generated for women in all planned settings for birth; the average cost of 
‘normal birth’ was £938; the average cost of a spontaneous vaginal birth 
without complications was £947, which is similar to the HRG code for 
‘NZ11B normal delivery no clinical complications’ estimated at £976. 
‘NZ11A’ is the HRG code for ‘normal delivery with clinical complications’ 
costing £1,711; we calculated the average cost of spontaneous vaginal birth 
with clinical complications to be £2,081. Our results tended to show similar 
costs when compared to the HRG code estimates for straightforward 
uncomplicated births. Our estimates were slightly lower, possibly because 
women with high risk of complications at the start of care in labour were 
excluded from our analysis. Our cost estimates tended to be elevated 
compared with HRG costs for deliveries with clinical complications, for 
example, we estimated the average cost of a spontaneous vaginal birth with 
an epidural and with complications to be £2,448, compared with the HRG 
code NZ11C, which estimated ‘normal delivery with epidural with clinical 
complications’ at £1,868. 
Total costs capture the resource use and the unit costs associated with 
them. The total mean costs per ‘low risk’ woman planning a birth in the 
alternative settings at the start of care in labour were as follows: OU 
£1,631.2, AMU £1,461.2, FMU £1,434.9 and home £1,066.5. 
When women with complicating conditions at the start of care in labour 
were excluded from the analysis of mean cost per women, the average 
costs generally reduced, although the patterns of resource use and average 
costs that were estimated for the planned OU and non-OU settings 
remained similar to those shown in table 2. 
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Health care cost data tend to be highly skewed. This can only be partly 
addressed using parametric methods because the arithmetic mean is the 
informative instrument, providing information about the cost of treating all 
patients, which is required for healthcare policy decisions. (10) In order to 
fully address the skewed nature of the data we performed additional non-
parametric analyses on the cost differences between the planned settings 
for birth. Initially, we conducted a bootstrap (using 1,000 replications with 
resampling) of the mean cost differences for each cost category within this 
dataset, for women both with and without complicating conditions at the 
start of care in labour as shown in tables 2 and 3. 
The bootstrapped mean differences in total cost between the planned OU 
and non-OU settings for all ‘low risk’ women are: -£564.6 (reflecting the 
average cost saving of planned birth at home compared with an OU), -
£195.4 (reflecting the average cost saving of planned birth in a FMU 
compared with an OU) and -£169.5 (reflecting the average cost saving of 
planned birth in an AMU compared with an OU). 
This was repeated for women at ‘low risk’ without complicating conditions at 
the start of care in labour. Total mean costs decreased across all planned 
settings for birth, but this reduction was substantial for births planned in an 
OU and relatively small for births planned in non-OU settings. Total mean 
costs for women without complicating conditions at the start of care in 
labour approximated as follows: OU £1,510.6, AMU £1,426.4, FMU £1,405.0 
and home £1,026.9. It was found that the bootstrapped mean cost 
differences were: -£483.8 (reflecting the average cost saving of planned 
birth at home compared with an OU), -£105 (reflecting the average cost 
saving of planned birth in a FMU compared with an OU) and -£84 (reflecting 
the average cost saving of planned birth in an AMU compared with the OU). 
The mean cost differences between the OU and non-OU settings decreased 
and this is due to the reduction in costs borne by the OU when women 
without complicating conditions at the start of care in labour were excluded. 
Furthermore, an additional adjustment of this cost data was performed 
using a bootstrap (1,000 replications with resampling) of the data adjusted 
for the same confounders as in the multiple regression on clinical outcomes. 
Mean cost differences and standard errors were generated for these 
estimates. They are shown in section ‎3.4. 
3.4 Generalised linear regression on cost 
‎Table 4 shows the results of a generalised linear regression on total cost. 
Planned place of birth acted as the main exposure. Included as potential 
confounders in the analysis were parity, completed weeks of gestation, BMI, 
ethnicity, maternal age, IMD quintiles and mother’s understanding of 
English. The following variables acted as referents; planned place of birth 
(OU), parity(nulliparous), gestational age at birth (40 weeks), marital status 
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(married), BMI (19-24 kg/m2), ethnic group (white British), maternal age 
(25-29 years), IMD score (least deprived quintile) and mother’s 
understanding of English (fluent). When compared with planned place of 
birth in an OU, this regression shows that planned place of birth in non-OU 
settings are cost saving. This finding is statistically significant. Planned birth 
at home reduces costs the most, followed by approximately similar cost-
savings for planned birth in a FMU and then an AMU. The estimates 
produced from this regression were -£310 (the average cost saving of 
planned birth at home compared with an OU), -£130 (the average cost 
saving of planned birth in a FMU compared with an OU) and £-134 (the 
average cost saving of planned birth in an AMU compared with an OU). 
Adjusting for parity resulted in sizable and significant cost differences, 
which overshadowed all other adjustments for confounding and the mean 
costs of care were substantially reduced for women who were parous 
compared to nulliparous. This cost-saving was accentuated for each 
previous pregnancy. 
The costs of care increased above 40 weeks gestation at birth; for example, 
birth at 42-44 weeks gestation reflected a much higher cost increase (£462) 
than birth at 41 weeks gestation (£112.2). 
A maternal age of 35 – 39 years and above increased the mean costs of 
care, and this was even more apparent in women aged over 40 years. 
Being married (referent) seemed to be associated with being cost-saving 
when compared with being single or unsupported by a partner. 
A BMI below the referent (19-24 kg/m2) seemed to be cost saving, and a 
greater BMI than the referent more costly in terms of the provision of 
maternity care. A BMI that was ‘not recorded’ was associated with the 
highest cost increment in this category, and might have reflected a higher 
BMI score on average that was not recorded prior to the start of care in 
labour. 
IMD score and women’s understanding of English did not have significant 
effects on total cost. 
An additional bootstrapped analysis was performed on the adjusted 
weighted cost data. It generated the following cost differences between 
births planned in the different settings: average cost difference between 
planned births in an OU and at home -£366.8 (SE 38.1); average cost 
difference between planned birth in an OU and a FMU -£182.1, (SE 44.0); 
and average cost difference between planned birth in an OU and an AMU -
£129.3, (SE 59.2). All these cost figures are negative reflecting the cost-
saving effect of planned birth in a non-OU setting compared with planned 
birth in an OU setting. 
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Table 4. Cost per woman adjusted for socio-demographic and other factors: 
generalised linear regression* 
Covariate Coef.  Std. 
Err. 
p 
value  
[95% CI] 
Planned place birth OU (referent) -     
Planned place birth: home -310.0 11.2 0.000 -
332.05 
-287.9 
Planned place birth: FMU -130.1 13.4 0.000 -156.5 -103.7 
Planned place birth: AMU -134.4 12.2 0.000 -158.5 -110.4 
Parity: 0 prev pregnancy (referent) -     
Parity: 1 prev pregnancy -917.7 11.9 0.000 -941.1 -894.5 
Parity: 2 prev pregnancies -
1037.7 
13.3 0.000 -
1063.8  
-
1011.6 
Parity: 3+ prev pregnancies -
1058.3 
15.4 0.000 -
1088.5 
-
1028.2 
37 weeks gestation 54.7 25.4 0.031 4.9 104.5 
38 weeks gestation -56.1 13.3 0.000 -82.2 -30.0 
39 weeks gestation -72.4 9.5 0.000 -91.2 -53.7 
40 weeks gestation (referent) -     
41 weeks gestation 112.2 11.3 0.000 89.9 134.6 
42-44 weeks gestation 462.5 48.6 0.000 367.2 557.9 
Married (referent) -     
Single/unsupported partner 45.7 17.1 0.008 12.1 79.2 
BMI not recorded 50.1 10.9 0.000 28.6 71.6 
BMI 10-18 -19.2 24.7 0.438 -67.6 29.3 
BMI 19-24 (referent) -     
BMI 25-29 35.9 9.9 0.000 16.4 55.4 
BMI 30-35 33.1 14.7 0.024 4.3 61.8 
White British (referent) -     
Indian/Bangladeshi 42.0 27.9 0.131 -12.5  96.7 
Pakistani 56.3 30.3 0.063 -3.1   115.8 
Black Caribbean -62.9 36.3 0.083 -134.1 8.2 
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Black African 59.2 30.3 0.051  -0.2  118.8 
Mixed 27.0 32.1 0.400 -35.8  89.9 
Other 29.4 24.1 0.223  -17.9  76.7 
Maternal age <20 -159.8 22.7 0.000  -204.5 -115.2 
Maternal age 20-24 -44.8  12.1 0.000  -68.7  -20.9 
Maternal age 25-29 (referent)  -     
Maternal age 30-34 37.6  10.3 0.000  17.3  57.9 
Maternal age 35-39 58.5  11.8 0.000  35.2  81.8 
Maternal age 40-60 151.3  24.8 0.000  102.7  199.9 
IMD 0.37-8.31 (least deprived -
referent) 
 -     
IMD 8.32-13.73   15.4  13.0  0.234  -10.0  40.9 
IMD 13.74-21.21   30.6  12.8  0.017  5.4   55.8 
IMD 21.22-34.41   33.9  12.4  0.007  9.4   58.3 
IMD 34.42-85.46 (most deprived)  24.0 12.0  0.047  0.3   47.7 
Fluent in English (referent)    -     
Some English   19.2  24.6  0.435  -29.0  67.4 
No English   -39.9  40.2  0.322  -118.8  39.0 
Constant 2004.7 17.7  0.000  1969.9  2039.5 
*UK Sterling (2009/10 prices), estimated using a gamma distribution and an identity link 
function 
n= 62036 AIC = 16.26562 
3.5 Additional analyses of costs by parity sub-group 
Additional subgroup analyses of total mean costs were conducted by parity. 
These found the total bootstrapped weighted mean cost per ‘low risk’ 
nulliparous woman to be £2075.2 for a planned OU birth, £1,983.1 for a 
planned AMU birth, £1,912.5 for a planned FMU birth and £1,793.7 for a 
planned home birth. This compared to total bootstrapped weighted mean 
costs per ‘low risk’ multiparous woman of £1,142.4, 991.3, £968.9 and 
£780.4 for a planned OU birth, a planned AMU birth, a planned FMU birth 
and a planned home birth, respectively. 
The total bootstrapped weighted mean cost per ‘low risk’ nulliparous woman 
without complicating conditions at the start of care in labour was £1,940.4 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  46    
      
 
for a planned OU birth, £1932.5 for a planned AMU birth, £1,880.7 for a 
planned FMU birth and £1,719.0 for a planned home birth. In contrast, the 
total bootstrapped weighted mean costs per ‘low risk’ multiparous woman 
without complicating conditions at the start of care in labour was £1076.9 
for a planned OU birth, £978.3 for a planned AMU birth, £953.7 for a 
planned FMU birth and £765.8 for a planned home birth. 
3.6 Cost effectiveness 
Three sets of cost-effectiveness analyses were conducted; for adverse 
perinatal outcome averted, maternal morbidity avoided and additional 
‘normal birth’. These three measures enable a comprehensive analysis of 
cost-effectiveness of planned place of birth for women at ‘low risk’ of 
complications prior to the onset of labour both the baby and mother. 
The ICERs that were generated in these analyses are shown in ‎Tables 5-17 
and weighted bootstrapped scatterplots are represented graphically in cost-
effectiveness planes in Figures 1-30. ICER estimates were recalculated for 
women without complicating conditions at the start of care in labour, and 
subgroup analyses by parity were conducted for the estimates of 
incremental cost per adverse perinatal outcome averted. 
All sets of ICERs were bootstrapped. The origin of the cost-effectiveness 
planes represents the average cost and average effect for the reference 
group, in this case planned birth in an OU. The point estimates of mean 
ICERs therefore represent the incremental changes in costs and effects 
generated by the differences between the OU and the alternative planned 
places of birth. In each analysis, 1,000 bootstrapped mean ICERs were 
plotted on the cost effectiveness plane. They show the uncertainty around 
the mean reported ICERs. An attempt was made to fit all the vertical and 
horizontal axes to the same scale (x axis: +/-0.4, y axis: +/-£600), but this 
caused several ICER scatterplots to shrink into near point estimates, so the 
axes were individually adjusted to maximise the scatterplot presentation. 
They have been standardised to common scales for each outcome measure; 
‘perinatal’ outcome (x axis: +/- 0.009, y axis: +/- £700), maternal outcome 
(x axis: +/- 0.02, y axis: +/- £600), ‘normal birth’ (x axis: +/- 0.03, y axis: 
+/- £600). 
3.6.1 Cost-effectiveness analyses for the primary outcome 
The primary outcome measure was defined as a case of ‘intrapartum 
stillbirth and early neonatal mortality and specific neonatal morbidity’. 
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Table 5. Incremental cost effectiveness ratios and net benefit statistics for 
the primary outcome 
 Incremental cost per additional case of intrapartum 
stillbirth and early neonatal mortality and specific neonatal 
morbidity avoided 
Baseline (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU and 
non-OU setting 
(95% CI) 
-565 
(-591, -538) 
-196 
(-229, -163) 
-170 
(-199, -141) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
for Mean ICER† 7 950 356 -431 873 -296 400 
Quadrant on the cost-
effectiveness plane 
south west south east south east 
Mean net benefit 
(95% CI)* 
591.8 
(547.1, 638.6) 
263.3 
(210.9, 314.8) 
167.2 
(111.4, 223.7) 
†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
Estimated at a £20,000 cost-effectiveness threshold 
‎Table 5 shows the estimate of the ICER using differences in costs divided by 
differences in effects between planned place of birth and using the OU as 
the reference group. 
Differences in effects are calculated as the change in adverse perinatal 
outcome (a measure of negative outcome), by subtracting adverse perinatal 
outcome for planned birth in an OU from adverse perinatal outcome for 
planned birth in a non-OU setting. 
Differences in costs are calculated by subtracting mean costs for planned 
birth in an OU setting from mean costs in a non-OU setting. Thus the 
changes incosts for planned places of birth from an OU to non-OU settings 
are reflected as negative values in the table above, because they are cost-
saving. This is true for all the cost changes for the planned places of birth 
shown above in table 5. 
The incidence of adverse perinatal outcomes (intrapartum stillbirth, early 
neonatal death, neonatal encephalopathy, meconium aspiration and 
specified birth related injuries including brachial plexus injury) was low in all 
settings. However, when differences in effects were measured, asmall 
increase in adverse perinatal outcome was identified in the planned home 
birth group, explaining the negative summary statistic as shown in the 
table. We know from the prospective cohort study that a significantly 
increased odds of an adverse perinatal outcome for ‘low risk’ nulliparous 
women was identified in the planned home birth group. For multiparous 
women, there were no statistically significant differences between birth 
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settings in rates of adverse perinatal outcome. The ICER measure shown in 
the table is, on average, positive for the cost-effectiveness analysis of 
switching from planned birth in an OU to home, being both cost saving but 
with a small increase in adverse perinatal outcome. It is, on average, 
negative for the switches to planned birth in midwifery units reflecting both 
cost-savings and positive perinatal effects. The differences in effects are 
very small; however these are magnified in the ICER calculations, as the 
mean differences in effects are used as the denominators of the ICER 
statistics. Thus the ICER estimates range from -£296,400 to £7,950,356, 
reflecting sizable reductions in cost and small changes in perinatal outcome 
when measuring differences between planned birth in an OU and non-OU 
settings. These estimates have very wide confidence intervals. 1,000 
bootstrapped weighted estimates for each of the ICERs are presented on 
cost-effectiveness planes in figures 1-3 below. 
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Figure 1. Cost effectiveness plane: planned birth at home compared with 
OU for all ‘low risk’ women 
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Figure 2. Cost effectiveness plane: planned birth in a FMU compared with 
OU for all ‘low risk’ women 
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Figure 3. Cost effectiveness plane: planned birth in an AMU compared with 
OU for all ‘low risk’ women 
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The scatterplots of bootstrapped ICERs fall across the south west and south 
east quadrants of the cost-effectiveness planes (Figures 1-3). This 
represents a lower cost attributable to births in planned non-OU settings, 
but also represents considerable uncertainty about any difference in the 
primary clinical outcome for the groups of women who planned their birth in 
non-OU settings. The south east quadrant represents improved outcomes 
and the south west quadrant worse outcomes, though they both represent 
lower cost. 
3.6.2 Cost-effectiveness analyses for the primary outcome for 
‘low risk’ women without complicating conditions at the start 
of care in labour 
The primary outcome is defined as a case of ‘intrapartum and early 
neonatal mortality and specific neonatal morbidity’. The analyses were 
repeated for women without complicating conditions at the start of labour 
care. 
Table 6 reflects very small differences in effectiveness between the planned 
places of birth. The mean ICER statistics is positive for the cost-
effectiveness analyses assessing changes from planned birth in an OU to 
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non-OU settings, being on average both cost-saving but with a small 
increase in adverse perinatal outcome. Asin table 5, the differences in 
effects are small; however these are magnified in the ICER calculations, as 
the mean differences in effectiveness are used as the denominators of the 
ICER statistics. Thus the mean ICER estimates range from £143,382 (AMU) 
to £497,595 (home), reflecting, on average, sizable reductions in costs and 
small changes in perinatal outcomes. These changes in adverse perinatal 
outcome were not significant for planned births in midwifery units. 
The cost differences between planned birth in the OU and non-OU settings 
were smaller in this set of analyses. This is due to the reduction in the total 
cost following the exclusion of women at ‘low risk’ who had complicating 
conditions at the start of care in labour. A disproportionate number of 
women with complicating conditions noted at the start of labour care were 
observed in the planned OU group. When excluded, summary statistics 
show a narrowing of the cost differences between the OU and the other 
birth settings. Consequently, in these additional analyses, reductions in the 
OU-related costs are captured by the decreased mean ICER statistics. The 
cost differences here are closer to the costs reflected in the adjusted costs 
shown in the multiple regression, which were -£310 (home compared with 
OU), -£130.1 (FMU compared with OU) and -£134 (AMU compared with the 
OU) (table 4). They are also similar to the cost differences calculated in the 
adjusted bootstrapped analysis (OU and home:-£366.8 OU and FMU -
£182.1, OU and AMU -£129.3), and are therefore possibly more 
representative of the true cost differences for outcomes of women at ‘low 
risk’ prior to the onset of labour.Figures 4-6 show scatterplots of the 1,000 
bootstrapped ICER estimates for the analyses shown in table 6. 
Table 6. Incremental cost effectiveness ratios and net benefit statistics for 
the primary outcome for women without complicating conditions at the 
start of care in labour 
 Incremental cost per additional case of intrapartum 
stillbirth and early neonatal mortality and specific 
neonatal morbidity avoided 
Baseline (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU and 
non-OU setting 
(95% CI) 
-484 
(-511, -456) 
-105 
(-139, -71) 
-84 
(-115, -53) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.0009 
(-0.0023, -0.0003) 
-0.0003 
(-0.0017, 0.0011) 
-0.0005 
(-0.0019, 0.0007) 
Mean ICER† 497 595 313 886 143 382 
Quadrant on the cost-
effectiveness plane 
south west south west south west 
Mean net benefit 
(95% CI)* 
482.8 
(434.3, 534.4) 
142.6 
(91.8, 192.5) 
58.3 
(4.5, 113.6) 
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†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
Estimated at a £20 000 cost-effectiveness threshold 
 
Figure 4. Cost effectiveness plane: planned birth at home compared with 
OU for ‘low risk’ women without complicating conditions at the start of 
care in labour 
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Figure 5. Cost effectiveness plane: planned birth in a FMU compared with 
OU for all ‘low risk’ women without complicating conditions at the start of 
care in labour 
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When women with complicating conditions at the start of labour care were 
excluded from these analyses (see figures 4-6), then we observed cost 
savings but with an associated small increase in adverse perinatal outcomes 
that was not statistically significant in the midwifery units. The cost savings 
were smaller than in the previous analyses. Although all the scatterplots fell 
within the south west and south east quadrants, their position changed 
reflecting reduced cost savings though similar levels of uncertainty 
surrounding the changes in adverse perinatal outcomes. 
3.6.3 Sensitivity analyses performed on the primary cost-
effectiveness outcome for all ‘low risk’ women 
Sensitivity analyses were performed on key cost variables. Uncertainty 
remained about the modelled overheads costs and the midwifery costs, 
which included CNST contributions. These were also seen to be generic cost 
drivers relevant to all settings of birth. Estimates of effects (adverse 
perinatal outcome) were not changed for these analyses. 
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Figure 6. Cost effectiveness plane: planned birth in an AMU compared with 
OU for all ‘low risk’ women without complicating conditions at the start of 
care in labour 
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When overheads for all birth settings (excluding home) were recoded to be 
20% greater than their original unit cost, the mean cost differences 
between planned birth at home and planned birth in an OU increased as 
would be expected, and narrowed between the planned OU and midwifery 
settings, reflecting the increased costs experienced by all units. When 
overheads were reduced by 20%, the mean cost differences narrowed. This 
shows that the OU has a higher overhead cost per labour episode per 
woman, and consequently carries more of the ‘burden’ of the overhead 
costs when compared with care in midwifery units. 
Occupancy rates in FMUs and AMUs were then increased to 50% greater 
than baseline, and for the OU up to full capacity (100% occupancy), which 
was less than the 50% increase for FMUs and AMUs. The cost differences 
between planned place of birth in an OU and at home narrow, as would be 
expected. Cost differences between all units increase as the FMUs and AMUs 
become more ‘efficient’ due to a higher throughput. The cost-savings 
increased and, as a result of higher occupancy rates, planned place of birth 
in non-OU midwifery units will become even more cost-effective. 
In this study, assumptions based on primary research had been made about 
midwifery staff to woman ratios during labour across different settings. This 
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was recorded as either intermittent or continuous support that midwifery 
staff were able to offer in different birth settings. Planned FMU and AMU 
births had all been attributed continuous midwifery support and this was 
reduced to 80% in a sensitivity analysis, with a consequent increase in the 
mean ICERs. Similarly, the midwifery staff to woman ratio during labour in 
OU settings had been set at 65% in the baseline analysis and this was 
subsequently varied to between 50% and 90%. As would be expected, the 
cost differences narrowed between settings when midwifery support during 
labour decreased in OU settings, and increased when midwifery support 
during labour increased in OU settings. It is impossible to comment on the 
‘quality of care’ impact that these proportional changes in dedicated staff 
time could have, but this would be valuable to ascertain in future research. 
The findings were generally robust to the sensitivity analyses that shed 
more light on the nature of the main cost drivers: overheads, occupancy 
rates and midwifery support during labour, and indicate that the cost-
effectiveness results depicted as ICERs respond to changes in these 
variables in a manner consistent with our expectations. 
Table 7. Sensitivity analyses performed on cost variables for the primary 
cost-effectiveness outcome 
Sensitivity analyses  
 Incremental cost per additional case of intrapartum 
stillbirth and early neonatal mortality and specific 
neonatal morbidity avoided 
1) Overheads 20% greater than baseline 
 (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-616 
(-744, -588) 
-160 
(-196, -125) 
-133 
(-164, -101) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
Mean ICER† 8 669 940 
 
-352 975 
 
-231 449 
 
Quadrant on the cost-
effectiveness plane  
south west south east south east 
2) Overheads 20% lower than baseline 
 (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-469 
(-495, -444) 
-168 
(-199, -136) 
-146 
(-175, -118) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
Mean ICER† 6 607 830 
 
-368 790 
 
-255 019 
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Quadrant on the cost-
effectiveness plane south west south east south east 
3) Occupancy rates 50% greater than baseline 
 (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-488 
(-514.-463) 
-234 
(-266, -202) 
-208 
(-236, -179) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
Mean ICER† 
 
6 875 502 
 
-514 135 
 
-361 770 
 
Quadrant on the cost-
effectiveness plane 
south west south east south east 
4) Midwifery staffing in the AMU and FMU 20% less than baseline (80% 
intermittent care) 
 (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-565 
(-591, -538) 
-294 
(-327, -261) 
-270 
(-299, -241) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
Mean ICER† 7 950 355 
 
-647 054 
 
-470 778 
 
Quadrant on the cost-
effectiveness plane 
south west south east south east 
5) Midwifery staffing in the OU 15% less than baseline (50% intermittent care) 
 (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-456 
(-482, -430) 
-87 
(-120, -55) 
-61 
(-90, -32) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
Mean ICER† 6 415 591 
 
-192 025 
 
-106 363 
 
Quadrant on the cost-
effectiveness plane 
south west south east south east 
6) Midwifery staffing in the OU 25% greater than baseline (90% intermittent 
care) 
 (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-746 
(-774, -719) 
-378 
(-412, -344) 
-352 
(-382, -321) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.00007 
(-0.0014, 0.0013) 
+0.0004 
(-0.0010, 0.0019) 
+0.0005 
(-0.0007, 0.0019) 
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Mean ICER† 10 508 297 
 
-831 620 
 
-613 129 
 
Quadrant on the cost-
effectiveness plane 
south west south east south east 
†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
3.6.4 Cost-effectiveness analyses for the primary outcome for 
‘low risk’ nulliparous women 
Table 8 captures the cost and effect differences between the planned OU 
and non-OU settings for ‘low risk’ nulliparous women. The mean ICER for 
planned birth at home lies in the south west quadrant of the cost-
effectiveness plane (figure 7), reflecting on average both a less effective 
and less-costly maternity option than planned birth in an OU. The 
differences in effects were calculated in the prospective cohort study and 
were found to be significant (0.05 level of statistical significance). The mean 
ICERs for planned birth in an FMU or an AMU did not reflect significant 
differences in effects and lay in the south east quadrants of the cost-
effectiveness plane (figures 8-9), reflecting, on average, reduced costs and 
improved outcomes but with substantial uncertainty surrounding the latter. 
The cost differences between planned OU and non-OU settings narrowed in 
comparison to the cost differences between the settings for all ‘low risk’ 
women. The costs of intrapartum maternity care in all settings was higher 
for nulliparous low risk women when compared with all ‘low risk’ women. 
Table 8. Incremental cost effectiveness ratios and net benefit statistics for 
the primary outcome for ‘low risk’ nulliparous women 
 Incremental cost per additional case of intrapartum 
stillbirth and early neonatal mortality and specific 
neonatal morbidity avoided 
Baseline (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-281 
(-342.6, -217.2) 
-163 
(-216.5, -108.3) 
-92 
(-142.4, -33.4) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.004 
(-0.008, -0.00001) 
0.0008 
(-0.002, 0.003) 
0.0005 
(-0.003, 0.003) 
Mean ICER† 69761.23 -98135.8 -47994.9 
Quadrant on the cost-
effectiveness plane 
south west south east south east 
Mean net benefit 
(95% CI)* 
203.8 
(77.4, 319.2) 
179.2 
(97.8, 259.3) 
103.3 
(9.2, 188.6) 
†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
*Estimated at a £20 000 cost-effectiveness threshold 
© Queen’s Printer and Controller of HMSO 2011. This work was produced by the Birthplace in 
England research programme et al. under the terms of a commissioning contract issued by the 
Secretary of State for Health. Project 08/1604/140  58    
      
 
Figure 7. Cost effectiveness plane: planned birth at home compared with 
OU for ‘low risk’ nulliparous women 
 
 
Figure 8. Cost effectiveness plane: planned birth in a FMU compared with 
OU for ‘low risk’ nulliparous women 
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Figure 9. Cost effectiveness plane: planned birth in an AMU compared with 
OU for ‘low risk’ nulliparous women 
 
3.6.5 Cost-effectiveness analyses for the primary outcome for 
‘low risk’ nulliparous women without complicating conditions 
at the start of care in labour 
When the data were analysed for low risk nulliparous women without 
complicating conditions at the start of care in labour, the ICER scatterplot 
for planned birth at home lay entirely within the south west quadrant of the 
cost-effectiveness plane (figure 10). This reflects both a less costly and less 
effective option for intrapartum maternity care than planned birth in an OU. 
The differences in effects were calculated in the prospective cohort study 
and were found to be significant (0.05 level of statistical significance). 
ICERs for this comparison are shown in Table 9. The differences in adverse 
perinatal outcomes generated by planned birth in a FMU or an AMU were 
not statistically significant (table 9). The cost differences between these 
settings and the OU setting narrow as shown in table 9 and the ICER 
scatterplots (figures 11-12). 
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Table 9. Incremental cost effectiveness ratios and net benefit statistics for 
the primary outcome for ‘low risk’ nulliparous women without 
complicating conditions at the start of care in labour 
 Incremental cost per additional case of intrapartum 
stillbirth and early neonatal mortality and specific 
neonatal morbidity avoided 
Baseline (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU and 
non-OU setting 
(95% CI) 
-222.4 
(-281.4, -157.3) 
-58.8 
(-117.1, -2.9) 
-8.04 
(-61.1, 48.1) 
Difference in adverse 
perinatal outcome 
(95% CI) 
-0.006 
(-0.011, -0.002) 
-0.001 
(-0.004, 0.0012) 
-0.00099 
(-0.0041, 0.0013) 
Mean ICER† 
(95% CI) 
39177.6 
(16734, 103511) 
30168.8 1630.8 
Quadrant on the cost-
effectiveness plane 
south west south west south west 
Mean net benefit 
(95% CI)* 
98.1 
(-34.5, 210.3) 
34.9 
(-34.4, 126.7) 
-12.7 
(-99.2, 63.5) 
†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
*Estimated at a £20 000 cost-effectiveness threshold 
Figure 10. Cost effectiveness plane: planned birth at home compared with 
OU for ‘low risk’ nulliparous women without complicating conditions at 
the start of care in labour 
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Figure 11. Cost effectiveness plane: planned birth in a FMU compared with 
OU for ‘low risk’ nulliparous women without complicating conditions at 
the start of care in labour 
 
Figure 12. Cost effectiveness plane: planned birth in an AMU compared with 
OU for ‘low risk’ nulliparous women without complicating conditions at 
the start of care in labour 
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3.6.6 Cost-effectiveness analyses for the primary outcome for 
‘low risk’ multiparous women 
When the cost-effectiveness analyses for the primary outcome were 
replicated for low risk multiparous women, all mean ICER statistics lay in 
the south east quadrant of the cost-effectiveness plane (Table 10), 
reflecting on average, reduced costs and improved perinatal outcomes in 
the planned non-OU settings, though considerable uncertainty surrounded 
the effects on perinatal outcomes (figures 13-15). 
 
Table 10. Incremental cost effectiveness ratios and net benefit statistics for 
the primary outcome for ‘low risk’ multiparous women 
 Incremental cost per additional case of intrapartum stillbirth 
and early neonatal mortality and specific neonatal morbidity 
avoided 
    
Baseline (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
    
Cost differences between 
planned birth in an OU and 
non-OU setting 
(95% CI) 
-362 
(-389.7, -335.2) 
-173 
(-207.8, -138.6) 
-151 
(-183.7, -117.0) 
Difference in adverse 
perinatal outcome 
(95% CI) 
0.001 
(-0.0004, 0.0025) 
0.0005 
(-0.0015, 0.0024) 
0.0007 
(-0.001, 0.003) 
Mean ICER† -323037.4 -128133.8 -119618.4 
Quadrant on the cost-
effectiveness plane 
south east south east south east 
Mean net benefit 
(95% CI)* 
381.7 
(336.1, 426.9) 
182.4 
(119.8, 244.0) 
164.6 
(114.6, 222.0) 
†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
*Estimated at a £20 000 cost-effectiveness threshold 
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Figure 13. Cost effectiveness plane: planned birth at home compared with 
OU for ‘low risk’ multiparous women 
 
 
Figure 14. Cost effectiveness plane: planned birth in a FMU compared with 
OU for ‘low risk’ multiparous women 
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Figure 15. Cost effectiveness plane: planned birth in an AMU compared with 
OU for ‘low risk’ multiparous women 
 
3.6.7 Cost-effectiveness analyses for the primary outcome for 
‘low risk’ multiparous women without complicating conditions 
at the start of care in labour 
When the cost-effectiveness analyses for the primary outcome were 
replicated for low risk multiparous women without complicating conditions 
at the start of care in labour, the mean ICER statistics for planned birth in a 
FMU and at home lay in the south east quadrant of the cost-effectiveness 
plane (table 11), reflecting, on average reduced costs and improved 
perinatal outcomes in these settings. In contrast, the mean ICER statistic 
for planned birth in an AMU lay in the south west quadrant of the cost-
effectiveness plane (table 11), reflecting, on average reduced costs and 
worst outcomes in this setting. Considerable uncertainty surrounded the 
effects on perinatal outcomes in all three comparisons (figures 16-18). 
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Table 11. Incremental cost effectiveness ratios and net benefit statistics for 
the primary outcome for ‘low risk’ multiparous women without 
complicating conditions at the start of care in labour 
 Incremental cost per additional case of intrapartum 
stillbirth and early neonatal mortality and specific 
neonatal morbidity avoided 
Baseline (OU ) → (Home) (OU ) → (FMU) (OU ) → (AMU) 
Cost differences between 
planned birth in an OU 
and non-OU setting 
(95% CI) 
-311.2 
(-340.4, -284.7) 
-123.6 
(-158.4, -87.7) 
-98.3 
(-64.01, -131.97) 
Difference in adverse 
perinatal outcome 
(95% CI) 
0.0005 
(-0.0008, 0.0019) 
0.0003 
(-0.0015, -
0.0020) 
-0.00009 
(-0.00196, 
0.00162) 
Mean ICER† -315419.8 -92180.1 47221.6 
Quadrant on the cost-
effectiveness plane 
south east south east south west 
Mean net benefit 
(95% CI)* 
321.2 
(270.7, 367.3) 
128.4 
(71.2, 183.2) 
97.8 
(40.7, 150.7) 
†95% CI surrounding the ICERs are not provided because bootstrapped replicates of the 
ICERs fall across more than one quadrant of the cost-effectiveness plane 
*Estimated at a £20 000 cost-effectiveness threshold 
Figure 16. Cost effectiveness plane: planned birth at home compared with 
OU for ‘low risk’ multiparous women without complicating conditions at 
the start of care in labour 
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Figure 17. Cost effectiveness plane: planned birth in a FMU compared with 
OU for ‘low risk’ multiparous women without complications at the start of 
care in labour 
 
 
Figure 18. Cost effectiveness plane: planned birth in an AMU compared with 
OU for ‘low risk’ multiparous women without complicating conditions at the 
start of care in labour 
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3.6.8 Cost-effectiveness analyses for maternal morbidity 
outcome for all ‘low risk’ women 
All three planned non-OU settings for birth led to increases in positive 
maternal outcomes and reductions in costs to the NHS when compared to 
planned birth in an OU (see table 12 and figures 19-21). In this analysis the 
negative ICER summary statistic reflects a cost saving (negative estimate) 
combined with a positive change in outcome (maternal morbidity avoided). 
The change in maternal morbidity avoided shown in table 12 is calculated as 
the estimate of maternal morbidity avoided for planned birth in an OU 
subtracted from planned birth at home, FMU or an AMU. The mean 
estimates of women without a maternal morbidity were generated using 
1,000 bootstrapped replications of weighted data. Table 12 reflects the 
differences in these outcome measures. 
Table 12. Incremental cost effectiveness ratios and net benefit statistics for 
the maternal outcome 
 Incremental cost per additional case of 
maternal morbidity avoided‡  
Baseline (OU ) → 
(Home) 
(OU ) → 
(FMU) 
(OU ) → 
(AMU) 
Cost differences between planned 
birth in an OU and non-OU setting 
(95% CI) 
-590 
(-618, -563) 
-247 
(-280, -211) 
-154 
(-190, -118) 
Differences in maternal morbidity 
avoided 
(95% CI) 
+0.195 
(+0.187, 
+0.204) 
+0.172 
(+0.168, 
+0.182) 
+0.116 
(+0.106, 
+0.126) 
Mean ICER -3024 -1442 -1322 
95% CI (-3138, -
2912) 
(-1600, -
1284) 
(-1572, -
1049) 
Quadrant on the cost-effectiveness 
plane 
south east south east south east 
Mean net benefit 
(95% CI)* 
4497.7 
(4305.5, 
4669.3) 
3683.1 
(3451.0, 
3904.3) 
2486.1 
(2259.4, 
2691.6) 
‡Avoidance of at least one of the following: general anaesthetic; instrumental birth; 
caesarean section, third or fourth degree perineal trauma; blood transfusion; 
admission to an intensive therapy unit, high dependency unit or specialist unit; 
and maternal death (within 42 days of giving birth). This is a composite measure 
and was also the secondary outcome of interest in the Birthplace prospective 
cohort study. 
*Estimated at a £20 000 cost-effectiveness threshold 
Figures 19-21 show cost-effectiveness scatterplots of the 1,000 
bootstrapped ICER estimates for the analyses summarised in table 12. 
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Figure 19. Cost effectiveness plane: planned birth at home compared with an 
OU for all ‘low risk’ women 
 
 
Figure 20. Cost effectiveness plane: planned birth in a FMU compared with 
an OU for all ‘low risk’ women 
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Figure 21. Cost effectiveness plane: planned birth in an AMU compared 
with an OU for all ‘low risk’ women 
 
All bootstrapped ICERs fell within the south east quadrant of the cost-
effectiveness planes (figures 19-21), suggesting that planned non-OU births 
for ‘low risk’ women will generate positive maternal outcomes and less 
costly care when compared with planned birth in an OU. 
3.6.9 Cost-effectiveness analyses for maternal morbidity 
outcome for ‘low risk’ women without complicating conditions 
at the start of care in labour 
When women with complicating conditions at the start of labour care were 
removed from these analyses, similar results were obtained, though the 
absolute cost savings were smaller (see table 13 and figures 22-24). These 
reductions in cost differences do not affect the uncertainty around the 
estimates reflected by the bootstrapped ICER scatterplots. They all fall 
within the south east quadrant of the cost-effectiveness plane, suggesting 
that planned place of birth in non-OU settings still generates positive effects 
in maternal morbidity avoided and less costly care, compared with planned 
birth in an OU. When planned birth in an AMU is compared with planned 
birth in an OU, the scatterplot falls very close to the x-axis, between the 
south east quadrant, which reflects reduced costs, and the north east 
quadrant, which reflects increased costs, though they both represent 
improved outcomes. Patterns of resource use in the AMU tend to reflect 
similarities with the OU, with a consequent converging of their total mean 
costs per woman. 
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Table 13. Incremental cost effectiveness ratios and net benefit statistics for 
the maternal outcome for women without complicating conditions at the 
start of care in labour 
 Incremental cost per additional case of 
maternal morbidity avoided‡  
Baseline (OU ) → 
(Home) 
(OU ) → 
(FMU) 
(OU ) → 
(AMU) 
Cost differences between planned 
birth in an OU and non-OU setting 
(95% CI) 
-504 
(-535, -474) 
-150 
(-186, -115) 
-69 
(-105, -36) 
Differences in maternal morbidity 
avoided 
(95% CI) 
+0.165 
(0.156, 0.174) 
+0.139 
(+0.131, 
+0.149) 
+0.088 
(0.078, 0.098) 
Mean ICER -3052 -1075 -782 
95% CI (-3215, -
2902) 
(-1285, -843) (-1130, -
431) 
Quadrant on the cost-effectiveness 
plane 
south east south east south east 
Mean net benefit 
(95% CI)* 
3807.7 
(3619.6, 
4011.7) 
2941.9 
(2742.7, 
3165.9) 
1827.9 
(1605.3, 
2058.9) 
‡Avoidance of at least one of: general anaesthetic; instrumental birth; caesarean 
section; third or fourth degree perineal trauma; blood transfusion; admission to 
an intensive therapy unit, high dependency unit or specialist unit; and maternal 
death (within 42 days of giving birth). This is a composite measure and was also 
the secondary outcome of interest in the Birthplace prospective cohort study. 
*Estimated at a £20 000 cost-effectiveness threshold 
Figure 22. Cost effectiveness plane: planned birth at home compared with an 
OU for women without complicating conditions at the start of care in 
labour 
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Figure 23. Cost effectiveness plane: planned birth in a FMU compared with 
an OU for women without complicating conditions at the start of care in 
labour 
 
 
Figure 24. Cost effectiveness plane: planned birth in an AMU compared with 
an OU for women without complicating conditions at the start of care in 
labour 
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3.6.10 Sensitivity analyses performed on maternal morbidity 
outcome for all ‘low risk’ women 
Sensitivity analyses were performed on key cost variables and the resulting 
impacts on the ICER statistics for the maternal morbidity outcome were 
estimated (table 14). The modelled overheads costs and the midwifery 
costs, which included CNST contributions, were varied. When overheads for 
all birth settings (excluding home) were recoded to be 20% greater than 
their original unit cost, the mean cost differences between planned birth at 
home and the OU increased, as would be expected, whilst they narrowed 
between the planned OU and midwifery settings, reflecting the increased 
costs experienced by all units. When overheads were reduced by 20%, the 
mean cost differences narrowed. This shows that the OU has a higher mean 
overhead cost per labour episode per woman, and consequently carries 
more of the ‘burden’ of the overhead costs when compared with care in 
midwifery units. 
The cost-savings increased with higher occupancy rates; consequently, the 
non-OU settings become even more cost-effective. 
Planned birth in FMUs and AMUs had all been attributed continuous support 
during labour and this was reduced to 80% in a sensitivity analysis, with a 
consequent increase in the mean ICER statistics. Similarly, the midwifery 
staff to woman ratio during labour in OU settings had been set at 65% in 
the baseline analyses, and this was subsequently varied between 50% and 
90% care. As would be expected, the cost differences narrowed between all 
settings midwifery support during labour in OU settings decreased, and 
increased when midwifery support during labour in OU settings was set at 
90% direct contact time. The findings were generally robust to changes in 
the sensitivity analyses and indicate that the cost-effectiveness results 
depicted as ICERs respond to changes in key cost variables in a manner 
consistent with our expectations. 
Table 14. Sensitivity analyses performed on cost variables for the maternal 
morbidity cost-effectiveness outcome 
 Incremental cost per additional case of 
maternal morbidity avoided 
 (OU ) → 
(Home) 
(OU ) → 
(FMU) 
(OU ) → 
(AMU) 
1) Overheads 20% greater than baseline 
Cost differences between planned birth in 
an OU and non-OU setting 
(95% CI) 
-686 
(-715, -658) 
-278 
(-312, -240) 
-176 
(-213, -138) 
Differences in maternal morbidity avoided 
(95% CI) 
0.195 
(0.187, 0.204) 
+0.171 
(0.162, 0.181) 
+0.116 
(0.106, 0.125) 
Mean ICER 
95% CI  
-3528 
(-3644, -3395) 
-1620 
(-1784, -
1457) 
-1511 
(-1771, -
1229) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
2) Overheads 20% lower than baseline 
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Cost differences between planned birth in 
an OU and non-OU setting 
(95% CI) 
-346 
(-374, -320) 
-165 
(-197, -131) 
-61 
(-96, -28) 
Differences in maternal morbidity avoided 
(95% CI) 
0.195 
(0.187, 0.204) 
+0.171 
(0.161, 0.182) 
+0.116 
(0.107, 0.126) 
Mean ICER 
95% CI 
-1773 
(-1873, -1661) 
-960 
(-1119, -792) 
-519 
(-778, -289) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
3) Occupancy rates 50% greater than baseline 
Cost differences between planned birth in 
an OU and non-OU setting 
(95% CI) 
-512 
(-540.-485) 
-282 
(-314, -248) 
-194 
(-228, -160) 
Differences in maternal morbidity avoided 
(95% CI) 
0.195 
(0.186, 0.204) 
+0.171 
(0.162, 0.181) 
+0.116 
(0.106, 0.125) 
Mean ICER 
95% CI 
-2628 
(-2736, -2528) 
-1648 
(-1796, -
1505) 
-1666 
(-1901, -
1407) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
4) Midwifery staffing in the AMU and FMU 20% less than baseline (80% intermittent 
care) 
Cost differences between planned birth in 
an OU and non-OU setting 
(95% CI) 
-590 
(-618, -562) 
-344 
(-376, -309) 
-256 
(-292, -221) 
Differences in maternal morbidity avoided 
(95% CI) 
0.195 
(0.187, 0.204) 
+0.171 
(0.162, 0.181) 
+0.116 
(0.106, 0.125) 
Mean ICER 
95% CI 
-3024 
(-3381, -2912) 
-2008 
(-2138, -
1879) 
-2201 
(-2447, -
1941) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
5) Midwifery staffing in the OU 15% less than baseline (50% intermittent care) 
Cost differences between planned birth in 
an OU and non-OU setting 
(95% CI) 
-480 
(-503, -453) 
-137 
(-170, -102) 
-44 
(-79, -9) 
Differences in maternal morbidity avoided 
(95% CI) 
0.195 
(0.187, 0.204) 
+0.171 
(0.162, 0.181) 
+0.116 
(0.106, 0.125) 
Mean ICER 
95% CI 
-2461 
(-2550, -2374) 
-801 
(-942, -650) 
-377 
(-656, -88) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
6) Midwifery staffing in the OU 25% greater than baseline (90% intermittent care) 
Cost differences between planned birth in 
an OU and non-OU setting 
(95% CI) 
-773 
(-802, -744) 
-430 
(-465, -393) 
-337 
(-367, -307) 
Differences in maternal morbidity avoided 
(95% CI) 
0.195 
(0.187, 0.204) 
+0.171 
(0.162, 0.181) 
+0.116 
(0.106, 0.125) 
Mean ICER 
95% CI 
-3926 
(-4096, -3824) 
-2509 
(-2676, 2355) 
-2896 
(-3115, -
2670) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
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3.6.11 Cost-effectiveness analyses for ‘normal birth’ outcome for 
all ‘low risk’ women 
In the third set of cost-effectiveness analyses, ‘normal birth’ was the 
effectiveness measure (‎see table 15 and figures 25-27). The incidence of 
‘normal births’ was highest for planned births at home, then planned births 
in a FMU, then planned births in an AMU and lowest in planned births in an 
OU. The results of the cost-effectiveness analyses were almost identical to 
those generated for the maternal morbidity outcome; all ICERs reflected 
both cost-savings and improved outcomes in ‘normal birth’ when planned 
place of birth changed from an OU to a non-OU setting. Planned birth at 
home generated both the greatest cost-savings and the highest proportion 
of ‘normal births’ when compared with the other non-OU settings, and 
consequently the largest (negative) mean ICER statistic (table 15). 
Table 15. Incremental cost effectiveness ratios and net benefit statistics for 
‘normal birth’ 
 Incremental cost per additional case of 
‘normal birth’ 
Baseline (OU ) → 
(Home) 
(OU ) → 
(FMU) 
(OU ) → 
(AMU) 
Cost differences between planned 
births in an OU and non-OU setting 
(95% CI) 
-590 
(-618, -563) 
-247 
(-280, -211) 
-154 
(-190, -118) 
Differences in ‘normal birth’ 
(95% CI) 
+0.30 
(+0.29,+0.31) 
+0.256 
(+0.245, 
+0.268) 
+0.184 
(+0.173, 
+0.194) 
Mean ICER -1960 -956 -836 
(95% CI) (-2034, -
1890) 
(-1076, -
847) 
(-1002, -
664) 
Quadrant on the cost-effectiveness 
plane 
south east south east south east 
Mean net benefit 
(95% CI)* 
6608.9 
(6411.2, 
6809.7) 
5376.5 
(5132.8, 
5618.4) 
3828.4 
(3599.9, 
4051.9) 
*Estimated at a £20 000 cost-effectiveness threshold 
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Figure 25. Cost effectiveness plane: planned birth at home compared with an 
OU 
 
 
Figure 26. Cost effectiveness plane: planned birth in a FMU compared with 
an OU 
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Figure 27. Cost effectiveness plane: planned birth in an AMU compared with 
an OU 
 
3.6.12 Cost-effectiveness analyses for ‘normal birth’ outcome for 
women without complicating conditions at the start of care in 
labour 
When women with complicating conditions identified at the start of care in 
labour were removed from these analyses, the findings broadly replicated 
those for the ‘normal birth’ cost-effectiveness outcome for all ‘low risk’ 
women (‎see table 16 and figures 28-30). We know from the prospective 
cohort study that for planned OU births, there appeared to be an 
association between complicating conditions at the start of care in labour 
and ‘normal birth’: 40% of women with complicating conditions at the start 
of care in labour had a ‘normal birth’ compared with 63% of women without 
complicating conditions at the start of care in labour.(9) Planned birth at 
home or in a FMU generates positive normal birth health effects and less 
costly care. Planned birth in an AMU generate cost savings though the 
bootstrap scatterplot approaches the x-axis of the cost-effectiveness plane. 
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Table 16. Incremental cost effectiveness ratios and net benefit statistics for 
‘normal birth’ for women without complicating conditions at the start of 
care in labour 
 Incremental cost per additional case of 
‘normal birth’ 
 (OU ) → 
(Home) 
(OU ) → 
(FMU) 
(OU ) → 
(AMU) 
Cost differences between planned births 
in an OU and non-OU setting 
(95% CI) 
-504 
(-535, -474) 
-150 
(-187, -116) 
-69 
(-105, -36) 
Differences in ‘normal birth’ 
(95% CI) 
+0.266 
(+0.256, 
0.275) 
+0.218 
(0.207, 
0.229) 
+0.149 
(+0.138, 
0.160) 
Mean ICER -1897 -689 -464 
(95% CI) (-1985, -
1812) 
(-823, -538) (-685, -254) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
Mean net benefit 
(95% CI)* 
5822.4 
(5611.7, 
6036.1) 
4507.4 
(4284.6, 
4766.0) 
3041.7 
(2811.6, 
3307.1) 
*Estimated at a £20 000 cost-effectiveness threshold 
 
Figure 28. Cost effectiveness plane: planned birth at home compared with an 
OU for women without complicating conditions at the start of care in labour 
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Figure 29. Cost effectiveness plane: planned birth in a FMU compared with 
an OU for women without complicating conditions at the start of care in 
labour 
 
Figure 30. Cost effectiveness plane: planned birth in a AMU compared with 
an OU for women without complicating conditions at the start of care in 
labour 
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3.6.13 Sensitivity analyses performed on cost variables for the 
‘normal birth’ cost-effectiveness outcome for all ‘low risk’ 
women 
The ICER estimates in table 17 reflect variations in the cost estimates for 
key cost drivers, and their impacts on the cost-effectiveness estimates for 
the normal birth outcome for all low risk women. Once again, the findings 
were generally robust to the sensitivity analyses performed and indicate 
that the cost-effectiveness results depicted as ICERs respond in a manner 
consistent with our expectations. 
Table 17. Sensitivity analyses performed for the ‘normal birth’ outcome 
Sensitivity analyses  
 Incremental cost per additional case of 
‘normal birth’. 
 (OU ) → 
(Home) 
(OU ) → 
(FMU) 
(OU ) → 
(AMU) 
1) Overheads 20% greater than baseline 
Cost differences between planned birth in an OU 
and non-OU setting 
(95% CI) 
-686 
(-715, -658) 
-278 
(-312, -240) 
-176 
(-213, -138) 
Change in ‘normal birth’ 
(95% CI) 
0.301 
(0.292, 
0.310) 
0.256 
(0.247, 
0.265) 
0.183 
(0.172, 
0.194) 
Mean ICER 
(95% CI) 
-2281 
(-2360, -
2208) 
-1084 
(-1198, -
964) 
-956 
(-1125, -
779) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
2) Overheads 20% lower than baseline 
Cost differences between planned birth in an OU 
and non-OU setting 
(95% CI) 
-346 
(-370, -323) 
-165 
(-196, -131) 
-61 
(-95, -28) 
Change in ‘normal birth’ 
(95% CI) 
0.301 
(0.292, 
0.310) 
0.256 
(0.247, 
0.265) 
0.183 
(0.173, 
0.194) 
Mean ICER 
(95% CI) 
-1150 
(-1214, -
1091) 
-642 
(-752, -
521) 
-329 
(-513, -
158) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
3) Occupancy rates 50% greater than baseline 
Cost differences between planned birth in an OU 
and non-OU setting 
(95% CI) 
-512 
(-541.-486) 
-282 
(-314, -249) 
-194 
(-228, -160) 
Change in ‘normal birth’ 
(95% CI) 
0.301 
(0.293, 
0.308) 
0.256 
(0.245, 
0.268) 
0.183 
(0.172, 
0.194) 
Mean ICER 
(95% CI) 
-1703 
(-1775, -
1634) 
-1103 
(-1206, -
996) 
-1054 
(-1211, -
889) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
4) Midwifery staffing in the AMU and FMU 20% less than baseline (80% intermittent 
care) 
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Cost differences between planned birth in an OU 
and non-OU setting 
(95% CI) 
-590 
(-618, -563) 
-344 
(-377, -309) 
-256 
(-292, -221) 
Change in ‘normal birth’ 
(95% CI) 
0.301 
(0.293, 
0.308) 
0.256 
(0.247, 
0.265) 
0.183 
(0.175, 
0.192) 
Mean ICER 
(95% CI) 
-1960 
(-2034, -
1890) 
-536 
(-634, -
429) 
-1392 
(-1530, -
1261) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
5) Midwifery staffing in the OU 15% less than baseline (50% intermittent care) 
Cost differences between planned birth in an OU 
and non-OU setting 
(95% CI) 
-480 
(-508, -453) 
-137 
(-170, -102) 
-44 
(-79, -9) 
Change in ‘normal birth’ 
(95% CI) 
0.301 
(0.292, 
0.308) 
0.256 
(0.245, 
0.267) 
0.183 
(0.172, 
0.194) 
Mean ICER 
(95% CI) 
-1595 
(-1670, -
1526) 
-536 
(-651, -
412) 
-239 
(-419, -53) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
6) Midwifery staffing in the OU 25% greater than baseline (90% intermittent care) 
Cost differences between planned birth in an OU 
and non-OU setting 
(95% CI) 
-773 
(-802, -744) 
-430 
(-465, -393) 
-337 
(-374, -301) 
Change in ‘normal birth’ 
(95% CI) 
0.301 
(0.293, 
0.308) 
0.256 
(0.245, 
0.265) 
0.183 
(0.175, 
0.192) 
Mean ICER 
(95% CI) 
-2568 
(-2648, -
2494) 
-1679 
(-1784, -
1571) 
-1832 
(-1972, -
1963) 
Quadrant on the cost-effectiveness plane 
south east south east south east 
3.6.14 Cost effectiveness acceptability curves 
Cost-effectiveness acceptability curves (CEACs) were generated to show the 
probability of each planned birth setting being optimal in terms of cost-
effectiveness at alternative cost-effectiveness thresholds held by decision-
makers. These were generated for each of the outcome measures explored, 
for both women with and without complicating conditions at the start of 
labour care, and for each parity sub-group. Cost-effectiveness thresholds 
were varied from £0 to £100,000, with £20 000 considered to be the most 
intuitive threshold for the primary outcome. For all analyses with the 
exception of two, birth at home generated the greatest mean net benefit, 
with a 100% probability of being the optimal setting across all cost-
effectiveness thresholds. However, for ‘low risk’ nulliparous women, planned 
place of birth in a FMU had a 0.35 probability of being the most cost-
effective option at a £20,000 cost-effectiveness threshold for the primary 
outcome (figure 31). This probability increased to 0.59 when the cost-
effectiveness threshold for the primary outcome increased to £30,000. 
Similarly, for ‘low risk’ nulliparous women without complicating conditions at 
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the start of care in labour, planned place of birth in a FMU had a 0.16 
probability of being the most cost-effective option at a £20,000 cost-
effectiveness threshold for the primary outcome (figure 32). This probability 
increased to 0.35 when the cost-effectiveness threshold for the primary 
outcome increased to £30,000. 
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Figure 31. Cost effectiveness acceptability curves for planned place of birth 
for ‘low risk’ nulliparous women for adverse perinatal outcome avoided 
 
 
Figure 32. Cost effectiveness acceptability curves for planned place of 
birth for ‘low risk’ nulliparous women without complicating conditions 
at the start of care in labour for adverse perinatal outcome avoided 
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4 Discussion and conclusions 
4.1 Summary of main findings 
This study aimed to determine the cost-effectiveness of different settings 
for birth; at home, in freestanding midwifery units, in alongside midwifery 
units and in obstetric units for women and babies at ‘low risk’ of 
complications prior to the onset of labour, based on individual level data 
collected in the prospective cohort study within Birthplace. The three 
effectiveness measures used were ‘intrapartum stillbirth, early neonatal 
mortality and specific neonatal morbidity’ avoided (a composite measure of 
perinatal mortality and intrapartum related morbidity and the primary 
outcome in the Birthplace prospective cohort study), ‘maternal morbidity 
avoided’ (a composite of some of the secondary outcomes in the Birthplace 
prospective cohort study) and ‘normal birth’. 
With regards to the baby; the incidence of adverse perinatal outcomes was 
low in all settings. The results of the cost-effectiveness analyses show that 
a change from planned place of birth in an OU to a FMU or AMU will 
generate incremental cost savings with uncertainty around the cases of 
adverse perinatal outcome averted. In all bootstrapped samples, for these 
comparisons, the scatterplots of mean ICERs fell across both the south west 
and south east quadrants of the cost-effectiveness planes. This implies a 
lower cost attributable to a non-OU midwifery setting planned place of birth, 
but represents uncertainty surrounding the impact on perinatal outcomes. 
For births planned at home for nulliparous ‘low risk’ women, the cost-
effectiveness analyses reflected a less effective and less-costly option for 
intrapartum care than birth planned in an OU. For births planned at home 
for multiparous low risk women, the cost-effectiveness analyses reflected 
lower costs and considerable uncertainty surrounding the impact on 
perinatal outcomes. 
With regards to the mother, planned place of birth in all non-OU settings 
generated incremental cost savings and improved maternal outcomes. 
There is uncertainty around the cost savings for planned birth in an AMU, 
but planned birth in an AMU still showed cost savings and more positive 
maternal outcomes. 
Planned births in an OU had a longer duration of labour per episode, as well 
as higher rates of epidural use, general anaesthesia, augmentation of labour 
and instrumental delivery. In addition to the greater burden of overheads 
for the OU, these interventions for women are costly and would have 
increased the mean total cost per woman planning a birth in an OU. The 
costs and outcomes for the AMU seemed to lie between those for the OU 
and FMU/home. Some of the characteristics of the women who had planned 
a birth in an AMU were similar to the planned OU birth group and these 
included higher rates of epidural use, augmentation of labour and active 
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management of labour and a longer total duration of labour.. They were 
more similar to the FMU and home groups in their mode of birth, use of a 
general anaesthetic, and rates of perineal trauma. Planned birth at home or 
in a FMU generates more effective and less costly maternal outcomes. This 
finding was repeated for the analysis of incremental cost per additional 
‘normal birth’. 
4.2 Strengths and weaknesses 
This study provides evidence for the cost-effectiveness of planned place of 
birth in four different settings. ‘Bottom up’ and ‘top down’ cost data were 
applied to resource use estimation which included all significant resource 
items collected from a health service perspective. All unit costs employed 
followed guidelines on costing health services as part of economic 
evaluation, including the calculation of these costs being underpinned by 
the concept of opportunity cost, which can be defined as the value of the 
next best alternative for using these resources (12-14). A comprehensive 
strategy for handling uncertainty surrounding individual parameters and the 
value of the cost-effectiveness threshold was conducted. 
Robust and detailed collection of effectiveness data was conducted through 
the prospective cohort study. An integrated programme of research of this 
size and design has not been undertaken before. The prospective cohort 
study identified maternal, intrapartum and neonatal outcomes for the 
different settings of planned place of birth, including the proportion of 
mothers and babies requiring transfer and the duration of transfer. The 
cost-effectiveness analysis was made possible by this rigorously designed 
and conducted observational study. 
The cost-effectiveness analysis was mainly designed to capture costs and 
outcomes attributed to intrapartum care. This was difficult to undertake 
because it required the disaggregation of trust based maternity service data 
as well as ‘within hospital/unit’ maternity data for both cost and resource 
use analyses. The collection of robust intrapartum cost data was limited by 
patchy and incomplete data returns from finance and other maternity 
service managers. Consequently, some of the cost data inputs were 
modelled from other sources. Although varied in sensitivity analyses, one 
should be cautious when interpreting these cost data. Routinely collected 
clinical and cost data should be available in a disaggregated form so that 
trusts can access their data and so that comprehensive national research 
and audit can be conducted. 
Low throughput has tended to cause health professionals to assume that 
FMUs might be less cost-effective than OUs. This study used occupancy 
rates which were modelled from data from the Healthcare Commission 
survey of maternity units and primary sources collected from finance 
managers. On average, FMUs did have a much lower occupancy rate than 
AMUs and OUs. The average occupancy rates used in the model for this 
analysis were: OUs (65.1%), FMUs (30.4%) and AMUs (56.5%). The 
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occupancy rates were then varied in sensitivity analyses, which included an 
increase of 50% occupancy rates for the AMUs and FMUs. Median, minimum 
and maximum occupancy rates were also calculated for the units. 
Irrespective, the OUs tended to carry a higher burden of overheads than 
FMUs once non-pay inputs and indirect costs were included (theatre, 
pathology etc). Should occupancy rates rise in FMUs they would become an 
increasingly cost-effective source of provision of maternity care. The cost 
calculations in this analysis are susceptible to changes in occupancy rates 
and relative cost-effectiveness will adjust accordingly. A key cost driver will 
be the overheads apportioned across the unit for intrapartum care. Fixed 
costs will include estate and capital investment costs and variable costs will 
include midwifery staffing directly apportioned to each intrapartum episode. 
Should changes to maternity service configuration be planned for cost-
effectiveness purposes, then commissioners would have to consider the 
resource use and related cost implications on the maternity service as a 
whole. This would require economic modelling and forecasting of occupancy 
rates, overheads, patient safety and transfer in view of fixed and variable 
costs, and the relative disinvestment in one form of maternity service 
provision in preference for another. The cost-effectiveness analysis 
presented here is most relevant for the duration of data collection of the 
Birthplace prospective cohort study and the context of the NHS maternity 
service for that time period. 
The limited time horizon of the study meant that the follow up of outcomes 
for both mother and the baby did not extend beyond the time period of 
labour care, or higher level postnatal or neonatal care when this was 
received. Serious adverse outcomes can result in associated life-long health 
and societal costs, as shown by the size of damages paid in obstetric 
litigation cases, which represent a substantial cost to the NHS. Less serious, 
but more frequent, morbidities associated with labour and birth and its 
management affect women and babies. Follow up over weeks or longer to 
monitor recovery, or a future assessment of the outcomes for mothers and 
babies at a later date, would shed more light on long term cost-
effectiveness. 
The effectiveness data used in the cost-effectiveness analysis are 
composites of perinatal and maternal outcomes. Although necessary for this 
study, the use of a composite measure does not capture the complexities of 
weighting for individual components. The methods of analysis employed in 
this cost-effectiveness analysis could not explore these complexities further. 
This is a particular weakness in this study. Furthermore, the study has an 
innate tension in holding the outcomes for both the mother and the baby in 
synergy as the cost-effectiveness analysis is limited by its inability to link 
the effectiveness outcomes together. In keeping with the prospective cohort 
study report, the results show cost-effectiveness for only the baby or only 
the mother separately according to planned place of birth, but not both 
together in the same analysis. This might be counter-intuitive because it 
would be invidious to ‘trade’ the outcomes for the mother with the 
outcomes for the baby. A decision analytic model has therefore been 
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designed to synthesise available published data with data collected from 
Birthplace to look at combined outcomes for both the mother and baby in a 
single analysis. This will be undertaken following this report. 
Assumptions based on primary research were made about midwifery ‘staff 
to woman’ ratios during labour. This was recorded asintermittent or 
continuous support that midwifery staff were able to offer women in 
different birth settings. The assumptions were generated from primary 
research conducted as part of the costing study. Birth at home, and in a 
FMU and AMU were attributed continuous midwifery care during labour, with 
65% intermittent midwifery support attributed to OUs. These were varied in 
the sensitivity analyses, but for cost-effectiveness purposes only. In this 
report, it is impossible to comment on the ‘quality of care’ consequences 
from these proportional changes in dedicated staff time, but this is noted by 
others, such as the HealthCare Commission who identified the need for 
adequate staffing levels, continuity of care for women during labour and 
support for women after the birth of their baby. Clearly, 1:1 continuous 
midwifery care is an additional benefit for women in the planned home, FMU 
and AMU groups. 
Furthermore, this study only used clinically defined outcomes to determine 
the cost-effectiveness of planned place of birth. Although these outcomes 
were rigorously collected and reviewed, outcomes which are also of 
importance to women and decision-makers, such as the quality of care 
offered, women’s experiences and support with breastfeeding were not 
addressed in the analysis. A broader economic approach to the 
measurement of outcomes, such as stated preference discrete choice 
modelling might have provided more information to decision makers, but 
this had not been practically possible given the size and anonymity of the 
study design. Within Birthplace, however, separate research was 
undertaken which aimed to describe women's experiences of care, 
management and experiences of transfer between services, and 
organisational and workforce issues, which may each impact on the quality 
of care in different locations. 
Although represented as costs, the findings shown here reflect the duration 
of labour, proportion of women and babies requiring transfer, mode of birth, 
levels of intervention required and admissions to postnatal and neonatal 
care according to their planned place of birth. Planned birth at home is 
shown to be the most cost-saving option, reflecting reduced medical 
intervention and a higher incidence of ‘normal birth’. This requires deeper 
analysis. When compared to women planning to give birth in an OU, women 
planning a birth at home were more likely to be white and have a fluent 
understanding of English, be married or living with a partner, to be living in 
a more socioeconomically advantaged area, and were markedly more likely 
to have had one or more previous pregnancies. Each of the above 
characteristics are associated with being cost-saving. The most marked 
contrast between the home birth group and the three other groups was in 
the distribution of parity, as far more women planning a birth at home were 
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multiparous compared to the FMU, AMU and OU groups. The regression on 
cost showed that being multiparous was associated with a significant and 
substantial cost-saving effect, and that this was apparent for each 
additional previous pregnancy. Analyses conducted in the prospective 
cohort study adjusting for differences in the characteristics of women 
planning birth in different settings, showed significantly increased odds of 
an adverse perinatal outcome for ‘low’ risk’ nulliparous women in the 
planned home birth group. For births planned at home in nulliparous ‘low 
risk’ women, the cost-effectiveness analyses reflected a less effective and 
less-costly option, on average, for maternity care than birth planned in an 
OU. For multiparous women, the cost-effectiveness analyses reflect lower 
costs and improved perinatal outcomes, on average, in the planned non-OU 
settings, though with considerable uncertainty around the latter. Overall for 
the baby, planned place of birth in FMU and AMU settings generate cost 
savings with uncertainty around the cases of adverse perinatal outcome 
averted. For the mother, planned place of birth in all non-OU settings 
generated cost savings and improved maternal outcomes. Future research 
will combine outcomes for both the mother and baby using decision-analytic 
modelling and will explore these complexities further. 
4.3 Conclusions 
The study found that planned births in non-OU settings were less costly and 
more cost-effective than births planned in an OU. There was no uncertainty 
in this finding for maternal outcomes and ‘normal birth’, though 
considerable uncertainty surrounded this finding for perinatal outcomes. 
The analyses generated by this study and the subsequent decision-analytic 
modelling attempt to make the costs and outcomes of planned place of birth 
explicit and to link these together within an evaluative framework. The 
decision analytic model will attempt to combine perinatal and maternal 
outcomes, and to synthesise the data from Birthplace with published 
clinical, epidemiological and economic evidence. The purpose of the 
modelling study will be to provide service commissioners and clinical 
managers, policy makers and parent representatives with robust 
information in order to to develop policy and to plan maternity services 
using relevant evidence. 
4.4 Key messages 
This study was conducted for women at ‘low risk’ of complications prior to 
the onset of labour. 
4.4.1 Costs  The average cost of ‘normal birth’ was £938. The average cost of a 
spontaneous vaginal birth without complications was £947.  Key cost drivers are overheads and staffing. 
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 Occupancy rates affect the cost of providing maternity care in 
different settings. There is substantial variability in the overheads 
costs and occupancy rates in all settings for birth, and for FMUs in 
particular. 
  It was found that the cost of intrapartum care and any costs 
associated with intrapartum related complications is less for birth 
planned at home, in an FMU and in an AMU compared with planned 
OU births.  The total mean costs per ‘low risk’ woman prior to the onset of labour 
were as follows: OU £1,631, AMU £1,461, FMU £1,435 and home 
£1,066.5. 
Total cost for women without complicating conditions at the start of care in 
labour approximated: OU £1,511, AMU £1,427, FMU £1,405 and home 
£1,027.  Costs were adjusted for confounders, skewness and weighting in the 
dataset. When these were accounted for, the differences in mean 
costs for planned births approximated: -£367(OU to home), -£182 
(OU to FMU), -£129 (OU to AMU). All the cost differences are 
negative reflecting the cost-saving effect of birth planned in a non-OU 
setting.  Being multiparous was associated with a cost-saving effect, and this 
was accentuated for each previous pregnancy.  For nulliparous women, the cost differences between alternative birth 
settings narrowed: 
 
o Total mean costs per ‘low risk’ nulliparous woman were: OU 
£2075.2, AMU £1,983.1, FMU £1,912.5 and home £1,793.7. 
 
o Total mean costs per ‘low risk’ nulliparous woman without 
complicating conditions at the start of care in labour were: OU 
£1,940.4, AMU £1932.5, FMU £1,880.7 and home £1,719.0. 
 
o Total mean costs per ‘low risk’ multiparous woman were: OU 
£1,142.4, AMU £991.3, FMU £968.9 and home £780.4. 
 
o Total mean costs per ‘low risk’ multiparous woman without 
complicating conditions at the start of care in labour were: OU 
£1076.9, AMU £978.3, FMU £953.7 and home £765.8.  Primary data was collected wherever possible, but costs were 
modelled if not available and interpretation of these costing results 
should be made with caution. 
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4.4.2 Effectiveness  The Birthplace national prospective cohort study showed that:  Overall, there were no differences in adverse perinatal outcomes 
between settings  Perinatal outcomes differ by planned place of birth in nulliparous 
women  Maternal outcomes were ‘better’ in the three non-OU settings 
4.4.3 Cost-effectiveness  When compared to planned births in an OU:  planned birth at home, in a FMU and an AMU generated incremental 
cost savings but uncertaintysurrounded adverse perinatal outcomes 
avoided 
o planned births at home for nulliparous ‘low risk’ women 
generated incremental cost savings but increased adverse 
perinatal outcomes 
o planned births at home for multiparous ‘low risk’ women 
generated incremental cost savings but uncertainty surrounded 
adverse perinatal outcomes avoided  planned birth at home, in a FMU and an AMU generated incremental 
cost savings per adverse maternal morbidity avoided  planned birth at home, in a FMU and an AMU generated incremental 
cost savings per additional ‘normal birth’  Overall, planned place of birth at home was found to be the most cost-
saving option; however, more women planning a birth at home were 
multiparous compared to the planned FMU, AMU and OU groups. 
4.4.4 Other  Routinely collected clinical and cost data should be available in a 
disaggregated form so that trusts can access their data and so that 
comprehensive national research and audit can be conducted. 
4.5 Future research questions 
Further research exploring the cost-effectiveness of planned place of birth 
will be presented in a final report to follow. This individual level cost-
effectiveness analysis will inform a decision-analytic model where the 
perinatal and maternal outcomes will be combined in a composite measure, 
and expressed as an incremental cost per healthy woman and baby at 
hospital discharge. 
Current findings suggest that the following research questions will be 
important:  What would be the financial impact on maternity services if more 
non-OU settings were utilised for intrapartum care? 
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 How might the intervention rates and outcomes for mothers and 
babies in OU settings differ if they were to receive continuous support 
(which tends to be more consistently provided in the non-OU 
settings) rather than intermittent midwifery support?  Less serious but more frequent morbidities associated with labour 
and birth and its management may affect women and babies. What is 
the long term cost-effectiveness for mothers and babies who are 
followed up over weeks or longer to monitor recovery?  How would the results of this study change when outcomes that are 
also of importance to women and decision-makers, such as the 
quality of care offered, women’s experience and support with 
breastfeeding are reflected in a broader economic evaluation 
framework? 
Recommendations for research will be made in view of the findings of the 
decision-analytic model to follow. 
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Appendix 1 Additional resource use data 
Table 18. Resource use data identified as part of the Birthplace prospective 
cohort study 
Birthplace 
DCF section 
Questions 
asked in the 
Birthplace 
data 
collection 
forms 
Resource 
variable 
identified 
Data collected 
in addition to 
the Birthplace 
DCFs 
Source of 
additional data 
collection for 
detailed 
resource use  
Prospective Cohort Study Data Collection forms from OUs, AMUs FMUs and 
homebirth 
Section B and 
C: Mother's 
details and 
pregnancy 
history 
 
 
Age 
Ethnic group 
Fluency 
Marital status 
BMI at booking 
(if recorded) 
Pregnancy 
history 
Medical 
conditions 
Demographic 
information 
  
Section D: 
Labour and 
birth 
 
Date and time 
midwife 
started/finished 
labour care 
 
‘episode of care’ 
to which a 
staff time cost 
will be attributed 
 
More midwifery or 
other health 
professional time 
to be included 
 
Structured 
questionnaire for 
OU, AMU, FMU and 
HB in the 4 
regional Birthplace 
centres with the 4 
RLMs. 
See Appendices 9 
and 10 
Section D: 
Maternal 
Transfer 
 
 
Mode of 
transfer, date 
and time of 
transfer 
 Duration of 
transfer: miles; 
minutes; networks 
Extra staff required 
for transfer 
Structured 
questionnaire with 
paramedic services 
in the 4 regional 
Birthplace centres. 
Appendix 9 
Section D: 
Maternal 
Transfer 
 
Date and time 
midwife 
started/finishes 
labour care in 
OU 
 
Change to 
staffing 
 
Start of 
midwifery and 
additional care in 
the OU 
Care continuous or 
intermittent 
Numbers of health 
professionals in 
attendance 
Structured 
questionnaire for 
OU in the 4 
regional Birthplace 
centres with the 4 
RLMs. 
Appendix 9  
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Birthplace 
DCF section 
Questions 
asked in the 
Birthplace 
data 
collection 
forms 
Resource 
variable 
identified 
Data collected 
in addition to 
the Birthplace 
DCFs 
Source of 
additional data 
collection for 
detailed 
resource use  
Section D: 
Maternal 
Transfer 
 
Date and time 
women receives 
first clinical 
assessment – 
 
Start of 
(possibly) clinical 
care in OU 
Care continuous or 
intermittent 
Numbers of health 
professionals in 
attendance 
Structured 
questionnaire for 
OU in the 4 
regional Birthplace 
centres with the 4 
RLMs. 
Appendix 9  
Section D: 
Maternal 
Transfer 
 
03 Meconium 
staining 
 
Postpartum 
haemorrhage 
 
Epidural 
 
Spinal 
 
General 
Anaesthetic 
 
Repair of 
perineal trauma 
    
 Costing of each 
clinical event – 
detailed bottom up 
costing 
Structured 
questionnaire for 
OU in the 4 
regional Birthplace 
centres with the 4 
RLMs. 
Appendix 9 
Section D: 
Labour and 
birth 
 
 
Mode of delivery 
 
 We anticipated 
attributing a cost 
to each mode of 
birth which would 
reflect the resource 
use and staffing 
requirements 
throughout the 
labour, based on 
primary costing  
Structured 
questionnaire for 
OU, AMU, FMU and 
HB in the 4 
regional Birthplace 
centres with the 4 
RLMs. 
Appendices 9 and 
10 
Section D: 
Labour and 
birth 
 
 
Active 
management of 
the third stage 
of labour 
   
Section D: 
Labour and 
birth 
 
 
Episiotomy    
Section D: 
Labour and 
birth 
 
 
Perineal Trauma 
involving the 
anal sphincter 
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Birthplace 
DCF section 
Questions 
asked in the 
Birthplace 
data 
collection 
forms 
Resource 
variable 
identified 
Data collected 
in addition to 
the Birthplace 
DCFs 
Source of 
additional data 
collection for 
detailed 
resource use  
Section D: 
Labour and 
birth 
and Section D: 
Maternal 
Morbidity Data 
Collection Form 
Stillbirth Time of stillbirth 
Stage of labour 
Post-mortem 
details 
  
Section E: 
After Birth 
and Section 
A: 
Maternal 
Morbidity 
Data 
Collection 
Form  
Mother received 
blood 
transfusion 
within 48 hours 
after birth 
 
Units of blood or 
packed cells 
given, cell saver 
used 
  
Section E: 
After Birth 
and Section B: 
Maternal 
Morbidity Data 
Collection Form  
Mother admitted 
to high 
dependency 
area within 48 
hours after birth 
 
Date of 
admission, time 
of admission, 
date of discharge, 
treatment 
received 
  
Section E: 
After Birth 
and Section B: 
Maternal 
Morbidity Data 
Collection Form 
Mother admitted 
to ITU within 48 
hours after birth 
 
Date of 
admission, time 
of admission, 
date of discharge, 
treatment 
received 
  
Section E: 
After Birth 
and Section B: 
Maternal 
Morbidity Data 
Collection Form 
Mother admitted 
to Specialist 
care within 48 
hours after birth 
 
Date of 
admission, time 
of admission, 
date of discharge, 
treatment 
received 
  
Section E: 
After Birth 
and Section A: 
Neonatal 
Morbidity 
Mortality Follow 
up Form  
Baby receiving 
special care 
 
Date of 
admission, time 
of admission, 
date of discharge, 
days of/and 
treatment 
received including 
method of 
feeding 
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Birthplace 
DCF section 
Questions 
asked in the 
Birthplace 
data 
collection 
forms 
Resource 
variable 
identified 
Data collected 
in addition to 
the Birthplace 
DCFs 
Source of 
additional data 
collection for 
detailed 
resource use  
Section E: 
After Birth 
and Section A: 
Neonatal 
Morbidity 
/Mortality 
Follow up Form  
Baby receiving 
high dependency 
care 
 
Date of 
admission, time 
of admission, 
date of discharge, 
days of/and 
treatment 
received, 
respiratory 
support 
(ventilator or 
CPAP) 
  
Section E: 
After Birth 
and 
Section A: 
Neonatal 
Morbidity 
/Mortality 
Follow up Form 
Baby receiving 
intensive care 
 
Date of 
admission, time 
of admission, 
date of discharge, 
days of/and 
treatment 
received, 
respiratory 
support 
(ventilator or 
CPAP) 
  
Section E: 
After Birth 
and Section K: 
Neonatal 
Morbidity 
Mortality Follow 
up Form 
Baby died 
 
   
Maternal Morbidity / Mortality Follow-up Data Collection forms 
Section C: 
Maternal 
Mortality 
 
Date and time of 
death, place of 
death, cause of 
death 
   
Neonatal Morbidity / Mortality Follow-up Data Collection forms 
Section B: 
Meconium 
Aspiration 
Baby receiving 
ECMO 
No of days of 
treatment / 
medication  
  
Section C: 
Encephalopathy 
Baby having 
seizures 
requiring cooling 
treatment 
No of days of 
treatment / 
medication 
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Appendix 2 Data collection form for a FMU/AMU 
Table 19. Example of a detailed data collection form for a FMU/AMU 
 DATA COLLECTION FORM 
FREE STANDING MIDWIFERY UNIT or ALONGSIDE MIDWIFERY UNIT 
(ALL QUESTIONS) 
 
Date form completed        
 
 Demographic data 
 
Q1 WoŵaŶ͛s age at deliǀery: (years) 
        
 
Q2 WoŵaŶ͛s ethŶiĐ group: (as recorded in her maternity notes) 
    
 
Q3 Father's occupation OPCS code 
   
 
Q4 Mother's occupation OPCS code 
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Q5 WoŵaŶ͛s uŶderstaŶdiŶg of EŶglish laŶguage - if a problem: 
 Mother tongue   
 Good English   
 Medium English   
 Minimal English   
 None   
 
Q6 WoŵaŶ͛s ŵarital / partŶer status: 
  Husband   
  Partner   
  Single   
 
Q7 WoŵaŶ͛s BMI at aŶy tiŵe iŶ pregŶaŶĐy or height/weight 
   
 
 
Q8 WoŵaŶ͛s full postĐode: 
    
 
 Current Pregnancy 
Q9 Expected date of delivery 
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 Admission to AMU / FMU for purpose of labour and delivery 
 
Q11 
 
Woman self-reported reason for arrival at FMU/AMU 
 Antenatal in labour    
 Antenatal not in labour    
 
 
 
Q12 Did the patient give birth in the same episode of care? 
 No   Go to Q13 
 Yes   Go to Q14 – Q18 
 
 
Q13 If no, please give reason and do not continue with the form 
  Delivered already   
  In labour   
  Returned home   
  Other   
 If other, specify  
 
 
Q14 If Yes, date of admission 
        
 
Q15 Time of admission (using 24 hour clock) 
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Q16 Place admitted to 
   
 
Q17 Date of first cervical assessment if done 
        
 
 Time (using 24 hour clock) 
   
 
Q18 Other procedures performed after admission and before ͚estaďlishŵeŶt of laďour͛ ;EOLͿ? ;e.g. EOL as 
marked by moving from a/n assessment to labour ward or receiving 1:1 care)
1
 
  Yes   
  No   
 
 
If Yes, please report procedures 
        
        
        
        
 
                                       
1 Guidance: EOL is hereby defined as moving from a/n assessment to labour ward in preparation for the delivery of the baby - or when a woman begins to receive 
1:1 care 
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 Augmentation  
Q19 Was an ARM performed? 
 
 Yes    
 No    
 
Q20 Date 
        
 
Q21 Time (using 24 hour clock) 
   
 
Q22 Was labour augmented in any other way? 
 
 Spontaneous    
 Induced    
 
 Pain relief 
 
Q23 Water 
 Yes    
 No    
 
 
Q24 Massage (by midwife) 
 Yes    
 No    
 
Q25 Tens machine 
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 Yes    
 No    
 
Q26 Entonox 
 Yes    
 No    
 
 
 
 
 
 
 
Q27 Opiates 
 Yes    
 No    
 If Yes, total dose of 
opiates  
    
 
 Midwifery support 
 
Q28 1. Did the woman receive continuous or intermittent midwifery support during established labour? 
 
 Continuous   
 Intermittent   If intermittent, proportion for midwifery time allocated to the 
mother during established labour 
    0-20% 
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    21-40% 
    41-60% 
    61-80% 
    81-100% 
 
 
 
 
Q29 Number of midwives / midwifery support workers in total caring for woman in established labour? 
Midwives  1   Midwifery support workers  1   
   2      2   
   3      3   
   4      4   
  ≥ 5     ≥ 5   
 
 Duration of first stage of labour 
Q30 Duration first stage labour (minutes) 
   
 
 Date, time and duration of second stage of labour- Delivery of the baby 
 
Q31 Date 
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Q32 Time (using 24 hour clock) 
   
 
Q33 Mode of delivery 
 
 Ventouse    
 Forceps    
 Water birth    
 SVD    
 CS    
 
Q34 Where did the birth take place? 
 On the bed   
 On the mat   
 On the birth stool   
 In the pool   
 Other   
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Q35 Birth position 
 Sitting supported by pillows   
 On the side   
 Standing   
 Squatting   
 All fours   
 Laying down   
 Laying with legs supported in 
stirrups  
  
 
Q36 Total number of vaginal examinations performed during labour? 
 1   
 2   
 3   
 4   
 5   
 6   
 ≥7   
 
 
 
 
 
Q37 Number of babies delivered  
 1  
 2  
 3   
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Q38 Type of presentation of the baby 
 Vertex   
 Breech   
 Oblique   
 Transfers   
 Face   
 
 
 The third stage of labour 
 
Q40 Was syntometrine/syntocinon used for the third stage of labour? 
 Yes  No  
 Syntometrine 
(ampules) 
   
 Syntocinon (I.U)    
 If Yes, total dose  _______________________________________ 
 
Q41 Duration of third stage of labour (minutes) 
   
 
 
  Baby Outcome: Vital statistics 
 
Q42 Birth outcome 
Q39 Duration second stage of labour ( minutes) 
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 Live birth   
 Still birth   
 
Q43 Sex of baby 
 Male   
 Female   
 
Q44 Birthweight 
     g 
 
Q45 Apgar at 5 minutes 
   
 
Q46 Apgar at 10 minutes 
   
 
Q47 Time when this episode of care was completed 2 (see footnote) 
 
  Hours  Minutes 
 
 
 
 Fetal outcome: Breastfeeding 
 
                                       
2 Guidance: the episode of labour care is completed when the woman and baby are discharged from the delivery room or when the midwife begins to complete the 
post-natal notes, whichever occurs first 
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Q48 Intended feeding 
 Breast   
 Bottle   
 Mixed feeding   
 
Q49 Was the baby breastfed for the first feed? 
 Yes   
 No   
 
Q50 Date of first feed 
        
 
Q51 Time of first feed (using 24 hour clock) 
    
 
Q52 Type of feeding established 
 Breast   
 Bottle   
 Mixed feeding   
 
Q53 Did the mother receive health care support for breastfeeding ? 
 Yes  If so by whom 
 No  
 
Q54 Did the baby have skin to skin contact at delivery? 
 Yes   
 No   
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 Discharge 
 
Q55 Date and time of discharge from AMU/FMU for mother 
 
Date:       
Time:  (Using 24 hour clock) 
 
Q56 Estimated total length of stay for mother 
 
 Length of stay  Days  Hours 
 
Q57 Destination on discharge from OU 
 Usual residence   
 Other residence   
 Other   
 
 
Q58 Date and time of discharge of baby from the AMU/ FMU 
 
Date:       
Time:  (Using 24 hour clock) 
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Maternal Transfers 
Q59. Date and time of decision to transfer:       : 
 
Q60. Primary reason for transfer: Please write in one code from list  
     01 Failure to progress (1st stage) 09 Fetal distress (2nd stage)  
    02 Fetal distress (1
st
 stage)  10 Postpartum haemorrhage 
    03 Meconium staining  11 Retained placenta 
    04 Epidural request   12 Repair of perineal trauma   
    05 Hypertension   13 Other maternal indication 
    06 Malposition   Please specify ________________ 
    07 Antepartum haemorrhage  14 Other fetal indication    
    08 Failure to progress (2
nd
 stage) Please specify ________________  
       
Q61. Date and time of start of transfer: 
 
Q62. Mode of transfer: 
 Private car  Ambulance  Wheelchair/Trolley/Bed Walking  Other 
 
If Other, please specify __________________________________________________________ 
 
Q63. Full name of unit woman transferred to: ____________________________________ 
 
Q64. Date and time of start of midwifery care in obstetric unit: 
         
  
Q65. Date and time of first clinical assessment by obstetrician: 
  
  
   Or tick if not assessed by an obstetrician   
 
Q66. Was labour augmented with syntocinon?   Yes No 
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Q67. Did this woman have an epidural or spinal?   Yes  No 
 
Q68. Did this woman have a general anaesthetic? Yes  No 
 Maternal Outcome: Postpartum Complications In Hospital 
 
Q69 Did the women have episiotomy? 
 Yes    
 No    
 
Q70 Was there perineal trauma involving the anal sphincter (3th/ 4
th
 degree tear) 
 Yes    
 No    
 
Q71 Did the woman receive perineal suturing after delivery? 
  
 No   
 Yes   If yes,  
    Suturing episiotomy  
    Suturing first degree tear  
    Suturing second degree tear  
    Suturing third degree tear  
    Suturing fourth degree tear  
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Q72 Maternal complication 1 
        
        
        
        
 
Q73 Maternal complication 2 
        
        
        
        
 
Q74 Maternal complication 3 
        
        
        
        
 
Q75 Maternal complication 4 
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Q76  Other maternal injury 
        
        
        
        
 
Q77 Estimate blood loss (mls) 
        
 
 
 
 
Q78 Did the woman have a blood transfusion? 
 
 No   
 Yes   If yes, complete medication form 
 
Q79 Did the woman receive antibiotics after delivery? 
   
 No   
 Yes   If yes, complete medication form 
 
Q80 Was a surgical procedure performed as a result of a complication? 
   
 No   
 Yes   If yes, specify ______________________________________________ 
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Q81 Were diagnostic imaging tests performed as a result of a complication? 
   
 No   
 Yes   If yes,  
  Type: _____________________________ Number of examinations: ________ 
  Type: _____________________________ Number of examinations: ________ 
 
Q82 Were additional consultants seen as a result of a complication? 
 
 No   
 Yes   If yes,  
  Specify: _________________________________ Number of visits: ________ 
  Specify: _________________________________ Number of visits: ________ 
 Postnatal care - mother in hospital 
 
Q83 Admission to postnatal care in hospital  
 
 Yes   If Yes, length of stay  Days  Hours 
 No   
 
Q84 Admission to ICU 
 
 Yes   If Yes, length of stay  Days  Hours 
 No   
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Q85 Admission to HDU 
 
 Yes   If Yes, length of stay  Days  Hours 
 No   
 
Q86 Admission to Specialist Unit 
 
 Yes   If Yes, length of stay  Days  Hours 
 No   
 
Q87 Did the women stay in any other ward other than those above after labour? 
 
 Yes   If Yes, length of stay  Days  Hours 
 No   
 
 
 
 Infant complications in hospital 
 
Q88 Resuscitation using bag and mask 
 Yes   
 No   
 
Q89 Resuscitation using endotrachael tube 
 Yes   
 No   
 
Q90 Drugs used during resuscitation 
 
 No   
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 Yes   If yes, complete medication form 
 
Q91 Neonatal complication 1 
        
        
        
        
 
Q92 Neonatal complication 2 
        
        
        
        
 
 
Q93 Neonatal complication 3 
        
        
        
        
 
Q94 Congenital malformation observed in baby 1 
 Yes   
 No   
 
Q95 Congenital malformation observed in baby 2 
 Yes   
 No   
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Q96 Congenital malformation observed in baby 3 
 Yes   
 No   
 
Q97 Congenital malformation observed in baby 4 
 Yes   
 No   
 
 Postnatal care – baby in hospital 
 
Q98 Admission to NICU 
 
  Yes   If Yes, length of stay  Days  Hours 
 No   
 
 
 
Q99 Admission to SCBU 
 
 Yes   If Yes, length of stay  Days  Hours 
 No   
 
Q100 Date and time of infant death 
 
Date:       
Time:  (Using 24 hour clock) 
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MEDICATION FORM 
 
 
Check recipient 
 
Medication used 
 
Route 
 
Dose given 
 
Total number of 
doses 
administered 
Mother Baby     
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Appendix 3 Data collection form for an OU 
Table 20. Example of a detailed data collection form for an OU 
  DATA COLLECTION FORM 
OBSTETRIC UNIT 
 
 
Date form completed        
 
Demographic data 
 
Q1 WoŵaŶ͛s age at deliǀery: (years) 
        
 
Q2 WoŵaŶ͛s ethŶiĐ group: (as recorded in her maternity notes) 
    
 
Q3 Father's occupation OPCS code 
   
 
Q4 Mother's occupation OPCS code 
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Q5 WoŵaŶ͛s uŶderstaŶdiŶg of EŶglish laŶguage - if a problem: 
 Mother tongue   
 Good English   
 Medium English   
 Minimal English   
 None  
 
Q6 WoŵaŶ͛s ŵarital / partŶer status: 
  Husband   
  Partner   
  Single  
 
Q7 WoŵaŶ͛s BMI at aŶy tiŵe iŶ pregŶaŶĐy 
   
 
Q8 WoŵaŶ͛s full postĐode: 
    
 
Q9 Expected date of delivery 
        
 
 Woman history / Previous pregnancy 
 
Q10 Nuŵďer of pregŶaŶĐies of ≥ Ϯϰ ǁeeks, prior to this pregŶaŶĐy: If none, write 0 
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 Admission for purpose of labour and delivery 
 
 
Q11 
 
Woman self-reported reason for arrival  
 Antenatal in labour    
 Antenatal not in labour    
 
 
Q12 Did the woman give birth in the same episode of care? 
No   Go to Q13 
 Yes   Go to Q14 – Q21 
 
 
Q13 If No, please give reason and do not continue with the form 
  ed already   
  In labour   
  Returned home   
    
 If other, specify  
 
 
Q14 If Yes, date of admission 
        
 
Q15 Time of admission (using 24 hour clock) 
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Q16 Place admitted to (e.g. triage /antenatal assessment/ delivery ward/birthing room/theatre) 
   
 
Q17 Date of first cervical assessment if done 
        
 
Q18 Time (using 24 hour clock) 
   
 
Q19 Cardiotocography on admission 
    
  No   
 
Q20 Other proĐedures perforŵed after adŵissioŶ aŶd ďefore ͚estaďlishŵeŶt of laďour͛ ;EOLͿ? ;e.g. EOL as 
marked by moving from a/n assessment to labour ward or receiving 1:1 care)
3 
    
  No   
 
                                       
3 Guidance: EOL is hereby defined as moving from a/n assessment to labour ward in preparation for the delivery of the baby - or when a woman begins to receive 1:1 care 
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If Yes, please report procedures 
        
        
        
        
 
 
Q21 Number of tests 
 1    
 2    
 3    
 4    
 ≥ 5    
 
Induction/ Augmentation 
 
Q22 Was an ARM performed? 
 
Yes    
 No    
 
Q23 Date of establishment of labour 
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Q24 Time (using 24 hour clock) 
   
 
Q25 Mode of onset of labour 
 
Spontaneous    
 Induced    
 
 
 
Pain relief 
 
 
Q26 Water 
 Yes    
 No    
 
 
 
 
Q27 Massage (by midwife) 
 Yes    
 No    
 
Q28 Tens machine 
 Yes    
 No    
 
Q29 Entonox 
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 Yes    
 No    
 
Q30 Opiates 
 Yes    
 No    
 If Yes, total dose of opiates      
 
Q31 Epidural/ Spinal 
 Yes    
 No    
 
Q32 General Anaesthetic 
 Yes    
 No    
 
Q33 Other 
 Yes    
 No    
 If other, specify  
 
MIDWIFERY SUPPORT  
 
Q34 Did the woman receive continuous or intermittent midwifery support during established labour? 
 
 Continuous   
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 Intermittent   If intermittent, proportion for midwifery time allocated to the 
mother during established labour 
    0-20% 
    21-40% 
    41-60% 
    61-80% 
    81-100% 
 
 
 
 
Q35 Number of midwives / midwifery support workers in total caring for woman in established labour? 
Midwives   ifery support workers   
   2      2   
   3      3   
   4      4   
  ≥ 5     ≥ 5   
 
DURATION OF FIRST STAGE OF LABOUR 
 
Q36 Duration first stage labour (minutes) 
   
Q37 cal or Other medical procedures performed during first stage of labour? 
 Yes    
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DATE, TIME AND DURATION OF SECOND STAGE OF LABOUR- DELIVERY OF THE BABY 
 
Q38 Date 
        
 
Q39 Time (using 24 hour clock) 
   
 
 
 
 
 
 
Q40 Mode of delivery 
 
 Ventouse   
 Forceps   
 Water birth   
 SVD   
 CS   
 
 No    
 If yes, specify  
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Q41 Where did the birth take place? 
 On the bed   
 On the mat   
 On the birth stool   
 In the pool   
 Other   
 
Q42 Birth position 
 Sitting supported by pillows   
 On the side   
 Standing   
 Squatting   
 All fours   
 Laying down   
 Laying with legs supported in 
stirrups  
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Q43 Total number of vaginal examinations performed during labour? 
   
   
   
   
   
 6   
 ≥7    
 
Q44 Number of babies delivered 
 1  
 2  
 3   
 
Q45  Type of presentation of the baby 
 Vertex   
 Breech   
 Oblique   
 Transfers   
 Face   
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Q46 Reason for emergency CS 1 
        
        
        
        
 
Q47 Reason for emergency CS 2 
        
        
        
        
 
Q48 Duration (hours, minutes) 
   
 
THE THIRD STAGE OF LABOUR:  
 
Q49 Date 
        
 
Q50 Time (using 24 hour clock) 
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Q51 Was syntometrine/ syntocinon used for the third stage of labour? 
  No  
 etrine (amples)   
 Syntocinon (I.U)    
 If Yes, total dose  _______________________________________ 
 
 
 
 
Q52 Did the woman have a manual removal of the placenta following vaginal delivery? 
 
 No   
 Yes    
 
Q53 Duration (minutes) 
   
 
 Maternal Outcome: Postpartum Complications 
 
Q54 Did the women have episiotomy? 
 Yes    
 No    
 
Q55 Was there perineal trauma involving the anal sphincter (3th/ 4
th
 degree tear) 
 Yes    
 No    
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Q56 Did the woman have perineal suturing after delivery? 
 
 No   
 Yes   If yes,  
    Suturing episiotomy  
    Suturing first degree tear  
    Suturing second degree tear  
    Suturing third degree tear  
    Suturing fourth degree tear  
 
Q57 Maternal complication 1 
        
        
        
        
 
Q58 Maternal complication 2 
        
        
        
        
 
Q59 Maternal complication 3 
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Q60 Maternal complication 4 
        
        
        
        
 
Q61  Other maternal injury 
        
        
        
        
 
Q62 Estimate blood loss (mls) 
        
 
Q63 Did the woman have a blood transfusion? 
 
 No   
 Yes   If yes, complete medication form 
 
Q64 Did the woman receive antibiotics after delivery? 
 
 No   
 Yes   If yes, complete medication form 
 
Q65 Was a surgical procedure performed as a result of a complication? 
 
 No   
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 Yes   If yes, specify _____________________________________________ 
 
Q66 Were diagnostic imaging tests performed as a result of a complication? 
 
 No   
 Yes   If yes,  
  Type: _______________________ Number of examinations: ________ 
  Type: _______________________ Number of examinations: ________ 
 
 
 
 
Q67 Were additional consultants seen as a result of a complication? 
 
 No   
 Yes   If yes,  
  Specify: _________________________________ Number of visits: ___ 
  Specify: _________________________________ Number of visits: ___ 
 
Postnatal care - mother  
 
Q68 Admission to postnatal care 
 Yes   If Yes, length of stay  
 No   
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Q69 Date when postnatal care started 
        
 
Q70 Time (using 24 hour clock) 
   
 
 
Q71 Admission to ICU 
 Yes   If Yes, length of stay  
 No   
 
Q72 Admission to HDU 
 Yes   If Yes, length of stay  
 No   
 
Q73 Admission to Specialist care 
 Yes   If Yes, length of stay  
 No   
 
Q74 Did the women stay in any other ward other than those above after labour? 
 Yes   If Yes, length of stay  
 No   
 
 Maternal discharge 
 
Q75 Date and time of discharge from hospital 
Date:       
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Time:  (Using 24 hour clock) 
 
Q76 Estimated total length of stay 
 Length of stay  
 
Q77 Destination on discharge from RLH 
 Usual residence   
 Other residence   
 Other   
 
 Baby outcome: Vital statistics 
 
Q78 Birth outcome 
 Live birth   
 Still birth   
 
 
Q79 Sex of baby 
 Male   
 Female   
 
Q80 Birthweight 
     g 
 
Q81 Apgar at 5 minutes 
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Q82 Apgar at 10 minutes 
   
 
Q83 Resuscitation using bag and mask 
 Yes   
 No   
 
Q84 Resuscitation using endotrachael tube 
 Yes   
 No   
 
Q85 Drugs used during resuscitation 
 
 No   
 Yes   If yes, complete medication form 
 
Q86 Neonatal complication 1 
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Q87 Neonatal complication 2 
        
        
        
        
 
Q88 Neonatal complication 3 
        
        
        
        
 
Q89 enital malformation observed in baby 1 
 Yes   
 No   
 
Q90 enital malformation observed in baby 2 
 Yes   
 No   
 
Q91 enital malformation observed in baby 3 
 Yes   
 No   
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Q92 Time when this episode of care was completed4 (see footnote) 
   
 
FETAL OUTCOME: BREASTFEEDING 
Q93 Intended feeding 
 Breast   
 Bottle   
 Mixed feeding  
 
Q94 Was the baby breastfed for the first feed? 
 Yes   
 No   
 
Q95 Date of first feed 
        
 
Q96 Time of first feed (using 24 hour clock) 
   
 
Q97 Type of feeding established 
 Breast   
 Bottle   
 Mixed feeding   
 
                                       
4 Guidance: the episode of labour care is completed when the woman and baby are discharged from the delivery room or when the midwife begins to complete the post-natal notes, 
whichever occurs first 
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Q98 Did the mother receive health care support for breastfeeding? 
 Yes  If so by whom 
 No  
 
 
Q99 
Did the baby have skin to skin contact at delivery? 
 Yes   
 No   
 
 
Postnatal care - baby 
 
Q100 Admission to NICU 
 Yes   If Yes, length of stay  
 No   
 
Q101 Admission to SCBU 
 Yes   If Yes, length of stay  
 No   
 
Q102 Date and time of discharge of baby 
Date:       
Time:  (Using 24 hour clock) 
 
Q103 Date and time of infant death 
Date:       
time:  (Using 24 hour clock) 
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Check recipient 
 
Medication used 
 
Route 
 
Dose given 
 
Total number of doses 
administered 
Mother Baby     
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Appendix 4 Structured questionnaire 
Table 21. Unit Cost and Resource Use Structured Questionnaire 
Top Down Costing 
Unit Cost and Resource Use Structured Questionnaire for design of unit cost database and 
related unit cost sensitivity analysis 
 
Interviews conducted with: 
 
Trust Unit names Units 
within 
trust 
Geographic 
location in 
England 
RLCM Place of 
Interview 
Dates of interviews 
Liverpool 
Women's 
Hospital NHS 
Foundation 
Trust 
Liverpool Women's NHS 
Foundation Trust 
Liverpool Women's NHS 
Foundation Trust 
 
OU 
 
AMU 
North Chelsea 
McDonough 
Liverpool 
 
Tuesday 24th March  
Oxford 
Radcliffe 
Hospitals 
NHS Trust 
Horton Hospital 
Chipping Norton Hospital 
Wallingford Hospital 
Wantage Hospital 
OU 
FMU 
FMU 
FMU 
South east Laura Stewart-
Maunder 
University of 
Oxford 
Richards 
building, 
DPHPC 
Wednesday 29th April 
and Wednesday 20th 
May 
 
Taunton and 
Somerset 
NHS Trust 
Mary Stanley Wing 
Bridgewater 
Bracken Birthing Centre 
FMU 
 
AMU 
South west Carol Puckett  Musgrove 
Park Hospital, 
Taunton 
Wednesday 16th April 
Kings College 
Hospital NHS 
Foundation 
Trust 
Kings College Hospital OU London June Grant  Kings College 
London 
Friday 6th March 2009 
and Friday 30th April 
2009 
 
Barts and the 
London Trust 
Royal London Hospital 
Barkantine Birth centre 
OU 
FMU 
London Ali Herron 
Jude Piper 
 
Royal London 
Hospital or 
Barkantine 
Birth Centre 
Numerous meetings 
between Jan 2008 and 
Dec 2009. Monthly 
structured meetings 
and informal meetings 
one-on-one with 
members of the team. 
 
Unit Cost and Resource Use Structured Questionnaire for design of unit cost database 
 
We͛d like to haǀe a disĐussioŶ aďout the ǁaǇ the OU, AMU aŶd FMU ŵaŶage the folloǁiŶg sĐeŶario͛s 
(i.e. what happens - usually / least complex scenario / most complex scenario) 
 
Where applicable we need to know about the ratio of staff to women 
 
 
Transfer: questions to FMU and AMU 
 
In utero transfer of mother 
 
What are the typical least complex and then most complex scenarios that lead to a decision to 
transfer a mother? 
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When this happens what do you do, what processes do you follow? 
Could you talk us through the ǁhole proĐess froŵ start to ǁheŶ Ǉou ǁould ĐoŶsider aŶ ͚iŶ-utero 
traŶsfer͛ to ďe fiŶished? 
 
(Extra Q – are these covered in what they describe?) 
 
Who do you contact? (Name, contact details) 
What does the person you called do? 
Who else do you contact if Ǉou ĐaŶ͛t get through the persoŶ? (Name, contact details) 
Are additional nurses or other health care professionals called in? (Grade) 
If assistance is requested who is contacted? (Name, contact details) 
Who is in the assistance team? 
Does the ǁoŵaŶ͛s partner/next of kin ever use their own transport? 
In the first instance which hospital is the woman normally transferred to? 
Does the midwife accompany the woman to hospital? 
When is there a handover of care in the OU? 
 
After birth: transfer of mother and /or baby 
 
after birth: if you need to transfer the mother what happens: Could you talk us through the whole 
proĐess froŵ start to ǁheŶ Ǉou ǁould ĐoŶsider a ͚post-Ŷatal ŵaterŶal traŶsfer͛ to ďe Đoŵpleted: 
 
after birth: if you need to transfer the baby what happens: Could you talk us through the whole 
proĐess froŵ start to ǁheŶ Ǉou ǁould ĐoŶsider a ͚post-Ŷatal ďaďǇ traŶsfer͛ to ďe Đoŵpleted: 
 
after birth: if you need to transfer the mother and baby what happens: Could you talk us through 
the whole process from start to ǁheŶ Ǉou ǁould ĐoŶsider a ͚post-Ŷatal ďaďǇ traŶsfer͛ to ďe 
completed: 
 
(Extra Q – are these covered in what they describe?) 
 
What are the typical least complex scenario/ most complex scenarios that lead to transfers? 
When something goes wrong what do you do? 
Who do you call? (Name, contact details) 
What does the person you called do? 
Who else do Ǉou ĐoŶtaĐt if Ǉou ĐaŶ͛t get through the persoŶ? (Name, contact details) 
Are additional nurses or other health care professionals called in? (Grade) 
If assistance is requested who is contacted? (Name, contact details) 
Who is in the assistance team? 
Does the ǁoŵaŶ͛s partŶer/Ŷeǆt of kiŶ eǀer use their oǁŶ traŶsport? 
In the first instance which hospital is the woman normally transferred to? 
Does the midwife accompany the woman to hospital? 
 
-Other 
Can you think of other scenarios that take place not discussed here and lead to transferring women? 
What are the typical least complex scenario/most complex scenarios? 
When something goes wrong what do you do? 
Who do you call? (Name, contact details) 
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What does the person you called do? 
Who else do Ǉou ĐoŶtaĐt if Ǉou ĐaŶ͛t get through the persoŶ? (Name, contact details) 
Are additional nurses or other health care professionals called in? (Grade) 
If assistance is requested who is contacted? (Name, contact details) 
Who is in the assistance team? 
Does the ǁoŵaŶ͛s partŶer/Ŷeǆt of kiŶ eǀer use their oǁŶ traŶsport? 
In the first instance which hospital is the woman normally transferred to? 
Does the midwife accompany the woman to hospital? Does anyone else? When is care and handover 
completed? 
 
Financial structure of OU, AMU, FMU 
 
AMU / FMU: 
Who manages the finances at the unit? (Name and contact details) 
 
How do they do this: 
 
What needs to be done to financially run the unit? 
What do they do to financially oversee the unit? 
Who assists them? (Name and contact details) 
Who manages the finances in their absence? (Name and contact details) 
What expenses are attributed to the unit? 
What expenses /running costs are not attributed to the unit? 
 
OU: 
Who manages the finances at the unit? (Name and contact details) 
 
How do they do this: 
 
What do they do to financially oversee the unit? 
Who assists them? (Name and contact details) 
Who manages the finances in their absence? (Name and contact details) 
What expenses are attributed separately to the OU maternity and neonatal departments? 
What expenses /running costs are not attributed to the OU maternity and neonatal departments? 
 
Please could you complete an overview of the running costs for this unit (OU/AMU/FMU) to 
include the following: 
 
A. Wages/salary 
 
B. Salary on-Đosts eŵploǇer͛s ĐoŶtriďutioŶ to superaŶŶuatioŶ. 
 
C. Qualifications 
 
D. Training 
 
E. Management and administrative costs, operational costs (e.g. vehicle running costs) and 
overheads (including heating and lighting, training, building maintenance and so on). 
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Direct overheads: Includes mobile phones, uniform replacement, stationery, thermometers, energy. 
 
Indirect overheads £ per year 
Include the personnel and finance functions. Costs need to be uprated by the HCHS Pay and Prices 
Inflator. 
 
G. Capital overheads 
£ per year Based on the new build and land requirements of NHS facilities. 
Office size. Capital to be annuitised at 3.5 per cent. 
 
Buildings and land 
Capital costs associated with the buildings and land 
 
H. Equipment costs 
 
 
Pharmacy and Drug Costs for the OU, FMU and AMU 
 
FMU/AMU/OU 
Do you have your own pharmacy for drugs that are used in the unit? 
What happeŶs ǁheŶ Ǉou ruŶ loǁ oŶ drugs aŶd doŶ͛t haǀe ĐertaiŶ drugs aǀailaďle? 
Where do you go? (Name and contact details) 
 
Pharmacy Drugs 
Who manages the drugs? (Name and contact details) 
How do they manage the drugs / What do they do to manage the drugs? 
 
Equipment 
 
Who manages the maintenance of the equipment? (Name and contact details) 
How do they manage it? 
What do they do? 
Who manages the replacing equipment? (Name and contact details) 
How do they manage it? 
What do they do? 
In a worst case scenario what do you do in event of equipment not suddenly working? (Details if 
possible) 
Who would manage the situation? 
How do they manage it? (Name and contact details) 
Any charity sponsored pieces that might not be included? 
 
Other activities the OU/FMU offer to the community (in addition to intrapartum and p/n care) 
 
What other activities are offered by FMU / AMU in addition to intrapartum and p/n care? 
 
What other activities are offered by the OU maternity and neonatal section in addition to 
intrapartum and p/n care? 
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(Extra Q – are these covered in what they describe?) 
 
What other activities are offered to the community? 
Who organises these activities (Name and contact details) 
How do they manage it? 
What do they do? 
Is additional staff required? Who are they? 
What type external training is provided to staff for these activities? 
If so, by who? 
Who are the external health care professionals that participate in activates? (Name and contact 
details) 
How do they participate? 
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Appendix 5 Design of micro-costing spreadsheet 
Table 22. Example of micro-costing of labour and post-natal care 
 
Place admitted to                           
                
What happens in the following places as a general description - from our perspective of needing to cost staff (numbers and staff time commitment to this place) 
   
     
 
                
Triage                               
Staff title 
and 
grade 
Length of 
time with 
staff 
 Cost (£) 
of 
staffing  
comments/ 
assumptions 
for costing 
Equipment  Cost (£)  comments/ 
assumptions 
for costing 
Drug Dose  Mode of 
administration 
 Cost (£)   comments/ 
assumptions 
for costing 
Length of 
time of 
procedure 
Cost 
(£)  
comments/ 
assumptions 
for costing 
 Total Cost (£)   
              
Antenatal assessment                           
Staff title 
and 
grade 
Length of 
time with 
staff 
 Cost (£) 
of 
staffing  
comments/ 
assumptions 
for costing 
Equipment  Cost (£)  comments/ 
assumptions 
for costing 
Drug (come 
from 
pharmacist) 
Dose  Mode of 
administration 
 Cost (£)   comments/ 
assumptions 
for costing 
Length of 
time of 
procedure 
Cost 
(£)  
   Total Cost (£)   
               
Birthing room                             
Staff title 
and grade 
Length 
of time 
with 
staff 
 Cost (£) 
of 
staffing  
comments/ 
assumptions 
for costing 
Equipment  Cost (£)  comments/ 
assumptions 
for costing 
Drug Dose  Mode of 
administration 
 Cost (£)   comments/ 
assumptions 
for costing 
Length of 
time of 
procedure 
Cost 
(£)  
Length of 
time of 
procedure 
 Total Cost (£)   
                
Theatre                               
Staff title 
and grade 
Length 
of time 
with 
staff 
 Cost (£) 
of 
staffing  
comments/ 
assumptions 
for costing 
Equipment  Cost (£)  comments/ 
assumptions 
for costing 
Drug Dose  Mode of 
administration 
 Cost (£)   comments/ 
assumptions 
for costing 
Length of 
time of 
procedure 
Cost 
(£)  
   Total Cost (£)   
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Appendix 6 Micro-costing of resource use variables 
Table 23. Micro-costing of resource variables for labour and post-natal care  
 
  
Staffing : Midwives       
Resource Use Variable Cost calculation: salary RLM interview Assumption made Unit cost Total  Source of Unit cost 
              
Staffing: first midwife  Band 6/7 mid-point =£32704, Base year 
2009/2010 Agenda for change 
B6 & 7 mw: tends to be 
1 for labour duration 
with second arrival for 
ďaďǇ͛s ďirth for a 
homebirth 
Time spent with woman = 
duration of labour 
£63 (£70) per hour of 
patient contact. 
 
£11.31 CNST contribution  
variable depending on 
duration of labour: 
hourly cost attributed 
to labour duration 
PSSRU: Unit costs of 
Health and Social care 
2010 
 
Primary cost data 
collection for CNST 
contributions 
  Salary on-costs: £7523 per annum 
(Employer's NI plus 14% 
superannuation)  
          
  Qualifications: £4801 per annum 
Education investment cost annuitied 
over working life 
          
  Overheads: £3130 per annum Indirect 
staffing overheads 
          
  Working time: 41.4 weeks per annum 
37.5 hours per week. Includes: 29 days 
A/L. 8 days statutory leave. 5 study 
days. 12 days sick leave. Hours per 
annum: 1547 
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Homebirth        
       
Resource 
Use Variable 
Cost calculation: salary RLM interview Assumption made Unit cost Total  Source of Unit cost 
              
Staffing: 
first midwife  
Band 6/7 mid point =£32704, 
Base year 2009/2010 Agenda 
for change 
B6 & 7 mw: tends to be 1 for 
labour duration with second 
arriǀal for ďaďǇ͛s ďirth 
Time spent with woman = duration 
of labour 
£81.31 per hour variable depending on 
duration of labour: hourly cost 
attributed to labour duration 
PSSRU: Unit costs of Health and 
Social care 2010  
  Salary oncosts: £7523 per 
annum (Employer's NI plus 
14% superannuation)  
         Primary cost data collection for 
CNST 
  Qualifications: £4801 per 
annum Education investment 
cost annuitied over working 
life 
          
  Overheads: £3130 per annum 
Indirect staffing overheads 
          
  Working time: 41.4 weeks per 
annum 37.5 hours per week. 
Includes: 29 days A/L. 8 days 
statutory leave. 5 study days. 
12 days sick leave. Hours per 
annum: 1547 
          
              
Staffing: 
second 
midwife 
as above time spent 1 hour approx Time spent with woman = 1 extra 
hour to cover birth of baby and intial 
support and clean up 
£81.31 per hour variable depending on 
duration of labour: hourly cost 
attributed to labour duration 
PSSRU: Unit costs of Health and 
Social care 2010 
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Homebirth Delivery pack: relevant resource items : given to woman at 38 weeks 
sterile single use instrument 
delivery pack: 
 1 8" lotion bowl, 5 xrd swabs 10 10 cm , 1 trolley cover, 2 artery forceps, 1 mayo 
scissors, 1 umbilical scissors 
£9.14  Taken from NHS supply chain catalogue 2009, page 
322 code EVX111  
sterile delivery pack:  1 placenta dish, 2 pulp kidney dishes, cord clamp, 2 wound pads, quilted baby wrap, 2 
dressing towels crepe white sterile filed, 1 60ml galipot, 1 underbuttock drape, 1 120ml 
galipot, 2 polybowls 500ml, 1 yellow poly bag 
£7.01  Taken from NHS supply chain catalogue 2009, page 
322 code EVC019 and code EVI010  
surgical gloves  
 
 
 
£0.41  Taken from NHS supply chain catalogue 2009, page 
195 code FTE883  
lidocaine hydrochloride 
 
 
 
£0.88 BNF 60: lidocaine hydrochloride 5%, net price 15 g = 
88p  
vitamin k injection  
 
 
 
£0.95 Konakion® MM Paediatric (Roche) Injection, 
phytomenadione 10 mg/mL in a mixed micelles 
vehicle, net price 0.2-mL amp = 95p 
gas and air mouthpiece 
 
 
 
£2.05  Taken from NHS supply chain catalogue 2009, page 
698 code FDQ501  
sharps box  
 
 
 
£0.76  Taken from NHS supply chain catalogue 2009, page 
179 codeFSL493  
amnihook  
 
 
 
£0.86  Taken from NHS supply chain catalogue 2009, page 
961 code FFY007  
Perineal suture pack: 3 drapes 75*90 com, instrument table cover, 5 gauze 22.5 ply xray, 1 needle 21g green, 
1 gown standard, 2 leggings 75*114cm blue absorbant impervious materieal, 1 xtray, 
jwire, 1 maternity pad looped 
£12.26  Taken from NHS supply chain catalogue 2009, page 
319 code EVX122  
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Total cost of pack:  £34.32  
 
 
The homebirth pack itself consists of : 
 
              
sterile 
delivery 
pack  
Sterile single use instrument delivery pack: 1 8" lotion bowl, 5 xrd swabs, 10 10 cm, 1 trolley cover, 2 artery forceps, 1 mayo scissors, 1 umbillical scissors 
  Pack sterile delivery: 1 placenta dish, 2 pulp kidney dishes, cord clamp, 2 wound pads, quilted baby wrap, 2 dressing towels crepe white sterile field, 1* 60 ml galipot, 1 underbuttock drape 
  Pack sterile delivery: 1* 120 ml galipot, 2 poly bowls 500ml, 1 yellow poly bag 
surgical gloves 
 
lydocaine hydochloride 
plastic aprons 
vitamin k injection 
 
gas and air mouthpiece 
 
clinical waste bags 
 
sharps box 
 
'detectable' guaze swabs (blue 
amniotomy hook 
 
bowl 
forceps scissors 
 
 maternity pads 
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sterile 
perinial 
suture 
pack 
3 drapes 75 * 90cm, instrument table cover, 5 gauze 22.5*22.5 12 ply xray, 1 needle 21g green, 1 gown large standard, 2 leggings 75*114cm blue absorbant impervious material, 1 xtray, jwire, 1 
maternity pad looped 
disposable stitches 
materity mats  
Resource Variable Unit cost  Unit cost range Explanation Source of Unit Cost Total cost applied to travel to and 
from homebirth  
 
         
NHS reimbursement of homebirth travel costs for midwife     
         
Cost of collection of car 
after a transfer and 
homebound journey 
50.41 pence per mile 36.09-110.35 pence per mile Standing charges and running costs 
per mile (pence) Used 23 miles as 
the distance mw had to travel to 
homebirths. Used the average 
distance between homebirth and 
Ous from Birthplace data equating 
to about 42. This is similar to the 
PSSRU ave ambulance journey (38 
minutes)minutes. 
AA Petrol car running 
costs – basic guide for 
2010 
http://www.theaa.com/al
laboutcars/advice/advice
_rcosts_petrol_table.jsp 
Accessed 22 March 2010 
23.1886  
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Resource Variable Unit cost  Unit cost range Explanation Source of Unit Cost 
     
Transfer     
intrapartum and neonatal 
ambulance transfers 
£6,7 per minute £257~38 minute journey~£6.7 per minute averaged costs using PSSRU 2007 and DH 
reference costs 
 A successful vehicle journey is equivalent to transporting a single 
patient 
  
 for A&E services. 
 
   
 Included in the costs are:   
 Overheads and management: management and administrative costs, operational costs (e.g. vehicle running costs) and overheads (including heating and lighting, training, building 
maintenance and so on).  
 Buildings and land: Capital costs associated with the buildings and land invested in the ambulance service were estimated by discounting their capital value over 60 years at 3.5 per 
cent. 
 Ambulances and equipment: Paramedic Units (PU) and Emergency Ambulances (EA) use exactly the same type of vehicle with similar equipment on board. The ambulances cost 
£47,297 new and standard equipment including defibrillators costs £11,824 per vehicle. Vehicles and the equipment are expected to last five years. Discounting at 3.5 per cent the 
annual cost of an EA is £13,095. The average number of journeys per emergency ambulance was 1,152. 
 Crew salaries and wages: A crucial distinguishing characteristic of the different services is the type of crew. A PU carries one paramedic (average salary £31,926 pa) and one technician 
(average salary £29,945). An EA is crewed by two technicians and a PTS by two care assistants (average salary £16,354). Once national insurance and pension payments are included 
the average annual crew cost is £67,077 for a PU; £69,173 for an EA; and £36,632 for a PTS. The average number of journeys per EA and PU crew is 480 per year, PTS crews provides an 
average of 339 journeys per PTS crew. 
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Resource Variable Unit cost  Unit cost range Explanation Source of Unit Cost 
Transfer per journey interquartile range (per journey)   
     
Paramedic Services per journey 
for Pregnancy / Childbirth / 
Miscarriage/ Gynaecological 
(rural)  
184  150- 169.5    DH Reference Costs 
Paramedic Services per journey 
for Pregnancy / Childbirth / 
Miscarriage/ Gynaecological 
(urban)  
194  136-153    DH Reference Costs 
Emergency transfers 240 206-362   DH Reference Costs 
Resource Variable Unit cost per hour Unit cost range Explanation Source of Unit Cost 
     
Private car 0  cost not attributed to the NHS  
Walking 
 
0    
Wheelchair / trolley / bed 
 
0.01  £170 per active user per chair per year PSSRU 
Rapid response ambulance car 
 
214 214 -241 lower interquartile range for ambulance transfer  
Helicopter 144.5 83-206 per hour Between £60 000 per month and £1.8 million per year to 
run, but NHS do not pay running costs - only the cost of 
consultants. Rest raised by donations. 
http://www.emas.nhs.uk/our-services/air-
ambulances/ or 
http://news.bbc.co.uk/1/hi/england/oxfordshir
e/7907106.stm  
Taxi 
 
0  cost not attributed to the NHS  
Not physically transferred from 
the AMU 
0  no cost attributed to mode and duration of transfer  
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Resource Variable Unit cost  Unit cost range Explanation Source of Unit Cost 
     
NHS reimbursement of homebirth transfer costs for midwife    
     
Cost of collection of car after a 
transfer and homebound journey 
50.41 per mile 36.09-110.35 Standing charges and running costs per mile (pence) AA Petrol car running costs – basic guide for 
2010 
http://www.theaa.com/allaboutcars/advice/adv
ice_rcosts_petrol_table.jsp Accessed 22 March 
2010 
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AUGMENTATION   comments/ assumptions and source of cost data  Cost (£)  
1 hour of FS doctor  PSSRU adjusted for direct patient time and CNST contributions £141.78 
ALARIS PUMP + cannulae equipment (8 hour duration)    primary cost data - Kings £2015 new  £0.40 
Imed or Ivac titration machine    
Appropriate giving set   Taken from NHS supply chain catalogue 2009, page 843 code FFSC087  £3.05 
Venflon cannula   Taken from NHS supply chain catalogue 2009, page 59 code FSP033  £0.83 
Syringe and needle   Taken from NHS supply chain catalogue 2009, page 352 code FWC032  £0.05 
Swabs   Taken from NHS supply chain catalogue 2009, page 769 code HHD090  £0.06 
Sterile dressing   Taken from NHS supply chain catalogue 2009, page 736 code EKG035  £2.48 
Syntocinon   oxytocin, net price 5 units/mL, 1-mL amp = 76p; 10 units/mL, 1-mL amp = 86p  £0.86 
Bag of fluid (dextrosaline)  Intravenous infusion, usual strength sodium chloride 0.9% (9 g, 150 mmol each of Na+ and 
Cl-/litre), this strength being supplied when normal saline for injection is requested. Net 
price 2-mL amp = 35p; 5-mL amp = 42p; 10-mL amp = 57p; 20-mL amp = £1.04; 50-mL 
amp = £2.01 
£2.01 
Local anaesthetic   Taken from BNF 59, 26/04/10 Naropin, injection (2mg/mL= £1.78)  £1.78 
Monitors and graph paper   Taken from NHS supply chain catalogue 2009, page 242 code FDI058  £0.07 
    
top up:    as above  £0.86 
top up:    as above  £2.01 
    
top up:    as above  £0.86 
top up:    as above  £2.01 
TOTAL   £159.11 
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ENTONOX   comments/ assumptions and source of cost data Cost (£) 
    
2.5 cylinders for homebirth  Scottish data: Cylinder size DD 460 litres (portable oxygen) 
http://www.lothianrespiratorymcn.scot.nhs.uk/wp-content/uploads/2010/01/Lothian-
Guideline-for-the-Domiciliary-Oxygen-Therapy-Service-for-COPD.pdf Accessed 18 March 
£57.45 
Mobile equipment with mask, mouth piece   Taken from NHS supply chain catalogue 2009, page 621 code FDC115 (ENTONOX KIT) AND 
delivery circuit mask code FDC346 
 £ 10.53  
filter or tubing   Taken from NHS supply chain catalogue 2009, page 677 CODE FDD254, FDE101, FDD148, 
FDD954 
 
 £ 0.47  
rubber gloves   Taken from NHS supply chain catalogue 2009, page 195 code FTE883   £ 0.20  
Total 68.65 
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EPIDURAL       
Staff title and grade  Cost (£) of 
staffing  
comments/ assumptions 
and source of cost data 
Equipment  Comments/ assumptions and source of cost data Total 
   Epidural pack   Taken from NHS supply chain catalogue 2009, page 328 code 
FYB062  
£32.10 
Anaesthetist 194.68 PSSRU 2010, page 218 
(medical consultant), 
Assumption- time spent 30 
MINUTES 
Inco pad   Taken from NHS supply chain catalogue 2009, page 961 code 
EAO500  
£0.09 
extra midwife 40.65 Band 7 mid-point =£32704, 
Base year 2007/2008, 
Assumption- time spent 30 
minutes 
Gloves   Taken from NHS supply chain catalogue 2009, page 200 code 
FTE888  
£4.68 
   chlorhexodine 0.5%  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 
2.5%, in industrial methylated spirit, net price 100 mL = 20p. 
Label: 15 
£0.02 
   Syringe 10ml (1)   Taken from NHS supply chain catalogue 2009, page 352 code 
FWC031  
£0.05 
   Ampoule 10 ml local anaesthetic   Taken from BNF 59, 26/04/10 Naropin, injection (10mg/mL= 
£3.20)  
£3.20 
   Syringe 2ml   Taken from NHS supply chain catalogue 2009, page 352 code 
FWC032  
£0.05 
   Ampoule 2ml local anaesthetic   Taken from BNF 59, 26/04/10 Naropin, injection (2mg/mL= 
£1.78)  
£1.78 
   Drugs - marcaine 10ml    Taken from BNF 59, 26/04/10 injection (10-mL= £1.21)  £1.21 
      Taken from NHS supply chain catalogue 2009, page 764 code 
EHH027  
£1.90 
   Hyperfix tape   Taken from NHS supply chain catalogue 2009, page 764 code 
EHH028  
£1.57 
   Blenderm tape   Taken from NHS supply chain catalogue 2009, page 766 code 
ECH011  
£0.36 
   Transpore tape   Taken from NHS supply chain catalogue 2009, page 764 code 
EHU009  
£0.28 
   Opcite spray  Xylocaine® (AstraZeneca) Spray (= pump spray), lidocaine 10% 
(100 mg/g) supplying 10 mg lidocaine/spray; 500 spray doses per 
container. Net price 50-mL bottle = £3.13 
£0.06 
   Mask (2 or 3)   Taken from NHS supply chain catalogue 2009, page 479 code 
BWM042 
 
£0.05 
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EPIDU‘AL CONT……/Ϯ   Hats (2 or 3)   Taken from NHS supply chain catalogue 2009, page 479 code 
BWF036  
£0.02 
   Gowns   Taken from NHS supply chain catalogue 2009, page 410 code 
BWK201  
£1.36 
   IV form   Taken from NHS supply chain catalogue 2009, page 293 code 
FFF171  
£1.04 
   Povidine iodine spray   Taken from BNF 59, 21/04/10 spray (150g= £2.63)  £2.63 
   Paper tray   Taken from NHS supply chain catalogue 2009, page 162 code 
FWK121  
£0.27 
   Water 10ml   £0.00 
   Syringe label   £0.00 
   Ephedrine 5ml ampoule  Ephedrine Hydrochloride (Non-proprietary) Injection, ephedrine 
hydrochloride 3 mg/mL, net price 10-mL amp = £2.83; 30 mg/mL, 
net price 1-mL amp = 50p 
£0.50 
   Needles: including filter needles   Taken from NHS supply chain catalogue 2009, page 332 code 
FTR394  
£4.07 
       
   If women does not have IV drip:   
   Fluid - Hartmans Solution  Intravenous infusion, usual strength sodium chloride 0.9% (9 g, 
150 mmol each of Na+ and Cl-/litre), this strength being supplied 
when normal saline for injection is requested. Net price 2-mL amp 
= 35p; 5-mL amp = 42p; 10-mL amp = 57p; 20-mL amp = £1.04; 50-
mL amp = £2.01 
£0.35 
   Giving set   Taken from NHS supply chain catalogue 2009, page 843 code 
FSC090  
£3.05 
   Venflon   Taken from NHS supply chain catalogue 2009, page 59 code 
FSP033  
£0.83 
   Local anaesthetic   Taken from BNF 59, 26/04/10 Naropin, injection (2mg/mL= 
£1.78)  
£1.78 
   Syringe and needle   Taken from NHS supply chain catalogue 2009, page 352 code 
FWC032  
£0.05 
   Swabs   Taken from NHS supply chain catalogue 2009, page 769 code 
HHD090 
£0.06 
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EPIDU‘AL CONT……/ϯ   sterile dressing   Taken from NHS supply chain catalogue 2009, page 736 code 
EKG035  
£2.48 
       
   If not already monitored:   
   Electronic fetal monitor  Primary data collection Fin Mger Kings £13500 per CTG £2.88 
   Fetal scalp electrodes   Taken from NHS supply chain catalogue 2009, page 960 code 
FDK314: £106.71 FOR BOX 25  
£4.27 
   Monitor graph paper   Taken from NHS supply chain catalogue 2009, page 242 code 
FDI058  
£0.07 
       
   Patient controlled Epidural 
Analgesia 
  Taken from NHS supply chain catalogue 2009, page 410 code 
BWK201  
£1.36 
   PCEA pump  Injection, prefilled disposable syringe, atropine sulphate 200 
micrograms/mL, net price 5 mL = £5.90; 300 micrograms/mL, 10 
mL = £5.91; 600 micrograms/mL, 1 mL = £5.91 
£5.91 
   syringe 10 mls    
      £0.08 
   1% Bupiricaine   Taken from BNF 59, 26/04/10 injection (10-mL= £1.21)  £1.21 
   2mcg Fenlanys  Fentanyl (Non-proprietary) Injection, fentanyl (as citrate) 
50 micrograms/mL, net price 2-mL amp = 30p, 10-mL amp = 64p 
£0.64 
   Top ups:     
   1% Bupiricaine   Taken from BNF 59, 26/04/10 injection (10-mL= £1.21)  £1.21 
   2mcg Fenlanys  Fentanyl (Non-proprietary) Injection, fentanyl (as citrate) 
50 micrograms/mL, net price 2-mL amp = 30p, 10-mL amp = 64p 
£0.64 
Total       £319.49 
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SPINAL 
Staff title and 
grade 
Length of 
time with 
staff 
comments/ assumptions for costing  Cost (£) 
of 
staffing  
Equipment Comments/ assumptions and source of cost data  Total Cost (£)  
    1 dressing  Taken from NHS supply chain catalogue 2009, page 736 code EKG035   £ 2.48  
Anaesthetist 20-30 mins PSSRU 2010, page 218 (medical 
consultant), Assumption- time spent 30 
MINUTES 
£194.68 Sleek tape  Taken from NHS supply chain catalogue 2009, page 764 code EHH027   £ 1.90  
ODA 20-30 mins Band 7 mid-point =£32704, Base year 
2007/2008, Assumption- time spent 30 
minutes 
£40.65 Hyperfix tape  Taken from NHS supply chain catalogue 2009, page 764 code EHH028   £ 1.57  
    Blenderm tape  Taken from NHS supply chain catalogue 2009, page 766 code ECH011   £ 0.36  
    Transpore tape  Taken from NHS supply chain catalogue 2009, page 764 code EHU009   £ 0.28  
    Epidural pack  Taken from NHS supply chain catalogue 2009, page 328 code FYB062   £ 32.10  
    Inco pad  Taken from NHS supply chain catalogue 2009, page 961 code EAO500   £ 0.09  
    Gloves  Taken from NHS supply chain catalogue 2009, page 200 code FTE888   £ 4.68  
    Spirit solution - 
chlorhexidine 0.5% 
BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 2.5%, in industrial 
methylated spirit, net price 100 mL = 20p. Label: 15 
 £ 0.02  
    Syringe 10ml (1)  Taken from NHS supply chain catalogue 2009, page 352 code FWC031   £ 0.05  
    Ampoule 10 ml local 
anaesthetic 
 Taken from BNF 59, 26/04/10 Naropin, injection (10mg/mL= £3.20)   £ 3.20  
    Syringe 2ml  Taken from NHS supply chain catalogue 2009, page 352 code FWC032   £ 0.05  
    Ampule 2ml local 
anaesthetic 
 Taken from BNF 59, 26/04/10 Naropin, injection (2mg/mL= £1.78)   £ 1.78  
    Drugs - marcaine 10ml   Taken from BNF 59, 26/04/10 injection (10-mL= £1.21)   £ 1.21  
    Opcite spray Xylocaine® (AstraZeneca) Spray (= pump spray), lidocaine 10% (100 mg/g) supplying 
10 mg lidocaine/spray; 500 spray doses per container. Net price 50-mL bottle = 
£3.13 
 £ 0.06  
    Mask (2 or 3)  Taken from NHS supply chain catalogue 2009, page 479 code BWM042   £ 0.05  
    Hats (2 or 3)  Taken from NHS supply chain catalogue 2009, page 479 code BWF036   £ 0.02  
    Gowns  Taken from NHS supply chain catalogue 2009, page 410 code BWK201   £ 1.36  
    IV form  Taken from NHS supply chain catalogue 2009, page 293 code FFF171   £ 1.04  
    Povidine iodine spray  Taken from BNF 59, 21/04/10 spray (150g= £2.63)   £ 2.63  
    Paper tray  Taken from NHS supply chain catalogue 2009, page 162 code FWK121   £ 0.27  
    Water 10ml  0 
    Ephedrine 5ml 
ampoule 
Ephedrine Hydrochloride (Non-proprietary) Injection, ephedrine hydrochloride 3 
mg/mL, net price 10-mL amp = £2.83; 30 mg/mL, net price 1-mL amp = 50p 
 
 £ 0.50  
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ACTIVE MANAGEMENT OF THE THIRD STAGE OF LABOUR 
Equipment  Cost (£)  Comments/ assumptions and source of cost data  Total Cost (£)  
Ampoule of Syntometrine *2 2.70  Injection, ergometrine maleate 500 micrograms, oxytocin 5 units/mL, net 
price 1-mL amp = £1.35 
 £2.70  
Ampoule of Syntocinon 1.35  Injection, ergometrine maleate 500 micrograms, oxytocin 5 units/mL, net 
price 1-mL amp = £1.35 
 £1.35  
TOTAL   £4.05  
 
 
 
SPINAL 
CONT.. 
    Injection, phenylephrine hydrochloride 10 mg/mL (1%), net price 1-mL amp = £5.50  £ 5.50  
    marcaine (for top ups)  Taken from BNF 59, 26/04/10 injection (10-mL= £1.21)   £ 6.05  
     Injection, powder for reconstitution, ceftriaxone (as sodium salt), net price 1-g vial 
= £10.17; 2-g vial = £20.36times 5 - many top ups: Ceftrioxone  
 £ 0.17  
Total Cost   235.33   302.75 
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GENERAL ANAESTHETIC 
Staff title and 
grade 
Length of time 
with staff 
 Cost (£) of 
staffing  
comments/ assumptions for costing Equipment  Source Cost 
Scrub midwife band 6 or 7 *1  £ 8.13 Band 7 mid-point =£32704. Base year 
2007/2008, Assumption- time spent 
10 MINUTES 
CTG in OU (per 8 hour 
Birthplace average labour 
duration) 
 Primary data collection Fin Mger Kings £13500 per CTG £ 2.88 
HCA *1   £ 3.36  Band 6 mid-point =£27388, Base year 
2007/2008, Assumption- time spent 
10 MINUTES 
Thiopentone  Injection, powder for reconstitution, thiopental sodium, net price 500-mg 
vial = £3.06 
 £ 3.06  
Obstetrician *2   £ 648.98  PSSRU 2010, page 218 (medical 
consultant). Assumption 50 minutes 
CNST added to calculation 
N/Saline  intravenous infusion, usual strength sodium chloride 0.9% (9 g, 150 mmol 
each of Na+ and Cl-/litre), this strength being supplied when normal saline 
for injection is requested. Net price 2-mL amp = 35p; 5-mL amp = 42p; 10-mL 
amp = 57p; 20-mL amp = £1.04; 50-mL amp = £2.01 
 £ 2.01  
Anaesthetist *1   £ 38.94  PSSRU 2010, page 218 (medical 
consultant),, Assumption- time spent 
10 MINUTES 
Vecuronium  Injection, powder for reconstitution, vecuronium bromide, net price 10-mg 
vial = £3.38 (with water for injections) 
 £ 3.38  
ODA *1 (assists anaesthetist)  £ 36.50  PSSRU 2010, page 218 (medical 
consultant), 
Syntocinon   oxytocin, net price 5 units/mL, 1-mL amp = 76p; 10 units/mL, 1-mL amp = 
86p  
 £ 0.86 
Pediatrician *1   £ 38.94 PSSRU 2010, page 218 (medical 
consultant), ),, Assumption- time 
spent 10 MINUTES 
Suxamenthonium  injection, suxamethonium chloride 50 mg/mL, net price 2-mL amp = 71p  £ 0.71  
    Atropine  Injection, atropine sulphate 600 micrograms/mL, net price 1-mL amp = 68p  £ 0.68  
    Pain relief:  Injection, fentanyl (as citrate) 50 micrograms/mL, net price 2-mL amp = 30p, 
10-mL amp = 64p 
 £ 0.30  
    Morphine  Intravenous infusion, morphine sulphate 1 mg/mL, net price 50-mL vial = 
£5.00; 2 mg/mL, 50-mL vial = £5.89 
 £ 5.00  
    Lignocaine for insertion of 
IVI 
 Injection 2%, lidocaine hydrochloride 20 mg/mL, net price 2-mL amp = 31p; 
5-mL amp = 31p; 10-mL amp = 60p; 20-mL amp = 80p 
 £ 0.31  
    Neostigmine and 
atrophine or 
 Injection, neostigmine metilsulfate 2.5 mg/mL, net price 1-mL amp = 58p  £ 0.58  
    Hartmann's 500ml  Intravenous infusion, usual strength sodium chloride 0.9% (9 g, 150 mmol 
each of Na+ and Cl-/litre), this strength being supplied when normal saline 
for injection is requested. Net price 2-mL amp = 35p; 5-mL amp = 42p; 10-mL 
amp = 57p; 20-mL amp = £1.04; 50-mL amp = £2.01 
£ 0.35 
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GENERAL ANAESTHETIC CONT.. Equipment:   
    Oximeter for mother  primary costing, minimal - set to 0.01  £ 0.01  
    ECG for mother   Taken from NHS supply chain catalogue 2009, page 222 code FDK129  £ 2.04 
    Defibrilator  primary costing, minimal - set to 0.01  £ 0.01  
    Datascope  primary costing, Equipment worth £3000 new  £ 0.10  
    Syringes:   
    20ml (1)   Taken from NHS supply chain catalogue 2009, page 352 code FWC030   £ 0.05  
    10ml (1)   Taken from NHS supply chain catalogue 2009, page 352 code FWC031   £ 0.05  
    5ml (1)   Taken from NHS supply chain catalogue 2009, page 352 code FWD063   0.06  
    2ml (6)   Taken from NHS supply chain catalogue 2009, page 352 code FWC032   £ 0.31  
    Needles:   Taken from NHS supply chain catalogue 2009, page 764 code EHH028   £ 1.57  
    21G   Taken from NHS supply chain catalogue 2009, page 337 code FTR167   £ 0.01  
    23G   Taken from NHS supply chain catalogue 2009, page 337 code FTR163   £ 0.01  
    27G   Taken from NHS supply chain catalogue 2009, page 337 code FTR348   £ 0.02  
        
    Electronic fetal monitor  Primary data collection Fin Mger Kings £13500 per CTG £2.88 
    Fetal scalp electrodes   Taken from NHS supply chain catalogue 2009, page 960 code FDK314: 
£106.71 FOR BOX 25  
£4.27 
    Monitor graph paper   Taken from NHS supply chain catalogue 2009, page 242 code FDI058   £ 0.07 
    Antiseptic wipe    Taken from NHS supply chain catalogue 2009, page 362 code VJT041   £ 0.06  
    Sticky tape and 
vetafix/micropore 
  Taken from NHS supply chain catalogue 2009, page 764 code EHH028   £ 1.57  
    14G or 16G Venflon   Taken from NHS supply chain catalogue 2009, page 59 code FSP033 
 
 
 £ 0.83 
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GENERAL ANAESTHETIC CONT.. 
    Giving set(1)   Taken from NHS supply chain catalogue 2009, page 843 code FSC090  £ 3.05 
    Endotracheal tube size 8.0   Taken from NHS supply chain catalogue 2009, page 646 code FDH745   £ 1.36  
    Connector/Catheter 
mount/Introducer 
  Taken from NHS supply chain catalogue 2009, page 623 code FDB145   £ 1.48  
    Laryngoscope   Taken from NHS supply chain catalogue 2009, page 236 code FSM109   £ 12.10  
    Dommete Bandage   Taken from NHS supply chain catalogue 2009, page 711 code EBA075   £ 3.04  
    Oro gastric tube + litmus   Taken from NHS supply chain catalogue 2009, page 353 code FWM871   £ 3.15  
    Suction liner   Taken from NHS supply chain catalogue 2009, page code FDR447   £ 2.07  
    Urinary 
catheter/Bag/Catheter 
pack 
  Taken from NHS supply chain catalogue 2009, page 1551 code FSS620, 
£44.67 for pack of 5  
 £ 8.93  
    Masks   Taken from NHS supply chain catalogue 2009, page 479 code BWM042   £ 0.05  
    Gowns   Taken from NHS supply chain catalogue 2009, page 479 code BWF036   £ 0.02  
    Shoes   Taken from NHS supply chain catalogue 2009, page 293 code FFF171   £ 1.04  
    Hats   Taken from NHS supply chain catalogue 2009, page 410 code BWK201   £ 1.36  
Total:    £ 774.85      £ 846.54 
 
 
SPONTANEOUS VERTEX BIRTH    
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Equipment  comments/ assumptions and source of cost data  Total Cost (£)  
OU:    
Delivery pack   Taken from NHS supply chain catalogue 2009, page 318 code EVX111 (sterile single use instrument delivery pack) + EVC019 
(pack sterile delivery) + EVI010 (pack sterile delivery) 
(pack 8=£73.09) AND page 317 code ECV019 (pack 20=£55.69)  
 £ 16.15  
Gloves   Taken from NHS supply chain catalogue 2009, page 200 code FTE888   £ 4.68  
Maternity pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500   in delivery pack  
Inco pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500   £ 0.09  
Syringe Needle   Taken from NHS supply chain catalogue 2009, page 352 code FWC032   £ 0.05  
Plastic cord clamp   Taken from NHS supply chain catalogue 2009, page 960 code FFK535   in delivery pack  
    £ 0.02  
  primary data collection  £ 0.08  
   Taken from NHS supply chain catalogue 2009, page 123 code FWC082   £ 0.04  
Materials for cord blood gases   Taken from NHS supply chain catalogue 2009, page 344 code FWC124   £ 2.14  
Heparinised syringes x2   Taken from NHS supply chain catalogue 2009, page 136 code FSL491   in delivery pack  
2 needles 1:10000    in delivery pack  
2 wide syringes  primary data collection  £ 0.10  
lydocaine hydochloride   lidocaine hydrochloride 5%, net price 15 g = 88p   £ 0.88  
vitamin k injection  phytomenadione 10 mg/mL in a mixed micelles vehicle, net price 0.2-mL amp = 95p 0.95 
amniotomy hook   Taken from NHS supply chain catalogue 2009, page 961 code FFY007   £ 0.86  
    
TOTAL: 
 
  £ 26.03 
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SVB CONT….    
AMU AND FMU    
Delivery pack   Taken from NHS supply chain catalogue 2009, page 318 code EVX111 (sterile single use instrument delivery pack) + EVC019 
(pack sterile delivery) + EVI010 (pack sterile delivery) 
(pack 8=£73.09) AND page 317 code ECV019 (pack 20=£55.69)  
 £ 16.15  
Gloves   Taken from NHS supply chain catalogue 2009, page 200 code FTE888   £ 4.68  
Maternity pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500   in delivery pack  
Inco pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500   £ 0.09  
Syringe Needle: giving drugs + taking cord 
blood 
  Taken from NHS supply chain catalogue 2009, page 352 code FWC032   £ 0.05  
Plastic cord clamp    in delivery pack  
Large disposal bag    in delivery pack  
plastic draw sheet    in delivery pack  
Catheter if required   Taken from NHS supply chain catalogue 2009, page 1551 code FST248, £46.69 for pack of 10   £ 4.69  
lydocaine hydochloride   lidocaine hydrochloride 5%, net price 15 g = 88p   £ 0.88  
vitamin k injection  phytomenadione 10 mg/mL in a mixed micelles vehicle, net price 0.2-mL amp = 95p 0.95 
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amniotomy hook   Taken from NHS supply chain catalogue 2009, page 961 code FFY007   £ 0.86  
TOTAL   29.53 
 
“VB CONT…    
HOMEBIRTH    
Vaginal examination pack   Taken from NHS supply chain catalogue 2009, page 324 code EVC011  £0.41 
KY jelly   Taken from NHS supply chain catalogue 2009, page 144 code FTM113  £1.08 
handwash   Taken from NHS supply chain catalogue 2009, page180 code MRB116, 75ml  £0.25 
Inco pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500  £0.09 
Paracetamol  http://bnf.org/bnf/bnf/current/3470.htm#_3470: paracetamol 500 mg, net price 16-tab pack = 17p £0.06 
Sociaide* hourly cost mulitplied by average 
duration labour 
 Sonicaid: http://www.medisave.co.uk/sonicaid-one-p-8466.html:  £0.08 
Urine test   Taken from NHS supply chain catalogue 2009, page 123 code KFK391  £0.09 
Blood pressure monitor  http://www.medisave.co.uk/blood-pressure-validated-c-50_366.html £0.01 
placenta bag + transportation box   Taken from NHS supply chain catalogue 2009, page 187 code FAL024   £ 21.80  
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Catheter if required   Taken from NHS supply chain catalogue 2009, page 1551 code FST248, £46.69 for pack of 10   £ 4.69  
TOTAL   £28.55 
 
 
 
 
ASSISTED DELIVERY: VENTOUSE 
Staff title and grade  Cost (£) of staffing  comments/ assumptions and source of 
cost data 
Equipment  comments/ assumptions and source of cost data  Total Cost (£)  
   Assisted delivery 
pack 
  Taken from NHS supply chain catalogue 2009, page 318 code EVX111 
(sterile single use instrument delivery pack) + EVC019 (pack sterile 
delivery) + EVI010 (pack sterile delivery) 
(pack 8=£73.09) AND page 317 code ECV019 (pack 20=£55.69)  
 £ 16.15  
obstetrician  £ 97.34 PSSRU 2008, page 160 (surgical consultant), Assumption- time spent 15   £ 97.34 
Pediatrician  £ 194.68 PSSRU 2010, page 218 (medical consultant), Assumption- time 
spent 30  
  £ 194.68 
Registrar teaching a FS  £ 97.34 PSSRU 2008, page 160 (surgical 
consultant), Assumption- time spent 15 
MINUTES 
Ventouse 
machine 
 Primary costing, annuitized multiplied by average labour duration  £ 1.32  
   Inco pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500   £ 0.09  
   Urinary Catheter   Taken from NHS supply chain catalogue 2009, page 1551 code FST248, 
£46.69 for pack of 10  
 £ 4.69  
   Gloves   Taken from NHS supply chain catalogue 2009, page 200 code FTE888   £ 4.68  
   Obstetric cream  http://www.shelfpharmacy.co.uk/products/more/KY-Jelly-82g/565.aspx: 
£3.25 for 82g, assumption one third of a tube used 
 £ 1.08  
   Swabbing solution  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 2.5%, in 
industrial methylated spirit, net price 100 mL = 20p. Label: 15 
 £ 0.02  
   Syringe 20ml (if 
not numbed) 
  Taken from NHS supply chain catalogue 2009, page 352 code FWC032   £ 0.10  
   Vial of lignocaine 
(1%) 
  lidocaine hydrochloride 5%, net price 15 g = 88p   £ 0.88  
   Needle (green)   Taken from NHS supply chain catalogue 2009, page 338 code FTR058   £ 0.13  
   Pudendal needle 
(if no epidural) 
  Taken from NHS supply chain catalogue 2009, page 339 code FTR016   £ 4.58  
   Materials for cord 
blood gases: 
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   Heparinised 
syringe*2 
  Taken from NHS supply chain catalogue 2009, page 109 code FWL061  £ 5.67 
   Blood gas 
machine 
 Primary costing - annuitized   £ 0.49  
Total        £ 429.23 
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ASSISTED DELIVERY : FORCEPS 
Staff title and 
grade 
Length of 
time with 
staff 
 Cost (£) of 
staffing  
comments/ 
assumptions and source 
of cost data 
Equipment  comments/ assumptions and source of cost data  Total Cost (£)  
obstetrician  30 mins £ 194.68 PSSRU 2010, page 160 
(surgical consultant) 
Assisted delivery pack   Taken from NHS supply chain catalogue 2009, page 318 code EVX111 (sterile 
single use instrument delivery pack) + EVC019 (pack sterile delivery) + EVI010 
(pack sterile delivery) 
 (pack 8=£73.09) AND page 317 code ECV019 (pack 20=£55.69)  
£ 16.15 
Pediatrician   £ 194.68 PSSRU 2008, page 160 
(surgical consultant) 
Rotational, midcavity or 
wringley forceps 
  Taken from NHS supply chain catalogue 2009, page 233 code FFI562+ FFI563 
 (pack 8=£73.09) AND page 317 code ECV019 (pack 20=£55.69)  
£ 52.36 
Registrar    
 £ 89.75 PSSRU 2008,pg 159 
Inco pads   Taken from NHS supply chain catalogue 2009, page 961 code EAO500  £ 0.09 
 
      Urinary catheter, not a 
retaining one 
  Taken from NHS supply chain catalogue 2009, page 1551 code FST248, 
£46.69 for pack of 10  
£ 4.69 
        Gloves   Taken from NHS supply chain catalogue 2009, page 200 code FTE888  £ 4.68 
        ky jelly  http://www.shelfpharmacy.co.uk/products/more/KY-Jelly-82g/565.aspx: 
£3.25 for 82g, assumption one third of a tube used 
£ 1.08 
        Swabbing solution  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 2.5%, in 
industrial methylated spirit, net price 100 mL = 20p. Label: 15 
£ 0.02 
        Heparinised syringe   Taken from NHS supply chain catalogue 2009, page 352 code FWC032  £ 0.10 
        Syringe 20ml (if not numbed) + 
needle 
  Taken from NHS supply chain catalogue 2009, page 352 code FWC032  £ 0.05 
        Vial of lignocaine (10%)   lidocaine hydrochloride 5%, net price 15 g = 88p  £ 0.88 
        Pudendal needle (if no 
epidural) 
  Taken from NHS supply chain catalogue 2009, page 339 code FTR016  £ 4.58 
        Materials for cord blood gases:  primary costing £ 0.10 
        Heparainised syringe  Injection, prefilled disposable syringe, atropine sulphate 200 micrograms/mL, 
net price 5 mL = £5.90; 300 micrograms/mL, 10 mL = £5.91; 600 
micrograms/mL, 1 mL = £5.91 
£5.91 
        Blood gas machine  primary costing £ 0.10 
Total:     £ 479.11        £ 569.89 
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CESEAREAN SECTION 
Staff title and grade  Cost (£) of staffing  comments/ assumptions 
for costing 
Equipment  Cost (£)  comments/ assumptions for costing  Total Cost (£)  
HCA *1 
 
 £ 14.05  Band 6 mid-point =£27388, 
Base year 2010, 
Assumption- time spent 1 
hour 
Epidural: see previous £ 84.15 THIS EXCLUDES THE PREVIOUS STAFFING COST £ 84.2 
Obstetrician *2  £ 389.36 PSSRU 2010, page 218 
(medical consultant), 
Assumption- time spent 30 
minutes 
Spinal needles  £ 5.91  Injection, prefilled disposable syringe, atropine sulphate 200 
micrograms/mL, net price 5 mL = £5.90; 300 micrograms/mL, 
10 mL = £5.91; 600 micrograms/mL, 1 mL = £5.91 
£ 5.91 
Anesthetist *1  £ 198.68 PSSRU 2010, page 218 
(medical consultant), 
Assumption- time spent 30 
MINUTES 
Skin prep for surgeon 
and patient 
 £ 0.02  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 
2.5%, in industrial methylated spirit, net price 100 mL = 20p. 
Label: 15 
£ 0.02 
ODA *1 (assists 
anaesthetist) 
 £ 89.75 PSSRU 2010, page 218 
(medical consultant), 
Assumption- time spent 30 
MINUTES 
Caesarean section pack  £ 26.08   Taken from NHS supply chain catalogue 2009, page 608 code 
EHC007  
 £ 26.08  
Pediatrician *1  £ 198.68 PSSRU 2010, page 218 
(medical consultant), 
Assumption- time spent 30 
MINUTES 
 
Selection of needles 
 
£ 0.10  Taken from NHS supply chain catalogue 2009, page 337 code 
FTR167, FTR163 and FTR348  
£ 0.10  
   Suction machine, tubing 
and attachment 
 £ 2.07   Taken from NHS supply chain catalogue 2009, page code 
FDR447  
 £ 2.07  
**only included medical staff (excluded runner/ porter) Diathermy sets +pad  £ 3.75   Taken from NHS supply chain catalogue 2009, page 217 code 
FGP799  
 £ 3.75  
   Betadine solution  £ 2.39  povidone–iodine 1.14% in a pressurised aerosol unit, net 
price 50-mL unit = £2.39 
 £ 2.39  
   Surgical spirits  £ 0.02  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 
2.5%, in industrial methylated spirit, net price 100 mL = 20p. 
Label: 15 
 £ 0.02  
   Gloves  £ 4.68   Taken from NHS supply chain catalogue 2009, page 200 code 
FTE888  
 £ 4.68  
   Electronic Mucus 
extractor 
 £ 0.16    £ 0.16  
   Urinary catheter and bag  £ 8.93   Taken from NHS supply chain catalogue 2009, page 1551 
code FSS620, £44.67 for pack of 5  
 £ 8.93  
   Vaginal examination 
pack 
 £ 0.41   Taken from NHS supply chain catalogue 2009, page 324 code 
EVC011  
 £ 0.41  
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Obstetric cream 
 £ 1.08  http://www.shelfpharmacy.co.uk/products/more/KY-Jelly-
82g/565.aspx: £3.25 for 82g, assumption one third of a tube 
used 
 £ 1.08  
   Inco pads  £ 0.09   Taken from NHS supply chain catalogue 2009, page 961 code 
EAO500  
 £ 0.09  
C/S CONT….       
   Sanitary towels  £ 0.09   Taken from NHS supply chain catalogue 2009, page 961 code 
EAO500  
 £ 0.09  
   Razor  £ 0.15   Taken from NHS supply chain catalogue 2009, page 219 code 
MRA033  
 £ 0.15  
   Tape, to go over jewellery   
   Hospital gown  £ 1.36   Taken from NHS supply chain catalogue 2009, page 410 code 
BWK201  
 £ 1.36  
   Support stockings  £ 1.04   Taken from NHS supply chain catalogue 2009, page 293 code 
FFF171  
 £ 1.04  
     £ 5.44   Taken from NHS supply chain catalogue 2009, page 410 code 
EGD192  
 £ 5.44  
   Materials for cord blood 
gases: 
 £ 2.14   Taken from NHS supply chain catalogue 2009, page 344 code 
FWC124  
 £ 2.14  
   Heparainised syringe  £ 5.91  Injection, prefilled disposable syringe, atropine sulphate 200 
micrograms/mL, net price 5 mL = £5.90; 300 micrograms/mL, 
10 mL = £5.91; 600 micrograms/mL, 1 mL = £5.91 
 £ 5.91  
   Spencer Wells forceps  included in packs   included in packs  
   Blood gas machine    
   4 sutures  £ 3.20  Taken from Barkantine purchase report 24/11/09  £ 3.20  
   needle protector pad  £ 0.33   Taken from NHS supply chain catalogue 2009, page 122 code 
KFK310  
 £ 0.33  
   sterile bed liner  £ 0.04   Taken from NHS supply chain catalogue 2009, page 674 code 
FDE384  
 £ 0.04  
   sterile water 1 litre  £ 2.55   Taken from NHS supply chain catalogue 2009, page 674 code 
FDE384  
 £ 2.55  
       
TOTAL  £ 890.52   £162.08   £ 1052.60 
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SUTURING EPISIOTOMY 
Staff title and grade Length of time with staff  Cost (£)  Comments/ assumptions for costing Total 
MW, band 6 or 7 
(NOT INCLUDED) 
60 minutes Perineal suture pack  £ 12.26   Taken from NHS supply chain catalogue 2009, page 319 code 
EVX122  
 £ 12.26  
  Selection of threads, vicryl sutures 2.0 rapide 
*2 
 £ 3.20  Taken from Barkantine purchase report 24/11/09  £ 3.20  
  Inco pads  £ 0.09   Taken from NHS supply chain catalogue 2009, page 961 code 
EAO500  
 £ 0.09  
  Swabbing solution  £ 0.02  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 
2.5%, in industrial methylated spirit, net price 100 mL = 20p. 
Label: 15 
 £ 0.02  
  Gloves  £ 0.20   Taken from NHS supply chain catalogue 2009, page 195 code 
FTE883  
 £ 0.20  
  Syringe 20ml if not numbed + needles  £ 0.05   Taken from NHS supply chain catalogue 2009, page 352 code 
FWC031  
 £ 0.05  
  1% 10 ml lignocaine  £ 0.88   lidocaine hydrochloride 5%, net price 15 g = 88p   £ 0.88  
  lighting source    
  gown   £ 1.36   Taken from NHS supply chain catalogue 2009, page 410 code 
BWK201  
 £ 1.36  
  Tray  £ 4.63   Taken from NHS supply chain catalogue 2009, page 143 code 
ij3097  
£ 4.63 
  lithohony set  £ 6.51   Taken from NHS supply chain catalogue 2009, page 387 code 
VJD782  
 £ 6.51  
Total       £ 24.57  
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SUTURING FIRST AND SECOND DEGREE TEAR 
 
Staff title and grade Length of time with staff Equipment  Cost (£)  Comments/ assumptions for costing  Total  
MW, band 6 or 7  30 - 45 mins     
  delivery pack (PS pack FMU)  £ 12.26   Taken from NHS supply chain catalogue 2009, page 319 code 
EVX122  
 £ 12.26  
  Selection of threads : Vicryl 2.0  £ 3.20  Taken from Barkantine purchase report 24/11/09  £ 3.20  
  10 ml 1% lignocaine  £ 0.88   lidocaine hydrochloride 5%, net price 15 g = 88p   £ 0.88  
  Gloves  £ 0.20   Taken from NHS supply chain catalogue 2009, page 195 code 
FTE883  
 £ 0.20  
  Syringe 20ml + needles  £ 0.05   Taken from NHS supply chain catalogue 2009, page 352 code 
FWC031  
 £ 0.05  
  Tray  £ 4.63   Taken from NHS supply chain catalogue 2009, page 143 code 
ilj3097  
 £ 4.63  
  Swabs  £ 0.06   Taken from NHS supply chain catalogue 2009, page 769 code 
HHD090  
 £ 0.06  
TOTAL     £21.28 
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SUTURING THIRD AND FOURTH DEGREE TEAR 
Staff title and grade Length of time with 
staff 
Cost Equipment  Cost (£)  comments/ assumptions for costing  Total  
Consultant obstetrician  45 mins £ 175.21 Perineal suture pack   £ 12.26   Taken from NHS supply chain catalogue 2009, page 319 code 
EVX122  
 £ 12.26  
Registrar 45 mins £ 134.61 Selection of sutures: 
PDS + vicryl 2.0 
 £ 3.20  Taken from Barkantine purchase report 24/11/09  £ 3.20  
Anaesthetist 45 mins £ 175.21 SPINAL  £ 67.41    £ 67.41  
scrub nurse 45 mins £ 13.95 urinary catheter (if 
needed) 
 £ 1.91   Taken from NHS supply chain catalogue 2009, page 1551 
code FSS394  
 £ 1.91  
   Catheter bag  £ 8.93   Taken from NHS supply chain catalogue 2009, page 1551 
code FSS620, £44.67 for pack of 5  
 £ 8.93  
   10mls syringe  £ 0.05   Taken from NHS supply chain catalogue 2009, page 352 code 
FWC031  
 £ 0.05  
   Water  £ 2.55   Taken from NHS supply chain catalogue 2009, page 134 code 
VMC019  
 £ 2.55  
       
Total   £ 498.98   £ 96.31   £595.30 
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MANUAL REMOVAL OF THE PLACENTA 
Staff title and grade Length of time 
with staff 
Cost Equipment  Cost (£)   Source   Total  
Extra MW band 6 or 7  30 - 60 mins £ 60.98 Theatre greens 
and shoes 
 £ 0.09   Taken from NHS supply chain catalogue 2009, page 479 code 
BWT028  
 £ 0.09  
Consultant obstetrician  45 mins £ 175.21 Sterile 
field/drapes 
 £ 3.93   Taken from NHS supply chain catalogue 2009, page 479 code 
BWP053  
 £ 3.93  
Registrar 45 mins £ 134.61 MRP 
pack/uterine 
pack 
 £ 16.15   Taken from NHS supply chain catalogue 2009, page 318 code 
EVX111 (sterile single use instrument delivery pack) + EVC019 
(pack sterile delivery) + EVI010 (pack sterile delivery) 
(pack 8=£73.09) AND page 317 code ECV019 (pack 
20=£55.69)  
 £ 16.15  
Anaesthetist 45 mins £ 175.21 Urinary 
catheter 
 £ 8.93   Taken from NHS supply chain catalogue 2009, page 1551 
code FSS620, £44.67 for pack of 5  
 £ 8.93  
scrub nurse 45 mins £ 13.95 Perineal suture 
pack 
 £ 12.26   Taken from NHS supply chain catalogue 2009, page 319 code 
EVX122  
 £ 12.26  
   Long gloves  £ 4.68   Taken from NHS supply chain catalogue 2009, page 200 code 
FTE888  
 £ 4.68  
   Cleaning fluid  £ 0.02  BNF: methyl salicylate 0.5 mL, diethyl phthalate 2%, castor oil 
2.5%, in industrial methylated spirit, net price 100 mL = 20p. 
Label: 15 
 £ 0.02  
   Antibiotics  £ 15.04  Primary costing of AP  £ 15.04  
   Syntocinon 
Infusion 
£ 0.86  oxytocin, net price 5 units/mL, 1-mL amp = 76p; 10 units/mL, 
1-mL amp = 86p  
£ 0.86 
   SPINAL  £ 67.41    £ 67.41  
Total:  £ 559.96   £ 129.36    £ 689.32 
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BLOOD TRANSFUSION 
Staff title and 
grade 
 Cost (£) of staffing  comments/ assumptions for 
costing 
Equipment  Cost (£)    Total  
Obstetrician  £ 38.94  PSSRU 2010, page 218 (medical 
consultant),, Assumption- time 
spent 10 MINUTES 
Cross matching at path lab £ 43.34 Primary Cost data collection: Pricing of blood and red blood 
cell for 2020 
£ 43.34 
Anesthetist  £ 38.94  PSSRU 2010, page 218 (medical 
consultant),, Assumption- time 
spent 10 MINUTES 
Blood tubes £ 0.46  Taken from NHS supply chain catalogue 2009, page 113 code 
KFK294  
£ 0.46 
   Blood bottles £ 0.41  Taken from NHS supply chain catalogue 2009, page 113 code 
KFK395  
£ 0.41 
   Syringe/needle £ 0.05  Taken from NHS supply chain catalogue 2009, page 352 code 
FWC032  
 £ 0.05  
   Swabs  £ 0.06   Taken from NHS supply chain catalogue 2009, page 769 code 
HHD090  
 £ 0.06  
   Giving sets  £ 0.36   Taken from NHS supply chain catalogue 2009, page 56 CODE 
FSB531  
 £ 0.36  
   Filters  £ 4.62   Taken from NHS supply chain catalogue 2009, page 142 
CODE FTC235  
 £ 4.62  
   Venflon  £ 0.83   Taken from NHS supply chain catalogue 2009, page 59 code 
FSP033  
 £ 0.83  
   Sterile dressing  £ 0.13   Taken from NHS supply chain catalogue 2009, page 764 code 
EHU019  
 £ 0.13  
   IV infusion  £ 15.04  primary costing  £ 15.04  
   Fluids  £ 2.01  intravenous infusion, usual strength sodium chloride 0.9% (9 
g, 150 mmol each of Na+ and Cl-/litre), this strength being 
supplied when normal saline for injection is requested. Net 
price 2-mL amp = 35p; 5-mL amp = 42p; 10-mL amp = 57p; 20-
mL amp = £1.04; 50-mL amp = £2.01 
 £ 2.01  
   Blood packs  167.31 for intra-
uterine 
transfusion of red 
cells, £330.30 for 
platelets 
Primary Cost data collection: Pricing of blood and red blood 
cell for 2020167.31 for intra-uterine transfusion of red cells, 
£330.30 for platelets 
167.31 for intra-
uterine 
transfusion of red 
cells, £330.30 for 
platelets 
Total :  £ 77.87    £ 67.32  £145.19 plus 
units of cells 
transfused 
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STILLBIRTH AND NEONATAL DEATH   
Procedures  Details Cost (£)  Comments/ assumptions for costing 
    
Real time ultrasonography 
Post-mortem / Autopsy 
   RCOG Greentop guidelines 55  
Real time ultrasonography 
Post-mortem / Autopsy 
͞ďaďǇgraŵ ďǇ faǆitroŶ, geŶetiĐ testiŶg, ŵiĐro, histo aŶd 
placenta (usually around 30 blocks total for a 
SB+placenta), it's a consultant led service in most depts, 
so factor in the cost of a consultant-takes about 2-3 
hours to do the PM, and about an hour to report, 
probably more, so that's one full session of consultant 
time. Cost of an MTO, cost of laď BM“ proĐessiŶg...͟ 
£600  Primary costing from the Royal College of Pathologists  
Total     
 
COUNSELLING ASSISTANCE 
   
Hospital bereavement midwife or counsellor: salary Assumption made Unit cost Source of Unit cost 
 Direct patient contact time of 1 hour  SANDS: Stillbirth and Neonatal Death Charity: primary costing : 
discussion about the availability of bereavement care following 
a baby death 
 
RCOG Greentop guidelines 55 
Band 7 mid at £35184, Base year 2009/2010 Agenda for change January to March 2010 NHS Staff Earnings 
estimates. 
£44 per hour direct contact PSSRU: Unit costs of Health and Social care 2010 
Salary oncosts: £8698 per annum (Employer's NI plus 14% superannuation)  
Qualifications: £4801 per annum 
 
Education investment cost annuitied over working life 
Overheads: £4388 per annum Indirect staffing /administration overheads 
Working time: 41.4 weeks per annum 37.5 hours per week. 
 
Includes: 29 days A/L. 8 days statutory leave. 5 study days. 12 days sick leave. 
TOTAL: £ 644  
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Appendix 7 Resource use measurement 
Table 24. Resource use during intrapartum caree 
 
Resource use variable OU 
n=18847 
Home 
n=16187 
FMU 
n=10971 
AMU 
n=16031 
HOME     
Homebirth packs 0.0 (0.0) 1.0 0.0 (0.0) 0.0 (0.0) 
Staff travel to homebirth – 
distance 23 miles return trip 
0.0 (0.0) 1.0 0.0 (0.0) 0.0 (0.0) 
     
ALL ͚non-OU͛ units     
Duration of labour care prior 
to transfer (hours) 0.0 (0.0) 1.20
¥
 ( 2.92) 1.45
¥
 (3.36 ) 1.72
¥
 (3.61) 
Transfer duration (hours) 0.0 (0.0) 0.10
§ 
(0.24) 0.13
§ 
(0.27) 0.05
§ 
( 0.12) 
Mode of transfer     
Ambulance 0.0 (0.0) 0.17 ( 0.38) 0.21 (0.41) 0.0 (0.0) 
Private car 0.0 (0.0) 0.031 (0.17) 0.005 (0.069) 0.0013 (0.0036) 
Wheelchair or trolley 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.21 (0.41) 
Bed 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.021 0.143 
Rapid response ambulance 
car 
0.0 (0.0) 0.00025 (0.016) 0.0 (0.0) 0 .0 (0.0) 
Helicopter 0.0 (0.0) 0.00006 (0.008) 0.0 (0.0) 0.0 (0.0) 
Taxi 0.0 (0.0) 0.0003 (0.019) 0.00009 (0.0009) 0.0 (0.0) 
No physical transfer 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0011 (0.034) 
     
Duration of labour care after 
transfer (hours) 
0.0 (0.0) 1.46 
€
 (3.71) 1.45
€
 (3.58) 1.81
€
 (4.01) 
     
ALL UNITS     
Duration of labour care from 
start to finish if no transfer 
(hours) 
9.01 (6.22) 6.61 (5.31) 7.49 (5.68) 7.92 (5.92) 
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e Values are given as means (standard deviations). Where numbers are extremely small 
they are shown to up to 5 decimal places, otherwise to three decimal places to 
reflect consistency in presentation of the results with the prospective cohort 
study. Includes all ‘low risk’ women where the primary outcome and potential 
confounders are not missing. n = 62036 
¥ when women who were not transferred from their planned place of birth were excluded 
from this analysis: duration of labour care (hours) prior to transfer was calculated 
as: 5.71 (home), 6.68 (FMU), 6.5 (AMU) 
§ when women who were not transferred from their planned place of birth were excluded 
from this analysis: duration of transfer (hours) was calculated as: 0.487 (home), 
0.592 (FMU), 0.175 (AMU) which is 29 minutes (home), 35 minutes (FMU) and 10 
minutes (AMU) respectively 
Resource use variable OU 
n=18847 
Home 
n=16187 
FMU 
n=10971 
AMU 
n=16031 
Mode of birth     
Spontaneous vertex birth 0.738 (0 .49) 0.928 (0.31) 0.907 (0.29) 0.859 (0.47) 
Vaginal breech birth 0.002 (0.04) 0.004 ( 0.06) 0.004 ( 0.058) 0.002 ( 0.03) 
Ventouse 0.081 (0.26) 0.021 ( 0.14) 0.027 (0.16) 0.048 (0.21) 
Forceps 0.068 (0.24) 0.021 (0 .15) 0.029 (0 .17) 0.047 (0.20) 
Caesarean section 0.11.1 (0.31) 0.028 (0 .16) 0.035 ( 0.18) 0.044 ( 0.36) 
 
Procedures related to intrapartum care 
Augmentation 
 
 
0.235 (0.42) 
 
 
0.054 (0 .23) 
 
 
0.071 ( 0 .26) 
 
 
0.103 (0 .30) 
Epidural/Spinal 0.307 ( 0.45) 0.083 (0.27) 0.106 (0.31) 0.153 (0.35) 
General Anaesthetic 0.015 (1.12) 0.005 (0.067) 0.005 (0.073) 0.006 (0.07) 
Active Management of the 
third stage of labour 
0.939 (0.23) 0.687 (0.46) 0.779 (0.42) 0.859 (0.46) 
Episiotomy 0.193 (0.39) 0.054 (0.23) 0.086 (0.28) 0.131 (0.33) 
Perineal trauma 0.032 (0.17) 0.19 (0.14) 0.023 (0.14) 0.032 (0.17) 
ECMO 0.0001 (0.014) 0.00018 ( 0.002) 0.00018 (0.19) 0.00049 ( 0.04) 
Total body cooling 0.0005 (0.02) 0.00045 (0.02) 0.00032 ( 0.02) 0.00031 ( 0.017) 
Care for a stillbirth 0.0002 (0.012) 0.0003 (0.018) 0.0004 (0.019) 0.0001 ( 0.007) 
Neonatal death 0.0003 (0.017) 0.0003 (0.027) 0.0004 (0.02) 0.0001 ( 0.0176) 
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€
 when women who were not transferred from their planned place of birth were excluded 
from this analysis: duration of labour care (hours) after transfer was calculated 
as: 6.8 (home), 6.6 (FMU), 6.89 (AMU) 
Table 20 (cont). Resource use during intrapartum care 
Resource use variable OU 
n=18847 
Home 
n=16187 
FMU 
n=10971 
AMU 
n=16031 
HIGHER LEVEL OF POST NATAL CARE FOR MOTHER 
 
Postnatal care (hours) 30.8 (22.7) 4.47 (14.4) 32.11 (25.4) 25.7 (20.3) 
 
High dependency care 
following birth provided 
within the labour ward (days) 
0.18 (0.38) 0.05 (0.23) 0.07 (0.26) 0.09 (0.29) 
Admission to intensive care 
unit (days) 
0.002 (0.034) 0.0009 (0.036) 0.0007 (0.021) 0.001 (0.023) 
Admission to high 
dependency unit (days) 
0.0057 (0.09) 0.003 (0.077) 0.0035 (0.101) 0.0038 (0.0062) 
Admission to specialist care 
(days) 
0.002 (0.003) 0.0009 (0.036) 0.0007 (0.0021)  0.0010 (0.0023) 
     
HIGHER LEVEL OF CARE FOR THE BABY 
 
Admission to neonatal 
intensive care unit (days) 
0.01 (0.24) 0.01 (0.246) 0.007 (0.210) 0.009 (0.329) 
Admission to neonatal high 
dependency unit (days) 
0.01 (0.376) 0.006 (0.229) 0.012 (0.312 0.007 (0.209) 
Admission to neonatal 
specialist care (days) 
0.094 (0.873) 0.0537 (0.616) 0.057 (0.785) 0.058 (0.801) 
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Addendum 
The Birthplace in England Research Programme combines the Evaluation of 
Maternity Units in England (EMU) study funded in 2006 by the National 
Institute for Health Research Service Delivery and Organisation (NIHR SDO) 
programme, and the Birth at Home study in England, funded in 2007 by the 
Department of Health Policy Research Programme (DH PRP). This 
document is part of a suite of reports representing the combined output 
from this jointly funded research. Should you have any queries please 
contact Sdoedit@southampton.ac.uk 
 
 
